
<html lang="en"     class="pb-page"  data-request-id="2c1add6f-91a1-48aa-978d-6e93afb5877a"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2012.55.issue-3;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm200720n"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity" /></meta><meta name="dc.Creator" content="Brent D. G.  Page" /></meta><meta name="dc.Creator" content="Haytham  Khoury" /></meta><meta name="dc.Creator" content="Rob C.  Laister" /></meta><meta name="dc.Creator" content="Steven  Fletcher" /></meta><meta name="dc.Creator" content="Megan  Vellozo" /></meta><meta name="dc.Creator" content="Alessia  Manzoli" /></meta><meta name="dc.Creator" content="Peibin  Yue" /></meta><meta name="dc.Creator" content="James  Turkson" /></meta><meta name="dc.Creator" content="Mark D.  Minden" /></meta><meta name="dc.Creator" content="Patrick T.  Gunning" /></meta><meta name="dc.Description" content="A growing body of evidence shows that Signal Transducer and Activator of Transcription 5 (STAT5) protein, a key member of the STAT family of signaling proteins, plays a pivotal role in the progress..." /></meta><meta name="Description" content="A growing body of evidence shows that Signal Transducer and Activator of Transcription 5 (STAT5) protein, a key member of the STAT family of signaling proteins, plays a pivotal role in the progress..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 13, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm200720n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm200720n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm200720n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm200720n" /></link>
        
    
    

<title>Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm200720n" /></meta><meta property="og:title" content="Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0010.jpeg" /></meta><meta property="og:description" content="A growing body of evidence shows that Signal Transducer and Activator of Transcription 5 (STAT5) protein, a key member of the STAT family of signaling proteins, plays a pivotal role in the progression of many human cancers, including acute myeloid leukemia and prostate cancer. Unlike STAT3, where significant medicinal effort has been expended to identify potent direct inhibitors, Stat5 has been poorly investigated as a molecular therapeutic target. Thus, in an effort to identify direct inhibitors of STAT5 protein, we conducted an in vitro screen of a focused library of SH2 domain binding salicylic acid-containing inhibitors (∼150) against STAT5, as well as against STAT3 and STAT1 proteins for SH2 domain selectivity. We herein report the identification of several potent (Ki &lt; 5 μM) and STAT5 selective (&gt;3-fold specificity for STAT5 cf. STAT1 and STAT3) inhibitors, BP-1-107, BP-1-108, SF-1-087, and SF-1-088. Lead agents, evaluated in K562 and MV-4-11 human leukemia cells, showed potent induction of apoptosis (IC50’s ∼ 20 μM) which correlated with potent and selective suppression of STAT5 phosphorylation, as well as inhibition of STAT5 target genes cyclin D1, cyclin D2, C-MYC, and MCL-1. Moreover, lead agent BP-1-108 showed negligible cytotoxic effects in normal bone marrow cells not expressing activated STAT5 protein. Inhibitors identified in this study represent some of the most potent direct small molecule, nonphosphorylated inhibitors of STAT5 to date." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm200720n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm200720n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm200720n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm200720n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm200720n&amp;href=/doi/10.1021/jm200720n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1047-1055</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201310y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2009088" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brent+D.+G.++Page">Brent D. G. Page</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haytham++Khoury">Haytham Khoury</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rob+C.++Laister">Rob C. Laister</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Fletcher">Steven Fletcher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Megan++Vellozo">Megan Vellozo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessia++Manzoli">Alessia Manzoli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peibin++Yue">Peibin Yue</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Turkson">James Turkson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+D.++Minden">Mark D. Minden</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+T.++Gunning">Patrick T. Gunning</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, University of Toronto, 3359 Mississauga Road North, Mississauga, ON, L5L 1C6, Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Princess Margaret Hospital, Ontario Cancer Institute, 610 University Avenue, Toronto, ON M5G 2M9, Canada</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Molecular Biology and Microbiology, Burnett College of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826, United States</span></div><div class="corresp-info"><strong>*</strong>Department of Chemical and Physical Sciences, University of Toronto, Mississauga, 3359 Mississauga Road North, Mississauga, ON, L5L 1C6 Canada. Tel: 905-828-5354. Fax: 905-569-5425. E-mail: <a href="/cdn-cgi/l/email-protection#03736277716a60682d64766d6d6a6d644376776c716c6d776c2d6062"><span class="__cf_email__" data-cfemail="1e6e7f6a6c777d7530796b70707770795e6b6a716c71706a71307d7f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm200720n&amp;href=/doi/10.1021%2Fjm200720n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1047–1055</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 9, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 June 2011</li><li><span class="item_label"><b>Published</b> online</span>13 January 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 February 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm200720n" title="DOI URL">https://doi.org/10.1021/jm200720n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1047%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBrent%2BD.%2BG.%2BPage%252C%2BHaytham%2BKhoury%252C%2BRob%2BC.%2BLaister%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D3%26contentID%3Djm200720n%26title%3DSmall%2BMolecule%2BSTAT5-SH2%2BDomain%2BInhibitors%2BExhibit%2BPotent%2BAntileukemia%2BActivity%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1055%26publicationDate%3DFebruary%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm200720n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3703</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">65</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm200720n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Brent&quot;,&quot;last_name&quot;:&quot;D. G. Page&quot;},{&quot;first_name&quot;:&quot;Haytham&quot;,&quot;last_name&quot;:&quot;Khoury&quot;},{&quot;first_name&quot;:&quot;Rob&quot;,&quot;last_name&quot;:&quot;C. Laister&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Fletcher&quot;},{&quot;first_name&quot;:&quot;Megan&quot;,&quot;last_name&quot;:&quot;Vellozo&quot;},{&quot;first_name&quot;:&quot;Alessia&quot;,&quot;last_name&quot;:&quot;Manzoli&quot;},{&quot;first_name&quot;:&quot;Peibin&quot;,&quot;last_name&quot;:&quot;Yue&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Turkson&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;D. Minden&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;T. Gunning&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;1047-1055&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm200720n&quot;},&quot;abstract&quot;:&quot;A growing body of evidence shows that Signal Transducer and Activator of Transcription 5 (STAT5) protein, a key member of the STAT family of signaling proteins, plays a pivotal role in the progression of many human cancers, including acute myeloid leukemia and prostate cancer. Unlike STAT3, where significant medicinal effort has been expended to identify potent direct inhibitors, Stat5 has been poorly investigated as a molecular therapeutic target. Thus, in an effort to identify direct inhibitors of STAT5 protein, we conducted an in vitro screen of a focused library of SH2 domain binding salicylic acid-containing inhibitors (∼150) against STAT5, as well as against STAT3 and STAT1 proteins for SH2 domain selectivity. We herein report the identification of several potent (Ki &lt; 5 μM) and STAT5 selective (&gt;3-fold specificity for STAT5 cf. STAT1 and STAT3) inhibitors, BP-1-107, BP-1-108, SF-1-087, and SF-1-088. Lead agents, evaluated in K562 and MV-4-11 human leukemia cells, showed potent induction of apoptosis (I&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200720n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200720n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200720n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200720n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm200720n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200720n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm200720n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm200720n&amp;href=/doi/10.1021/jm200720n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm200720n" /></input><a href="/doi/pdf/10.1021/jm200720n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm200720n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm200720n%26sid%3Dliteratum%253Aachs%26pmid%3D22148584%26genre%3Darticle%26aulast%3DPage%26date%3D2012%26atitle%3DSmall%2BMolecule%2BSTAT5-SH2%2BDomain%2BInhibitors%2BExhibit%2BPotent%2BAntileukemia%2BActivity%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D3%26spage%3D1047%26epage%3D1055%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jmcmar.2012.55.issue-3/production/jmcmar.2012.55.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A growing body of evidence shows that Signal Transducer and Activator of Transcription 5 (STAT5) protein, a key member of the STAT family of signaling proteins, plays a pivotal role in the progression of many human cancers, including acute myeloid leukemia and prostate cancer. Unlike STAT3, where significant medicinal effort has been expended to identify potent direct inhibitors, Stat5 has been poorly investigated as a molecular therapeutic target. Thus, in an effort to identify direct inhibitors of STAT5 protein, we conducted an <i>in vitro</i> screen of a focused library of SH2 domain binding salicylic acid-containing inhibitors (∼150) against STAT5, as well as against STAT3 and STAT1 proteins for SH2 domain selectivity. We herein report the identification of several potent (<i>K</i><sub>i</sub> < 5 μM) and STAT5 selective (>3-fold specificity for STAT5 cf. STAT1 and STAT3) inhibitors, <b>BP-1-107</b>, <b>BP-1-108</b>, <b>SF-1-087</b>, and <b>SF-1-088</b>. Lead agents, evaluated in K562 and MV-4-11 human leukemia cells, showed potent induction of apoptosis (IC<sub>50</sub>’s ∼ 20 μM) which correlated with potent and selective suppression of STAT5 phosphorylation, as well as inhibition of STAT5 target genes <i>cyclin D1</i>, <i>cyclin D2</i>, <i>C-MYC</i>, and <i>MCL-1</i>. Moreover, lead agent <b>BP-1-108</b> showed negligible cytotoxic effects in normal bone marrow cells not expressing activated STAT5 protein. Inhibitors identified in this study represent some of the most potent direct small molecule, nonphosphorylated inhibitors of STAT5 to date.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>∥</span> Author Contributions</h4><p class="last">These authors contributed equally to this work.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15676" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15676" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Signal Transducers and Activators of Transcripion (STAT) family of proteins play important and diverse cell signaling and transcriptional roles in cells. STAT signaling is transiently activated in normal cells and is deactivated by a number of different cytosolic and nuclear regulators, including phosphatases, SOCS, PIAS, and proteasomal degradation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Of the seven STAT isoforms (STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, and STAT6), STAT3 and STAT5 have gained notoriety for their aberrant role in human cancers and tumorigenesis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Abnormal STAT5 activity has been found in many cancers, including those of the breast, liver, prostate, blood, skin, head, and neck.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Because of their similar structures and function (93% sequence homology),<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> we will use the term STAT5 to mean both STAT5a and STAT5b and will use the specific notation of STAT5a or STAT5b when referring to a specific isoform of the STAT5 protein. Despite significant evidence implicating STAT5's causal role in human malignancies, there has been very little progress in identifying small molecule inhibitors of STAT5 function. The majority of medicinal research on STAT function in transformed cells has been aimed at identifying an inhibitor of STAT3 protein. As a result, several direct inhibitors of STAT3 including peptidomimetics, small molecules, and oligonucleotide-based inhibitors have entered preclinical trials as a STAT3-targeting therapeutic.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> Progress toward a potent and direct inhibitor of STAT5 function for the treatment of human malignancies has been disappointingly limited.</div><div class="NLM_p">STAT5 activation involves a complex signaling cascade beginning at the cell surface. Stimulation by growth factors such as Kit ligand/Stem Cell Factor, erythropoietin, or prolactin results in receptor dimerization and activation of STAT5 by intracellular kinases such as Janus Kinases (JAKs).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In addition, oncogenes such as BCR-ABL and FLT3-ITD induce activation of STAT5. Phosphorylation of the receptor’s cytoplasmic tail provides docking sites for recruitment of monomeric, nonphosphorylated STAT5 proteins via their SH2 domain. Activated tyrosine kinases, such as JAK2 phosphorylate recruited STAT5 proteins at a specific tyrosine near the carboxy terminus (Tyr694 in STAT5a and Tyr699 in STAT5b). Phosphorylated STAT5 (pSTAT5) protein is released from the receptor, and dimerization occurs through reciprocal phosphotyrosine–SH2 domain interactions. Phosphorylation of a serine residue then allows the STAT5 dimers to translocate to the nucleus where STAT5 binds to a consensus DNA sequence and promotes gene expression.<a onclick="showRef(event, 'ref2 ref7'); return false;" href="javascript:void(0);" class="ref ref2 ref7">(2, 7)</a></div><div class="NLM_p">In cancer cells, STAT5 is routinely constitutively phosphorylated which leads to the aberrant expression of STAT5 target genes resulting in malignant transformation. Cancer cells harboring persistently activated STAT5 overexpress antiapoptotic proteins such as BCL-XL, MYC, and MCL-1, conferring significant resistance to natural apoptotic cues and administered chemotherapeutic agents.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Of particular interest, STAT5 has been identified as a key regulator in the development and progression of acute myelogenic (AML) and acute lymphoblastic leukemias (ALL).<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> Moreover, inhibitors of upstream STAT5 activators (such as JAK and FLT3) have been shown to exhibit promising anticancer properties.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> However, a shortcoming of tyrosine kinase inhibitors, and other upstream effectors of kinase activity, is the disruption of multiple downstream signaling pathways, increasing the likelihood of undesirable toxicity. In addition, it is possible that other proteins in the malignant cell may also be activating STAT5; this signaling would not be affected by an upstream-targeted inhibitor. Therefore, silencing a downstream signaling target such as STAT5 would ultimately result in fewer side effects and would thus represent a more attractive candidate for a molecularly targeted drug for the treatment of human cancers harboring aberrant STAT5 activity.</div><div class="NLM_p">To date, inhibition of STAT function has been achieved through <i>N</i>-terminal domain binders, DNA binding domain-targeting oligonucleotides, and most popularly, SH2 domain binders that block STAT phosphorylation, dimerization, and target gene expression.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> However, the vast majority of medicinal chemistry effort has been conducted against STAT3 and not against STAT5. To the best of our knowledge, only one family of chromone-based STAT5 SH2 domain binding small molecules has been identified as being direct inhibitors of STAT5 activity <i>in vitro</i>.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In this work, Berg and co-workers identified several small molecule chromone-based compounds that potently bound to STAT5's SH2 domain, as assessed by a competitive STAT5 fluorescence polarization (FP) assay and by <i>in silico</i> docking studies.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, despite promising <i>in vitro</i> disruption of STAT5/phosphopeptide interactions (IC<sub>50</sub> ∼15–50 μM), much higher concentrations of inhibitor were required to elicit the inhibition of STAT5 activation in lymphoma whole cells (100–200 μM).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thus, while STAT5 remains a highly appealing and validated molecular target, the discovery of a potent STAT5 inhibitor with <i>in vivo</i> efficacy has yet to be achieved.</div><div class="NLM_p last">Thus, in an effort to identify potent and direct inhibitors of STAT5 function, we have investigated the application of small molecule scaffolds targeting STAT5′s SH2 domain to disrupt STAT5 signaling and the expression of STAT5 gene targets. Through an <i>in silico</i> screening of a National Cancer Institute library of compounds, we identified compounds containing salicylic acid as being effective SH2 domain binders, likely a result of effective phosphotyrosine mimicry.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a><i>In silico</i> docking with GOLD software showed the salicylic component making binding interactions with the key pTyr binding pocket. Upon the basis of the salicylic acid moiety, we constructed a library of rationally designed SH2 domain binders targeting STAT3's SH2 domain.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> As previously reported, this SAR study yielded a number of potent STAT3 inhibitors, including <b>SF-1-066</b>,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> which was shown to potently inhibit STAT3 function <i>in vitro</i> and in <i>in vivo</i> models of breast cancer.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Given that each inhibitor in the family possessed an SH2 binding salicylic moiety, we reasoned that our library of privileged structures could contain potent STAT5 binding agents. Thus, we screened our library of ∼150 compounds for <i>in vitro</i> STAT5 SH2 domain binding activity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The library was subjected to a high-throughput STAT5b FP assay to determine binding affinity for the STAT5b SH2 domain.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This competitive assay is based upon the small molecule-mediated displacement of a STAT5-SH2 domain binding 5-carboxyfluorescein-labeled (F*) erythropoietin phosphopeptide, F*-GpYLVLDKW from the STAT5b-SH2 domain, wherein the unbound F*-GpYLVLDKW results in reduced polarization of the emitted fluorescence due to a higher mobility of the unbound phosphopeptide fluorophore. The library was first screened for activity against STAT5b at 25 and 50 μM, and compounds eliciting potent activity at <25 μM were further evaluated to determine <i>K</i><sub>i</sub> values and STAT specificity. The most potent STAT5b inhibitors identified were subjected to previously described STAT1<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and STAT3<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> FP assays. The STAT5, STAT3, and STAT1 <i>K</i><sub>i</sub> values are reported in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparative STAT Isoform Selectivity Data (<i>K</i><sub>i</sub> Values, μM) as Assessed by STAT5, STAT3 and STAT1 FP Assays</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0009.gif" alt="" id="GRAPHIC-d4761e401-autogenerated" /></img><div></div></div><div class="NLM_p">First, as a negative control, we evaluated <b>SF-1-066</b>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> a previously reported, potent and selective STAT3 protein inhibitor. Unsurprisingly, <b>SF-1-066</b> showed no inhibitory effect against STAT5b or STAT1 phosphopeptide binding (<i>K</i><sub>i</sub>’<i>s</i> > 25 μM). More generally, and most encouragingly, out of the approximately 150 compounds screened in parallel, we identified a number of lead compounds including, <b>BP-1-075</b>, <b>BP-1-122</b>, <b>SF-2-096</b>, <b>BP-1-107</b>, <b>BP-1-108</b>, <b>BP-1-111</b>, <b>BP-1-122</b>, <b>SF-1-087</b>, and <b>SF-1-088</b> that showed impressive STAT5b binding affinity (<i>K</i><sub>i</sub>’<i>s</i> < 10 μM). Next, lead compounds were subjected to FP binding assays for both STAT3 and STAT1 affinity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>., and <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). Encouragingly, of the 10 lead compounds, six agents, <b>BP-1-107</b>, <b>BP-1-108</b>, <b>SF-1-087</b>,<b> BP-1-111</b>, and <b>SF-1-088</b> showed promising STAT5b specificity (2–3-fold specificity). Most notably, <b>BP-1-108</b>, <b>SF-1-088</b>, and <b>BP-1-111</b> exhibited the highest selectivity for STAT5b (∼3-fold specificity for STAT5 cf. STAT1 and STAT3). While <b>BP-1-075</b>, incorporating a large substituted terphenyl R group, was a potent binder of STAT5b (<i>K</i><sub>i</sub> = 3.8 μM), we determined that it was equipotent against both STAT1 (<i>K</i><sub>i</sub> = 3.2 μM), a tumor suppressor gene,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and STAT3 (<i>K</i><sub>i</sub> = 2.8 μM). Moreover, the structurally similar <b>BP-2-122</b>, showed similar STAT5b potency (<i>K</i><sub>i</sub> = 4.8 μM) as well as limited STAT isoform selectivity (<2 fold). Structurally, STAT5b inhibitors generally contained a bulky and, in most cases, hydrophobic R substituent (cyclohexylbenzyl, terphenyl or a substituted benzyl piperidyl). However, of note, <b>SF-1-088</b>, incorporating the smallest R and R′ substituent, an <i>N</i>-benzyl and tolyl group, respectively, exhibited the highest STAT5 specificity, i.e., STAT5b <i>K</i><sub>i</sub> = 8 μM cf. STAT1 and >25 μM cf. STAT3 >25 μM. Moreover, unlike the majority of STAT5b inhibitors identified in this screen, <b>SF-1-088</b> is equipped with a bulky R′′ group (R′′ = <i>N</i>-<i>tert</i>-butyloxycarbonyl). We also investigated the disruption of preformed STAT5–STAT5 dimers by electrophoretic mobility shift assay (EMSA) analysis of nuclear extracts taken from NIH3T3/hEGFR cells, harboring activated STAT5. While <b>BP-1-108</b> was shown to disrupt STAT5–STAT5 dimers with an IC<sub>50</sub> of approximately 100 μM (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>), the modest potency exhibited in this assay suggested that this class of compound will only poorly disrupt activated STAT5 dimers. Instead, inhibitory function will most likely be derived from binding to the unphosphorylated STAT5 monomer and thus prevent STAT5 phosphorylation and/or binding to the phosphorylated STAT5 protein disrupting the formation of STAT5 dimers.</div><div class="NLM_p">Next, computational docking analysis using Genetically Optimized Ligand Docking Software (GOLD)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> of agents was performed with the STAT5a crystal structure (pdb:1Y1U<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a>). Given the near identical sequences of the STAT5a and STAT5b SH2 domains (>93%), we reasoned that inhibitor docking in silico with the STAT5a crystal structure may also offer some insight into possible inhibitor binding to STAT5b’s SH2 domain. GOLD docking studies revealed that the salicylic acid component of <b>SF-1-088</b> docks within the STAT5a pTyr binding site composed of polar residues Arg618, Lys600, and Ser622 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The hydrophobic benzyl substituent interacts with the hydrophobic portion of the Lys644 side chain as well as with the Leu643 side chain. The <i>tert</i>-butyl portion of the <i>N</i>-<i>tert</i>-butyloxycarbonyl group forms van der Waals interactions with Leu643 and Trp631. <b>SF-1-088</b>’s tetrapodal projection of functionality facilitates access to a number of subpockets within the STAT5a SH2 domain. Future work will seek to delineate inhibitor binding via a thorough structure–activity relationship against STAT5's SH2 domain.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Low energy GOLD<sup>45</sup>-docked <b>SF-1-088</b> (yellow) in the STAT5a SH2 domain (pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U">1Y1U</a>): pink = hydrophobic residues; blue = hydrophilic residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next assessed the whole cell potency of lead STAT5 inhibitors in the acute myeloid leukemia cell line, MV-4-11, known to harbor activated STAT5 via constitutive FLT-3 kinase activity,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> as well as in K562 leukemia cells, which also contain constitutive STAT5 activity via the presence of BCR-ABL.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Both cancer cell lines were treated with inhibitors, <b>BP-1-107</b>, <b>BP-1-108</b>, <b>SF-1-087</b>, <b>BP-1-075</b>, and <b>SF-1-088</b> at 10, 20, and 40 μM concentrations and cell viabilities determined using Almar Blue (Invitrogen) fluorescent staining in 96-well plates over 3 consecutive days. Encouragingly, in MV-4-11 cells, we found that <b>BP-1-108</b>, <b>SF-1-087</b>, and <b>BP-1-075</b> inhibited cell viability with IC<sub>50</sub> values of 17, 51, and 24 μM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Similarly, in K562 cells, <b>BP-1-075</b> and <b>BP-1-108</b> inhibited cell viability with IC<sub>50</sub> values of 24 and 42 μM, respectively. The cytotoxic potential of <b>BP-1-108</b> was confirmed using an Annexin V/PI assay in K562 cells. In this assay, <b>BP-1-108</b> (40 μM, 24 h) induced apoptosis in K562 cells as measured by annexin V staining (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). In contrast, <b>BP-1-108</b> minimally affected healthy patient bone marrow cells that do not harbor constitutive STAT5 activity (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>) even at concentrations of up to 160 μM. To determine whether the biological effects correlated with intracellular STAT5 suppression, we next measured inhibitor mediated suppression of STAT5 phosphorylation in the K562 cells.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Selected IC<sub>50</sub> Values (μM) of Inhibitors in MV-4-11 and K562 Cells at 48 h Post-Treatment</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> values (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" valign="top">compd</th><th class="colsep0 rowsep0" align="center" valign="top">MV-4–11</th><th class="colsep0 rowsep0" align="center" valign="top">K562</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SF-1-088</td><td class="colsep0 rowsep0" align="left">>80</td><td class="colsep0 rowsep0" align="left">77 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SF-1-087</td><td class="colsep0 rowsep0" align="left">51 ± 7</td><td class="colsep0 rowsep0" align="left">>80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BP-1-107</td><td class="colsep0 rowsep0" align="left">>80</td><td class="colsep0 rowsep0" align="left">80 ± 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BP-1-108</td><td class="colsep0 rowsep0" align="left">17 ± 1</td><td class="colsep0 rowsep0" align="left">42 ± 16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BP-1-075</td><td class="colsep0 rowsep0" align="left">24 ± 2</td><td class="colsep0 rowsep0" align="left">24 ± 3</td></tr></tbody></table></div></div><div class="NLM_p">To evaluate the inhibition of intracellular STAT5 in K562 leukemia cells, carrying the <i>BCR-ABL</i> oncogene, were treated with <b>BP-1-107</b>, <b>BP-1-108</b>, <b>SF-1-087</b>, and <b>SF-1-088</b>. After 6 h of exposure to the drug, we measured the level of STAT5 phosphorylation by Western blot analysis. Consistent with the cytoxic effects on leukemia cells, we observed dose-dependent inhibition of STAT5 phosphorylation after treatment with inhibitors confirming that these agents inhibit oncogene mediated STAT5 activation in tumor cells (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A and <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). Presumably, this resulted from the blockade of STAT5 binding to the pTyr motifs in BCR-ABL or other proteins recruited by BCR-ABL, and the subsequent prevention of <i>de novo</i> phosphorylation of STAT5 by tyrosine kinases. We next evaluated <b>BP-1-108</b> induced dose-dependent decreases in pSTAT5, pSTAT3, and pAKT using phospho-flow cytometry to measure inhibitor-induced effects. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B, and consistent with the Western blot studies, <b>BP-1-108</b> is a potent inhibitor of STAT5 phosphorylation. Moreover, <b>BP-1-108</b> elicited minimal perturbation of both pSTAT3 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C) and pAKT (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D) phosphorylation in K562 cells at 40 μM, suggesting a STAT5 specific effect.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Western blot analysis of STAT5 inhibition in K562 cells treated with <b>BP-1-107</b>, <b>BP-1-108</b>, <b>SF-1-087</b>, and <b>SF-1-088</b> STAT5 inhibitors. The different sized bands in the pSTAT5 and STAT5 panels arise due to alternate forms (STAT5a and STAT5b) and post-translational modifications of the proteins.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> (B) Dose-dependent inhibition of pSTAT5 by <b>BP-1-108</b> as measured by phospho-flow cytometry. (C) Minimal inhibition of pSTAT3. (D) pAkt by <b>BP-1-108</b> as measured by phospho-flow cytometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The above data suggests that the growth inhibitory effect of <b>BP-1-108</b> is as a result of blocking the phosphorylation of STAT5. Alternatively, the drug might be causing death due to the inhibition of phosphorylation of other down stream targets of BCR-ABL. Analysis by phospho-flow cytometry also indicates that <b>BP-1-108</b> does not affect the level pERK 1,2. Finally, to demonstrate that <b>BP-1-108</b> is not acting directly on the tyrosine kinase activity of BCR-ABL we compared the effect of the BCR-ABL inhibitor imatinib to <b>BP-1-108</b>. As can be seen in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, imatinib caused a marked reduction in both pSTAT5 and pERK1,2, while <b>BP-1-108</b> only blocked the phosphorylation of pSTAT5. Taken together, this suggests that <b>BP-1-108</b> does not inhibit the JAK/STAT3 pathway, the PI3K pathway, or MAPK pathways and that it specifically inhibits the phosphorylation of STAT5.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. K562 cells nontreated or treated with imatinib or <b>BP-1-108</b> were fixed and stained for the levels of pSTAT5 and pERK1,2. The <i>Y</i> axis is pSTAT5, and the <i>X</i> axis is pERK1,2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To exclude the possibility that this effect on STAT5 was a peculiarity of cells with an activated oncogene, we used the IL-3 dependent cell line 32D. The level of pSTAT5 was determined by flow cytometry. In the presence of IL-3, the peak is shifted to the left in comparison to no IL-3. The addition of <b>BP-1-108</b> to cells grown in IL-3 resulted in a major reduction in the level of pSTAT5 (shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>BP-1-108</b> on IL-3 mediated phosphorylation of STAT5. IL-3 dependent 32D cells were assessed for the level of pSTAT5 by flow cytometry under different growth conditions; with IL-3 (green line), IL-3 and <b>BP-1-108</b> (blue line); or no IL-3 (orange line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previous reports indicate that knockdown of phosphorylated STAT5 (pSTAT5) in AML cells abrogates MCL-1 expression at both the mRNA and protein level and is sufficient to induce apoptosis.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Indeed, suppression of MCL-1 in chronic lymphocytic leukemia and myeloma cells rapidly induced apoptosis, identifying MCL-1 as a potential key therapeutic target. Critically, in AML cells, MCL-1 expression is highly dependent upon STAT5 mediated signaling pathways, suggesting that STAT5 inhibitors might be important for triggering apoptosis in AMLs. Thus, we reasoned that promising inhibitors of STAT5 should decrease target gene expression, including <i>MCL-1</i>, <i>cyclin D1/D2</i>, and <i>BCL-XL</i>, and induce apoptosis as was observed in K562 and MV-4-11 viability assays. To confirm the inhibitory effects of lead STAT5 inhibitors, we conducted experiments to measure changes in the level of expression of known STAT5-regulated genes, including <i>MCL-1</i>, <i>C-MYC</i>, <i>cyclin D1</i>, and <i>cyclin D2</i>, in K562 cells. In keeping with our hypothesis, after treatment with 40 μM of <b>BP-1-108</b>, <b>BP-1-075</b>, <b>BP-1-111</b>, and <b>SF-1-087</b> for 6 h, we observed a significant reduction of <i>MCL-1</i>, <i>C-MYC</i>, <i>cyclin D1</i>, and <i>cyclin D2</i> mRNA (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). These data, in conjunction with the Western blot analysis of STAT5 phosphorylation, the potent <i>in vitro</i> disruption of STAT5/phosphopeptide complexation (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), and whole cell results (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), indicate that the lead STAT5 binding agents potently inhibit the transcriptional function of STAT5 and as a result suppress tumor cell growth, proliferation, and survival, culminating in cellular apoptosis.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. RT-PCR analysis of K562 whole cell lysates treated with <b>BP-1-108</b>, <b>BP-1–75</b><b>, BP-1–111</b>, and <b>SF-1-087</b> to evaluate the levels of cMYC, Cyclin D1, Cyclin D2, and MCL-1 transcripts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To confirm that <b>BP-1-108</b> disrupted STAT5 binding to the <i>C-MYC</i> and <i>cyclin D1</i> promoter regions, we performed a chromatin immunoprecipitation assay (Millipore, Billerica, MA, USA). PCR of STAT5 immunoprecipitated chromatin fragments of whole cell lystates taken from K562 cells treated with <b>BP-1-108</b> (40 μM, 6 h) showed no STAT5 binding to either the <i>C-MYC</i> or <i>cyclin D1</i> promoter regions (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A) as compared with untreated control cells, in which pSTAT5 antibody was able to precipitate both <i>C-MYC</i> and <i>cyclin D1</i> promoters (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). Thus, <b>BP-1-108</b>-mediated inhibition of STAT5 activation can inhibit the high level expression of C-MYC and cyclin D1 in K562 leukemia cells.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chromatin immunoprecipitation of <i>C-MYC</i> and <i>cyclin D1</i> promoters using STAT5 antibody in K562 cells treated with 40 μM <b>BP-1-108</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, we have identified a number of promising STAT5 SH2 domain inhibitors that exhibit potent and selective <i>in vitro</i> binding activity for STAT5, effectively disrupting STAT5/phosphopeptide interactions (<i>K</i><sub>i</sub>’s < 5 μM). Moreover, unlike traditional SH2 domain targeting phosphopeptide mimetics, the structures identified do not contain a pharmacokinetically labile phosphotyrosyl group. Moreover, in AML cell lines MV-4-11, carrying a FLT3-ITD and BCR-ABL positive K562, our lead agent <b>BP-1-108</b> suppresses STAT5 phosphorylation and inhibits STAT5 mediated gene expression, including the down regulation of C-MYC, cyclin D1, cyclin D2, and MCL-1, important inhibitors of apoptosis and regulators of the cell cycle. Particularly, MCL-1 has been shown as a key therapeutic target in leukemias.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> As a result, <b>BP-1-108</b> exhibited encouraging antileukemic activity in K562 cells (IC<sub>50</sub> = 17 μM) while showing no cytotoxicity against healthy bone marrow cells at concentrations up to 160 μM (<a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>). These molecules represent the most potent direct inhibitors of STAT5 function reported to date. Given the current dearth of small molecules effectively targeting STAT5–STAT5 protein complexes in human cancers, our work in conjunction with that of Berg<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> shows that STAT5 protein–protein interactions are an appealing and viable target for small molecule disruptors.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Fluorescent Polarization Assay</h3><div class="NLM_p last">Fluorescence polarization experiments were performed on an Infinite M1000 (Tecan, Crailsheim, Germany) using black 384-round-bottom well plates (Corning) and buffer containing 50 mM NaCl, 10 mM Hepes, pH 7.5, 1 mM EDTA, and 2 mM dithiothreitol and a final concentration of 5% DMSO. STAT protein (120 nM, 150 nM, and 105 nM for STAT1, STAT3, and STAT5, respectively) were treated with varying concentrations of inhibitor compounds (200 to 0.2 μM final concentrations). The fluorescent probe was added at a final concentration of 10 nM. Protein, inhibitor, and probe were combined and incubated for 15 min prior to analysis. Polarized fluorescence was plotted against concentration and fitted using a standard dose–response curve.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Cell Culture, Treatment, and Viability Testing</h3><div class="NLM_p last">To determine whether STAT5 inhibitors could be cytotoxic in cell lines that have constitutive activation of STAT5, the cell lines K562 and MV-4-11 were cultured at a concentration of 1 × 10<sup>5</sup>, to ensure that the cells are at the exponential stage of growth, and treated with the different synthesized molecules at concentrations of 10, 20, and 40 μM. Viability were determined using Almar Blue (Invitrogen) in a 96-well plate over 3 consecutive days. Fluorescence was quantified using Spectra Max M5 (Molecular Devices).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Annexin V/PI Assay</h3><div class="NLM_p last">K562 cells treated with 40 μM of <b>BP-1-108</b> for 24 h or were untreated and washed twice with PBS and then stained consecutively with FITC-coupled Annexin V (Becton Dicknson) antibody for 15° and PI (Becton Dickinson) for 10°. Then, data were acquired using FacsCaliber and analyzed using FlowJo software.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Determining Inhibition of Intracellular STAT5, STAT3, and STAT1 Phosphorylation</h3><div class="NLM_p last">Cells were treated with the potential STAT5 inhibitors for 6 h, then 1 × 10<sup>7</sup> were lysed using RIPA buffer. Lysates were loaded on SDS–PAGE in order to size-fractionate the proteins. Thereafter, proteins were blotted onto PVDF membrane (PALL Life Sciences). The membrane was blocked using 5% BSA in PBS containing 0.1% Tween 20 (Sigma) and then probed with antibodies against pSTAT5, STAT5, pSTAT3, STAT3 (Cell Signaling), and GAPDH. Secondary staining was performed with antirabbit IgG coupled with HRP (Amersham Bioecinces), and chemiluminescence reaction was carried out using ECL Plus (Amersham Biosciences). Proteins were quantified using Typhoon 9410 (Amersham Biosciences).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Inhibition of IL-3-Induced STAT5 Phosphorylation</h3><div class="NLM_p last">IL-3 dependent 32D cells were grown in the absence of IL-3, with IL-3 alone, or with IL-3 and <b>BP-1-108</b> for 6 h. Following this, the cells were washed, fixed, stained for pSTAT5, and assessed by flow cytometry.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Flow Cytometry</h3><div class="NLM_p last">K562 cells were treated (40 μM <b>BP-1-108</b>) or untreated for 6 h, then fixed and stained for pSTAT3, pSTAT5, pAKT1, or pERK1,2. For pSTAT3, pSTAT5 and pAKT1 nonlabeled rabbit monoclonal antibodies were used first, followed by detection with Cy5 coupled antirabbit IgG antibodies. pERK1 was detected using an Alexa448-coupled rabbit monoclonal antibody.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chromatin Immunoprecipitation (ChIP)</h3><div class="NLM_p last">ChIP assay was performed using the EZ ChIP kit (Millipore, Billerica, MA, USA) as per the manufacturer’s instructions. Briefly, after cross-linking with formaldehyde (1%), cells were lysed using SDS Lysis Buffer containing Protease Inhibitor Cocktail, and nuclear extracts were obtained. Then, cross-linked DNA was sheared using sonication; sheared DNA size was checked on agarose gel and ranged, in all cases, between 300 and 500 bp. An amount of 1/20 of the shared chromatin was kept as an input. Sheared chromatin was incubated with rabbit polyclonal Phospho-STAT5 (Tyr694) Antibody (Cell Signaling, Danvers, MA, USA) at a dilution of 1:50 or rabbit polyclonal IgG at an appropriate concentration. Incubation was performed at 4 °C overnight. The antibody/chromatin complex was precipitated using Protein G Agarose beads. After elution, the cross-link of protein/DNA was reversed, and DNA was purified using Spin Columns. PCR was performed using platinum Taq (Invitrogen Canada, Burlington, ON, Canada). Two sets of primers were designed to amplify two DNA segments that contain STAT5-binding sites located 1672bp and 428bp upstream of the start sites of <i>C-MYC</i> and <i>cyclin D1</i>, respectively. The STAT5-binding site in the <i>C-MYC</i> promoter is characterized by a 4N spacer and has the sequence (ttcccccgaa), whereas the one in the <i>cylcin D1</i> promoter is characterized by a 3N spacer and has the sequence (ttcttggaa).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Chemical Methods</h3><div class="NLM_p last">Anhydrous solvents methanol, DMSO, CH<sub>2</sub>Cl<sub>2</sub>, THF, and DMF were purchased from Sigma Aldrich and used directly from Sure-Seal bottles. Molecular sieves were activated by heating to 300 °C under vacuum overnight. All reactions were performed under an atmosphere of dry nitrogen in oven-dried glassware and were monitored for completeness by thin-layer chromatography (TLC) using silica gel (visualized by UV light or developed by treatment with KMnO<sub>4</sub> stain or phosphomolybdic acid stain). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on Bruker 400 MHz spectrometer in CDCl<sub>3</sub>, CD<sub>3</sub>OD, or <i>d</i><sub>6</sub>-DMSO. Chemical shifts (δ) are reported in parts per million after calibration to a residual isotopic solvent. Coupling constants (<i>J</i>) are reported in Hz. Before biological testing, inhibitor purity was evaluated by reversed-phase HPLC (rpHPLC). Analysis by rpHPLC was performed using a Microsorb-MV 300 A C18 250 mm × 4.6 mm column run at 1 mL/min and using gradient mixtures. The linear gradient consisted of a changing solvent composition of (I) 100% H<sub>2</sub>O with 0.1% TFA for 2 min to 100% MeCN with 10% H<sub>2</sub>O and 0.1% TFA (v/v) at 22 min and UV detection at 254 nm, (II) 100% H<sub>2</sub>O with 0.1% TFA for 2 min to 100% MeCN with 10% H<sub>2</sub>O and 0.1% TFA (v/v) at 62 min and UV detection at 214 nm, (III) 100% H<sub>2</sub>O (0.01 M NH<sub>4</sub>OAc) for 2 min to 100% MeOH at 22 min and UV detection at 254 nm or (IV) 100% H<sub>2</sub>O (0.01 M NH<sub>4</sub>OAc) for 2 min to 100% MeOH at 62 min and UV detection at 254 nm, (V) 100% H<sub>2</sub>O (0.01 M NH<sub>4</sub>OAc) for 2 min to 100% MeOH at 25 min and UV detection at 254 nm, or (VI) 100% H<sub>2</sub>O (0.01 M NH<sub>4</sub>OAc) for 2 min to 100% MeOH at 62 min and UV detection at 254 nm, each ending with 5 min of 100% B. For reporting HPLC data, percentage purity is given in parentheses after the retention time for each condition. All biologically evaluated compounds are >95% chemical purity as measured by HPLC. The HPLC traces for all tested compounds are provided in <a class="ref internalNav" href="#notes-2" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Final Molecule Characterization</h3><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<b>SF1-066</b>) 4-(<i>N</i>-(4-Cyclohexylbenzyl)-2-(<i>N</i>,4-dimethylphenylsulfonamido)acetamido)-2-hydroxybenzoic Acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, <i>d</i><sub>6</sub>-DMSO) 1.14–1.40 (m, 5H, CH<sub>2</sub>), 1.64 – 1.81 (m, 5H, CH<sub>2</sub>), 2.36 (s, 3H, CH<sub>3</sub>Ar), 2.44 (s (br), 1H, CH), 2.77 (s, 3H, NCH<sub>3</sub>), 3.86 (s, 2H, COCH<sub>2</sub>), 4.79 (s, 2H, CH<sub>2</sub>Ar), 6.79 (d, <i>J</i> = 8.6 Hz, 1H, CH (Ar)), 6.86 (s (br), 1H, CH (Ar)), 7.06 (d, <i>J</i> = 7.8 Hz, 2H, 2 CH (Ar)), 7.13 (d, <i>J</i> = 7.8 Hz, 2H, 2 CH (Ar)), 7.35 (d, <i>J</i> = 8.0 Hz, 2H, 2 CH (Ar)), 7.54 (d, <i>J</i> = 8.0 Hz, 2H, 2 CH (Ar)), 7.77 (d, <i>J</i> = 8.3 Hz, 1H, CH (Ar)), 11.30 (s (br), 1H, OH); δ<sub>C</sub> (400 MHz, <i>d</i><sub>6</sub>-DMSO) 21.2, 25.1(2), 26.6, 34.2, 36.1, 42.3, 43.6, 51.2, 51.9, 112.7, 116.3, 118.9, 126.9, 127.2, 127.8, 129.9, 131.6, 134.5, 135.3, 143.4, 146.8, 147.3, 161.8, 167.0, 171.5; HRMS (ES+) calcd for [C<sub>30</sub>H<sub>35</sub>N<sub>2</sub>O<sub>6</sub>S + H] 551.2223; found, 551.2210; HPLC (I) <i>t</i><sub><i>R</i></sub> = 24.35 min (98.11%), (II) <i>t</i><sub><i>R</i></sub> = 52.80 min (98.16%).</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (<b>BP1-075</b>) 4-(2-(<i>N</i>,4-Dimethylphenylsulfonamido)-<i>N</i>-((3′-(methoxycarbonyl)terphenyl-4-yl)methyl) acetamido)-2-hydroxybenzoic Acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, <i>d</i><sub><i>6</i></sub><i>-</i>DMSO) 2.36 (s, 3H, CH<sub>3</sub>), 2.81 (s, 3H, CH<sub>3</sub>), 4.90 (s, 2H, CH<sub>2</sub>), 6.80 (d, 1H, <i>J</i> = 8.4 Hz, CH), 6.89 (s, 1H, CH), 7.29 (d, <i>J</i> = 8.4 Hz, 2H, CH), 7.36 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.61–7.67 (m, 5H, CH), 7.76–7.79 (m, 4H, CH), 7.96 (d, <i>J</i> = 7.6 Hz, 1H, CH), 8.00 (d, <i>J</i> = 8.0 Hz, 1H, CH), 8.24 (s, 1H, CH), 8.32 (s, 1H, CH); δ<sub>C</sub> (400 MHz, <i>d-</i>CDCl<sub>3</sub>) 20.87, 35.80, 50.85, 51.57, 52.16, 115.95, 117.44, 118.14, 126.47, 126.89, 127.13, 127.20, 127.34, 127.89, 128.05, 128.34, 129.46, 129.54, 130.30, 131.26, 135.06, 136.38, 137.86, 138.17, 139.10, 139.98, 143.05, 146.39, 161.85, 166.04, 166.73, 171.05; HRMS (ES+) calcd for [C<sub>37</sub>H<sub>32</sub>N<sub>2</sub>O<sub>8</sub>S + H] 679.2108; found, 679.2080; HPLC (I) <i>t</i><sub><i>R</i></sub> = 23.34 min (96.76%), (II) <i>t</i><sub><i>R</i></sub> = 50.50 min (98.76%).</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (<b>BP2-122</b>) 4-(<i>N</i>-((4″-Carbamoyl-[1,1′:4′,1″-terphenyl]-4-yl)methyl)-2-(<i>N</i>,4-dimethylphenyl sulfonamido)acetamido)-2-hydroxybenzoic Acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, <i>d</i><sub>6</sub>-DMSO) 2.35 (s, 3H, CH<sub>3</sub>), 2.79 (s, 3H, CH<sub>3</sub>), 3.87 (s, 2H, CH2), 4.88 (s, 2H, CH<sub>2</sub>), 6.78 (d, <i>J</i> = 6.4 Hz, 1H, CH), 6.86 (s, 1H, CH), 7.29 (d, <i>J</i> = 8.4 Hz, 2H, CH), 7.37 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.55–7.69 (m, 6H, CH), 7.76–7.84 (m, 4H, CH), 7.95–8.04 (m, 3H, CH); δ<sub>C</sub> (100 MHz, <i>d</i><sub>6</sub>-DMSO) 21.3, 30.7, 51.3, 52.0, 103.0, 116.2, 118.4, 126.2, 126.5, 127.0, 127.1, 127.3, 128.2, 128.4, 128.7, 128.8, 129.6, 131.4, 131.5, 132.0, 132.1, 132.2, 133.1, 133.2, 135.1, 136.4, 138.1, 138.3, 139.1, 142.1, 143.1, 146.8, 161.7, 166.8, 167.5, 171.1, 172.0; HRMS (ES+) calcd for [C<sub>37</sub>H<sub>33</sub>N<sub>3</sub>O<sub>7</sub>S + H] 664.2111; found, 664.2141; HPLC (III) <i>t</i><sub>R</sub> = 19.22 min (76.63%), (IV) <i>t</i><sub>R</sub> = 43.81 min (79.95%).</div></div><div id="sec4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<b>SF2-096</b>) 4-(<i>N</i>-(4-(1-(4-Cyanophenyl)piperidin-4-yl)benzyl)-2-(N,4-dimethylphenyl-sulfon-amido)acetamido)-2-hydroxybenzoic Acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, <i>d</i><sub>6</sub>-DMSO) 1.56–1.68 (m, 2H, CH<sub>2</sub>), 1.80–1.83 (m, 2H, CH<sub>2</sub>), 2.36 (s, 3H, CH<sub>3</sub>), 2.74–2.75 (m, 1H, CH), 2.52–2.53 (m, 2H, CH<sub>2</sub>), 2.77 (s, 3H, CH<sub>3</sub>), 2.88–2.98 (m, 2H, CH2), 3.86 (s, 2H, CH<sub>2</sub>), 4.80 (s, 2H, CH<sub>2</sub>), 6.79 (dd, <i>J</i> = 8.0 and 2.0 Hz, 1H, CH), 6.87 (d, <i>J</i> = 2.0 Hz, 1H, CH), 7.03 (d, <i>J</i> = 7.2 Hz, 2H, CH), 7.09 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.17 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.35 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.53–7.56 (m, 4H, CH), 7.77 (d, <i>J</i> = 8.4 Hz, 1H, CH); δ<sub>C</sub> (100 MHz, <i>d</i>-CDCl<sub>3</sub>) 21.4, 29.5, 32.4, 35.8, 41.9, 48.2, 51.5, 52.9, 99.4, 114.3, 116.8, 118.9, 126.8, 127.4, 128.6, 129.4, 133.4, 134.3, 134.9, 143.4, 144.8, 147.4, 153.2, 162.8, 165.6, 171.8; LRMS (ES+) calcd for [C<sub>36</sub>H<sub>36</sub>N<sub>4</sub>O<sub>6</sub>S + H] 653.24; found, 653.46 [M + H]; HPLC (I) <i>t</i><sub>R</sub> = 23.32 min (99.22%), (II) <i>t</i><sub>R</sub> = 49.33 min (99.66%).</div></div><div id="sec4_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<b>SF3-006</b>) 4-(<i>N</i>-(4-(1-(4-Carbamoylphenyl)piperidin-4-yl)benzyl)-2-(<i>N</i>,4-dimethyl-phenyl-sulfonamido)acetamido)-2-hydroxybenzoic acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, <i>d</i><sub>6</sub>-DMSO) 1.66–1.80 (m, 2H, CH<sub>2</sub>), 1.82–1.91 (m, 2H, CH<sub>2</sub>), 2.33 (s, 3H, CH<sub>3</sub>), 2.58–2.68 (m, 1H, CH), 2.77 (s, 3H, CH<sub>3</sub>), 2.86 (t, <i>J</i> = 12.0 Hz, 2H, CH<sub>2</sub>), 3.72 (s, 2H, CH<sub>2</sub>), 3.89 (d, <i>J</i> = 12.0 Hz, 2H, CH<sub>2</sub>), 4.75 (s, 2H, CH<sub>2</sub>), 6.49 (d, <i>J</i> = 7.2 Hz, 1H, CH), 6.58 (s, 1H, CH), 6.87 (d, <i>J</i> = 8.8 Hz, 2H, CH), 7.00–7.09 (m, 4H, CH), 7.20 (d, <i>J</i> = 8.0 Hz, 1H, CH), 7.54 (d, <i>J</i> = 8.0 Hz, 1H, CH), 7.67 (d, <i>J</i> = 8.4 Hz, 2H, CH), 7.80 (d, <i>J</i> = 8.0 Hz, 1H, CH); δ<sub>C</sub> (100 MHz, <i>d</i><sub>6</sub>-DMSO) 21.2, 29.4, 32.5, 35.7, 41.9, 51.3, 52.7, 114.1, 116.4, 118.6, 121.6, 126.7, 127.2, 128.5, 128.9, 129.4, 132.0, 134.2, 134.9, 143.4, 144.9, 146.5, 150.2, 153.6, 162.4, 166.8, 169.2, 171.3; HRMS (ES+) calcd for [C<sub>36</sub>H<sub>38</sub>N<sub>4</sub>O<sub>7</sub>S + H] 671.2533; found, 671.2545; HPLC (III) <i>t</i><sub><i>R</i></sub> = 17.72 min (84.23%), (IV) <i>t</i><sub><i>R</i></sub> = 24.81 min (74.07%).</div></div><div id="sec4_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<b>BP1-107</b>) 4-(<i>N</i>-(4-Cyclohexylbenzyl)-2-(<i>N</i>-methylbiphenyl-4-ylsulfonamido)acetamido)-2-hydroxybenzoic Acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, <i>d</i><sub>6</sub>-DMSO) 1.23–1.38 (m, 5H, CH<sub>2</sub>), 1.62–1.78 (m, 5H, CH<sub>2</sub>), 2.35–2.44 (m, 1H, CH), 2.08 (s, 3H, CH<sub>3</sub>), 3.96 (s, 2H, CH<sub>2</sub>), 4.78 (s, 2H, CH<sub>2</sub>), 6.80 (dd, <i>J</i> = 8.4 and 2.0 Hz, 1H, CH), 6.89 (d, <i>J</i> = 2.0 Hz, 1H, CH), 7.04 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.09 (d, <i>J</i> = 8.4 Hz, 2H, CH), 7.44 (d, <i>J</i> = 8.0 Hz, 1H, CH), 7.51 (t, <i>J</i> = 7.6 Hz, 2H, CH), 7.68–7.81 (m, 5H, CH), 7.86 (d, <i>J</i> = 8.4 Hz, 2H, CH); δ<sub>C</sub> (100 MHz, <i>d</i><sub>6</sub>-DMSO) 25.4, 26.2, 33.7, 35.8, 43.2, 50.7, 51.6, 115.9, 118.4, 120.3, 126.5, 126.9, 127.2, 127.4, 127.5, 128.4, 129.0, 131.3, 134.1, 136.9, 138.3, 144.1, 146.3, 146.8, 161.6, 166.5, 171.1; HRMS (ES+) calcd for [C<sub>35</sub>H<sub>36</sub>N<sub>2</sub>O<sub>6</sub>S + H] 613.2366; found, 613.2356; HPLC (V) <i>t</i><sub><i>R</i></sub> = 22.09 min (96.50%), (VI) <i>t</i><sub><i>R</i></sub> = 38.47 min (89.47%).</div></div><div id="sec4_9_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<b>BP1-108</b>) 4-(<i>N</i>-(4-Cyclohexylbenzyl)-2-(<i>N</i>,2,4,6 tetramethylphenylsulfonamido)acetamido)-2-hydroxybenzoic Acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, <i>d</i><sub>6</sub>-DMSO) 1.26–1.40 (m, 5H, CH<sub>2</sub>), 1.64–1.81 (m, 5H, CH<sub>2</sub>), 2.26 (s, 3H, CH<sub>3</sub>), 2.44 (s, 7H, CH<sub>3</sub> and CH), 2.84 (s, 3H, CH<sub>3</sub>), 3.84 (s, 2H, CH<sub>2</sub>), 4.75 (s, 2H, CH<sub>2</sub>), 6.62 (dd, <i>J</i> = 8.4 and 2.0 Hz, 1H, CH), 6.70 (d, <i>J</i> = 2.0 Hz, 1H, CH), 6.99 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.03 (s, 2H, CH), 7.11 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.75 (d, <i>J</i> = 8.4 Hz, 1H, CH); δ<sub>C</sub> (100 MHz, <i>d</i><sub>6</sub>-DMSO) 20.3, 22.1, 25.4, 26.2, 33.8, 34.4, 43.2, 49.1, 51.5, 116.0, 118.4, 120.2, 126.5, 127.4, 131.2, 131.7, 132.1, 134.1, 139.4, 142.1, 146.7, 146.7, 161.5, 166.6, 171.0; HRMS (ES+) calcd for [C<sub>32</sub>H<sub>38</sub>N<sub>2</sub>O<sub>6</sub>S + H] 613.2366; found, 613.2356; HPLC (V) <i>t</i><sub><i>R</i></sub> = 21.29 min (96.82%), (VI) <i>t</i><sub><i>R</i></sub> = 37.54 min (95.30%).</div></div><div id="sec4_9_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<b>BP1-111</b>) 4-(2-(4-Chloro-<i>N</i>-methylphenylsulfonamido)-<i>N</i>-(4-cyclohexylbenzyl)acetamido)-2-hydroxybenzoic Acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, <i>d-</i>CDCl<sub>3</sub>) 1.34 (m, 5H, CH<sub>2</sub>), 1.75 (m, 5H, CH<sub>2</sub>), 2.44 (m, 1H, CH), 2.84 (s, 3H, CH<sub>3</sub>), 3.96 (s, 2H, CH<sub>2</sub>), 4.77 (s, 2H, CH<sub>2</sub>), 6.80 (dd, <i>J</i> = 8.4 and 2.0 Hz, 1H, CH), 6.89 (d, <i>J</i> = 2.0 Hz, 1H, CH), 7.04 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.13 (d, <i>J</i> = 8.0 Hz, 2H, CH), 7.64 (d, <i>J</i> = 8.8 Hz, 2H, CH), 7.72 (d, <i>J</i> = 8.8 Hz, 2H, CH), 7.78 (d, <i>J</i> = 8.4 Hz, 1H, CH); δ<sub>C</sub> (100 MHz, <i>d-</i>CDCl<sub>3</sub>) 25.4, 26.2, 33.8, 35.8, 43.2, 50.8, 51.6, 112.4, 115.9, 118.4, 126.5, 127.4, 128.8, 129.1, 131.2, 134.1, 137.1, 137.5, 146.4, 146.8, 161.5, 166.4, 171.0; HRMS (ES+) calcd for [C<sub>29</sub>H<sub>31</sub>ClN<sub>2</sub>O<sub>6</sub>S +H] 571.1664; found, 571.1682; HPLC (V) <i>t</i><sub><i>R</i></sub> = 20.92 min (96.73%), (VI) <i>t</i><sub><i>R</i></sub> = 35.97 min (97.88%).</div></div><div id="sec4_9_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<b>SF1-087</b>) 4-(2-(<i>N</i>-(<i>tert</i>-Butoxycarbonyl)-4-methylphenylsulfonamido)-<i>N</i>-(4-cyclohexyl benzyl)acetamido)-2-hydroxybenzoic Acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 1.22–1.45 (m, 14H), 1.70–1.85 (m, 5H, CH<sub>2</sub>), 2.42 (s, 3H, CH<sub>3</sub>), 2.46 (s (br), 1H, CH), 4.46 (s, 2H, COCH<sub>2</sub>), 4.91 (s, 2H, CH<sub>2</sub>Ar), 6.70 (d, <i>J</i> = 8.0 Hz, 1H, CH (Ar)), 6.82 (s (br), 1H, CH (Ar)), 7.10–7.15 (m, 4H, 4 CH (Ar)), 7.30 (d, <i>J</i> = 8.0 Hz, 2H, 2 CH (Ar)), 7.88 (d, <i>J</i> = 8.4 Hz, 1H, 1 CH (Ar)), 8.02 (d, <i>J</i> = 8.2 Hz, 2H, 2 CH (Ar)), 10.66 (s (br), 1H, OH); !C (100 MHz, CDCl<sub>3</sub>) 21.6, 26.0, 26.8, 27.7, 34.3, 44.2, 47.5, 53.1, 84.7, 111.6, 117.2, 119.3, 126.9, 128.3, 128.8, 129.0, 132.3, 133.5, 136.6, 144.2, 147.5, 147.9, 50.5, 162.9, 166.7, 172.6; HRMS (ES+) calcd for [C<sub>34</sub>H<sub>41</sub>N<sub>2</sub>O<sub>8</sub>S + H] 637.2547; found, 637.2578; HPLC (I) <i>t</i><sub><i>R</i></sub> = 26.55 min (97.80%), (II) <i>t</i><sub><i>R</i></sub> = 59.27 min (100%).</div></div><div id="sec4_9_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (<b>SF1-088</b>) 4-(<i>N</i>-Benzyl-2-(<i>N</i>-(<i>tert</i>-butoxycarbonyl)-4-methylphenylsulfonamido)acetamido)-2-hydroxybenzoic Acid</h4><div class="NLM_p last">δ<sub>H</sub> (400 MHz, CDCl<sub>3</sub>) 1.31 (s, 9H, 3(CH<sub>3</sub>)), 2.41 (s, 3H, CH<sub>3</sub>Ar), 4.47 (s, 2H, COCH<sub>2</sub>), 4.95 (s, 2H, CH<sub>2</sub>Ar), 6.69 (d, <i>J</i> = 8.4 Hz, 1H, CH (Ar)), 6.81 (s, 1H, CH (Ar)), 7.20–7.32 (m, 7H, CH (Ar)), 7.87 (d, <i>J</i> = 8.4 Hz, 1H, CH (Ar)), 8.00 (d, <i>J</i> = 8.2 Hz, 2H, 2 CH (Ar)), 10.68 (s (br), 1H, OH); δ<sub>C</sub> (400 MHz, CDCl<sub>3</sub>) 21.6, 27.7, 47.4, 53.3, 84.8, 111.6, 117.2, 119.2, 127.7, 128.4, 128.5, 128.7, 129.0, 132.3, 136.2, 136.6, 144.2, 147.7, 150.6, 162.9, 166.8, 172.6; HRMS (ES+) calcd for [C<sub>28</sub>H<sub>31</sub>N<sub>2</sub>O<sub>8</sub>S + H] 557.1615; found, 577.1615; HPLC (I) <i>t</i><sub><i>R</i></sub> = 21.67 min (99.02%), (II) <i>t</i><sub><i>R</i></sub> = 46.05 min (98.14%).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27"><a href="/doi/suppl/10.1021/jm200720n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38836" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38836" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Chemical methods; selected FP binding data; cell culture, treatment and viability testing; annexin V/PI assay; determining the inhibition of intracellular Stat5, Stat3, and Stat1 phosphorylation; real-time RT-CR; chromatin immunoprecipitation (ChIP); effect of BP-1-108 on Stat5 by electrophoretic mobility shift assay (EMSA); sequences of primers used in quantitative real-time RT-PCR; and sequences of primers used in promoter regions amplification post ChIP. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200720n/suppl_file/jm200720n_si_001.pdf">jm200720n_si_001.pdf (532.98 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm200720n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75443" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75443" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark D. Minden</span> - <span class="hlFld-Affiliation affiliation">Princess Margaret Hospital, Ontario Cancer Institute, 610 University Avenue, Toronto,
ON M5G 2M9, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8bfbeafff9e2e8e0a5ecfee5e5e2e5eccbfeffe4f9e4e5ffe4a5e8ea"><span class="__cf_email__" data-cfemail="deaebfaaacb7bdb5f0b9abb0b0b7b0b99eabaab1acb1b0aab1f0bdbf">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick T. Gunning</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University of Toronto, 3359 Mississauga Road North,
Mississauga, ON, L5L 1C6, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ee9e8f9a9c878d85c0899b8080878089ae9b9a819c81809a81c08d8f"><span class="__cf_email__" data-cfemail="abdbcadfd9c2c8c085ccdec5c5c2c5ccebdedfc4d9c4c5dfc485c8ca">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brent D. G. Page</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University of Toronto, 3359 Mississauga Road North,
Mississauga, ON, L5L 1C6, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haytham Khoury</span> - <span class="hlFld-Affiliation affiliation">Princess Margaret Hospital, Ontario Cancer Institute, 610 University Avenue, Toronto,
ON M5G 2M9, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rob C. Laister</span> - <span class="hlFld-Affiliation affiliation">Princess Margaret Hospital, Ontario Cancer Institute, 610 University Avenue, Toronto,
ON M5G 2M9, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Fletcher</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry, University of Toronto, 3359 Mississauga Road North,
Mississauga, ON, L5L 1C6, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Megan Vellozo</span> - <span class="hlFld-Affiliation affiliation">Princess Margaret Hospital, Ontario Cancer Institute, 610 University Avenue, Toronto,
ON M5G 2M9, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessia Manzoli</span> - <span class="hlFld-Affiliation affiliation">Princess Margaret Hospital, Ontario Cancer Institute, 610 University Avenue, Toronto,
ON M5G 2M9, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peibin Yue</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Biology
and Microbiology, Burnett College of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826,
United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Turkson</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Biology
and Microbiology, Burnett College of Biomedical Sciences, University of Central Florida, Orlando, Florida 32826,
United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack" id="ACK-d4761e2062-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Science Engineering Research Councils (NSERC) (to P.T.G.), University of Toronto (to P.T.G.), Leukemia and Lymphoma Society of Canada (to M.M.), and an NSERC training fellowship (to B.D.G.P.).</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32065" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32065" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lai, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, F. M.</span><span> </span><span class="NLM_article-title">Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1016%2Fj.drup.2010.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=20471303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVSmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=67-78&author=S.+Y.+Laiauthor=F.+M.+Johnson&title=Defining+the+role+of+the+JAK-STAT+pathway+in+head+and+neck+and+thoracic+malignancies%3A+Implications+for+future+therapeutic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches</span></div><div class="casAuthors">Lai, Stephen Y.; Johnson, Faye M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">67-78</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the role of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway has been most extensively studied in hematopoietic cells and hematol. malignancies, it is also activated in epithelial tumors, including those originating in the lungs and head and neck.  The canonical pathway involves the activation of JAK following ligand binding to cytokine receptors.  The activated JAKs then phosphorylate STAT proteins, leading to their dimerization and translocation into the nucleus.  In the nucleus, STATs act as transcription factors with pleiotropic downstream effects.  STATs can be activated independently of JAKs, most notably by c-Src kinases.  In cancer cells, STAT3 and STAT5 activation leads to the increased expression of downstream target genes, leading to increased cell proliferation, cell survival, angiogenesis, and immune system evasion.  STAT3 and STAT5 are expressed and activated in head and neck squamous cell carcinoma (HNSCC) where they contribute to cell survival and proliferation.  In HNSCC, STATs can be activated by a no. of signal transduction pathways, including the epidermal growth factor receptor (EGFR), α7 nicotinic receptor, interleukin (IL) receptor, and erythropoietin receptor pathways.  Activated STATs are also expressed in lung cancer, but the biol. effects of JAK/STAT inhibition in this cancer are variable.  In lung cancer, STAT3 can be activated by multiple pathways, including EGFR.  Several approaches have been used to inhibit STAT3 in the hopes of developing an antitumor agent.  Although several STAT3-specific agents are promising, none are in clin. development, mostly because of drug delivery and stability issues.  In contrast, several JAK inhibitors are in clin. development.  These orally available, ATP-competitive, small-mol. kinase inhibitors are being tested in myeloproliferative disorders.  Future studies will det. whether JAK inhibitors are useful in the treatment of HNSCC or lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZgZHT6MxwX7Vg90H21EOLACvtfcHk0ljlizI9N-vzEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVSmur8%253D&md5=76183fde53da20b0a15bb4f000feb8f5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2010.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2010.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DS.%2BY.%26aulast%3DJohnson%26aufirst%3DF.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520the%2520JAK-STAT%2520pathway%2520in%2520head%2520and%2520neck%2520and%2520thoracic%2520malignancies%253A%2520Implications%2520for%2520future%2520therapeutic%2520approaches%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2010%26volume%3D13%26spage%3D67%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Müller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">Discovery of chromone-based inhibitors of the transcription factor STAT5</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=723-727&author=J.+M%C3%BCllerauthor=B.+Sperlauthor=W.+Reindlauthor=A.+Kiesslingauthor=T.+Berg&title=Discovery+of+chromone-based+inhibitors+of+the+transcription+factor+STAT5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DJ.%26aulast%3DSperl%26aufirst%3DB.%26aulast%3DReindl%26aufirst%3DW.%26aulast%3DKiessling%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520chromone-based%2520inhibitors%2520of%2520the%2520transcription%2520factor%2520STAT5%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D723%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Page, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Signal transducer and activator of transcription 3 inhibitors: A patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1517%2F13543776.2011.539205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=21114420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFyktrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=65-83&author=B.+D.+Pageauthor=D.+P.+Ballauthor=P.+T.+Gunning&title=Signal+transducer+and+activator+of+transcription+3+inhibitors%3A+A+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transducer and activator of transcription 3 inhibitors: a patent review</span></div><div class="casAuthors">Page, Brent D. G.; Ball, Daniel P.; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-83</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Aberrant activation of signal transducer and activator of transcription (Stat) 3, a member of the STAT family of proteins, is prevalent in numerous human cancers and is now widely recognized as a crit. mol. abnormality and a master regulator of tumor processes.  Thus, the identification of potent and selective Stat3 inhibitors will have a high com. potential as anticancer drugs, given the many tumors in which Stat3 is implicated.  Areas covered in this review: This review covers the structures and activities of direct inhibitors of Stat3 protein activity described in the patent literature since the research field's inception in 2001.  The patents reviewed include peptide and peptidomimetic compds., small mols., oligonucleotides and platinum-based Stat3 inhibitors.  What the reader will gain: Readers will gain an understanding of how Stat3 protein function has been inhibited by a wide variety of structurally diverse therapeutic compds.  Readers will learn about which classes of patented Stat3 inhibitors are most advanced toward clin. trials, and will be exposed to the proposed mechanisms of inhibition and scope of their application in treating human cancers.  Take home message: Numerous groups have shown that in vivo administration of inhibitors of activated Stat3 induce human tumor regression in xenograft models.  Indeed, the growing no. of preclin. studies in numerous cancer types, as well as the first Phase 0 clin. trial of a Stat3 inhibitor, suggest that Stat3 is a valid and exciting therapeutic target for mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogO9J3Yw_G5bVg90H21EOLACvtfcHk0lhbL7cB8BpI3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFyktrvJ&md5=338065a442a0de9993a90b1c25a5e084</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.539205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.539205%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DBall%26aufirst%3DD.%2BP.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DSignal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520inhibitors%253A%2520A%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D65%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewry, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahani, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, B. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein</span> <span class="citation_source-journal">Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1139%2FO09-044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=19935868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGjsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=825-833&author=S.+Fletcherauthor=J.+A.+Drewryauthor=V.+M.+Shahaniauthor=B.+D.+G.+Pageauthor=P.+T.+Gunning&title=Molecular+disruption+of+oncogenic+signal+transducer+and+activator+of+transcription+3+%28STAT3%29+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein</span></div><div class="casAuthors">Fletcher, Steven; Drewry, Joel A.; Shahani, Vijay M.; Page, Brent D. G.; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">825-833</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review.  Signal transducer and activator of transcription protein 3 (STAT3) is a latent cytosolic transcription factor that is widely recognized as being a master regulator of the cellular functions that lead to the cancer phenotype.  Constitutively activated STAT3 protein activity is routinely obsd. in human cancers, promoting uncontrolled cell proliferation and suppressing apoptosis.  Until relatively recently, inhibition of STAT3 transcriptional activity was achieved indirectly via suppression of upstream kinase activators and extracellular cytokine and (or) growth factor stimuli.  However, activated STAT3 forms transcriptionally functional STAT3-STAT3 dimers, providing a valid juncture for targeted downstream mol. inhibition.  STAT3's prominent role in cancer has seen a decade of innovative and novel approaches to targeting constitutively active STAT3 protein-protein complexes.  This mini-review outlines the progress made towards identifying mol. agents capable of silencing aberrant STAT3 signaling through the disruption of STAT3 complexation events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu6ixTckciHLVg90H21EOLACvtfcHk0lhbL7cB8BpI3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGjsrzL&md5=fd14e8ec8d52605bfaac7e83dca75d21</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1139%2FO09-044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252FO09-044%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DDrewry%26aufirst%3DJ.%2BA.%26aulast%3DShahani%26aufirst%3DV.%2BM.%26aulast%3DPage%26aufirst%3DB.%2BD.%2BG.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DMolecular%2520disruption%2520of%2520oncogenic%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520%2528STAT3%2529%2520protein%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D87%26spage%3D825%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Haftchenary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avadisian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Inhibiting aberrant Stat3 function with molecular therapeutics: A progress report</span> <span class="citation_source-journal">Anticancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=115-127&author=S.+Haftchenaryauthor=M.+Avadisianauthor=P.+T.+Gunning&title=Inhibiting+aberrant+Stat3+function+with+molecular+therapeutics%3A+A+progress+report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaftchenary%26aufirst%3DS.%26aulast%3DAvadisian%26aufirst%3DM.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DInhibiting%2520aberrant%2520Stat3%2520function%2520with%2520molecular%2520therapeutics%253A%2520A%2520progress%2520report%26jtitle%3DAnticancer%2520Drugs%26date%3D2011%26volume%3D22%26spage%3D115%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Neculai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neculai, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfitzner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span> </span><span class="NLM_article-title">Structure of the unphosphorylated STAT5a dimer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">40782</span><span class="NLM_x">–</span> <span class="NLM_lpage">40787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=40782-40787&author=D.+Neculaiauthor=A.+M.+Neculaiauthor=S.+Verrierauthor=K.+Straubauthor=K.+Klumppauthor=E.+Pfitznerauthor=S.+Becker&title=Structure+of+the+unphosphorylated+STAT5a+dimer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeculai%26aufirst%3DD.%26aulast%3DNeculai%26aufirst%3DA.%2BM.%26aulast%3DVerrier%26aufirst%3DS.%26aulast%3DStraub%26aufirst%3DK.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DPfitzner%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%26atitle%3DStructure%2520of%2520the%2520unphosphorylated%2520STAT5a%2520dimer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D40782%26epage%3D40787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Tan, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, M. T.</span><span> </span><span class="NLM_article-title">Signal transducer and activator of transcription 5A/B in prostate and breast cancers</span> <span class="citation_source-journal">Endocr. Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1677%2FERC-08-0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=18508994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVGjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=367-390&author=S.+H.+Tanauthor=M.+T.+Nevalainen&title=Signal+transducer+and+activator+of+transcription+5A%2FB+in+prostate+and+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transducer and activator of transcription 5A/B in prostate and breast cancers</span></div><div class="casAuthors">Tan, Shyh-Han; Nevalainen, Marja T.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine-Related Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">367-390</span>CODEN:
                <span class="NLM_cas:coden">ERCAE9</span>;
        ISSN:<span class="NLM_cas:issn">1351-0088</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">A review.  Protein kinase signaling pathways, such as Janus kinase 2-Signal transducer and activator of transcription 5A/B (JAK2-STAT5A/B), are of significant interest in the search for new therapeutic strategies in both breast and prostate cancers.  In prostate cancer, the components of the JAK2-STAT5A/B signaling pathway provide mol. targets for small-mol. inhibition of survival and growth signals of the cells.  At the same time, new evidence suggests that the STAT5A/B signaling pathway is involved in the transition of organ-confined prostate cancer to hormone-refractory disease.  This implies that the active JAK2-STAT5A/B signaling pathway potentially provides the means for pharmacol. intervention of clin. prostate cancer progression.  In addn., active STAT5A/B may serve as a prognostic marker for identification of those primary prostate cancers that are likely to progress to aggressive disease.  In breast cancer, the role of STAT5A/B is more complex.  STAT5A/B may have a dual role in the regulation of malignant mammary epithelium.  Data accumulated from mouse models of breast cancer suggest that in early stages of breast cancer STAT5A/B may promote malignant transformation and enhance growth of the tumor.  This is in contrast to established breast cancer, where STAT5A/B may mediate the crit. cues for maintaining the differentiation of mammary epithelium.  In addn., present data suggest that activation of STAT5A/B in breast cancer predicts favorable clin. outcome.  The dual nature of STAT5A/B action in breast cancer makes the therapeutic use of STAT5 A/B more complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0kOyp-BAmKrVg90H21EOLACvtfcHk0lgzxz-LQ46KQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVGjsrw%253D&md5=eff440bb054c1e33352e71a8b26b72e3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1677%2FERC-08-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252FERC-08-0013%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%2BH.%26aulast%3DNevalainen%26aufirst%3DM.%2BT.%26atitle%3DSignal%2520transducer%2520and%2520activator%2520of%2520transcription%25205A%252FB%2520in%2520prostate%2520and%2520breast%2520cancers%26jtitle%3DEndocr.%2520Relat.%2520Cancer%26date%3D2008%26volume%3D15%26spage%3D367%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ferbeyre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span> </span><span class="NLM_article-title">The role of Stat5 transcription factors as tumor suppressors or oncogenes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1815</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1815&publication_year=2011&pages=104-114&author=G.+Ferbeyreauthor=R.+Moriggl&title=The+role+of+Stat5+transcription+factors+as+tumor+suppressors+or+oncogenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerbeyre%26aufirst%3DG.%26aulast%3DMoriggl%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520Stat5%2520transcription%2520factors%2520as%2520tumor%2520suppressors%2520or%2520oncogenes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1815%26spage%3D104%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debierre-Grockiego, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capiod, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claisse, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delobel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prin, L.</span><span> </span><span class="NLM_article-title">Activated Stat related transcription factors in acute leukemia</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.3109%2F10428199709058334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=9498707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis1arsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1997&pages=83-88&author=V.+Gouilleux-Gruartauthor=F.+Debierre-Grockiegoauthor=F.+Gouilleuxauthor=J.+C.+Capiodauthor=J.+F.+Claisseauthor=J.+Delobelauthor=L.+Prin&title=Activated+Stat+related+transcription+factors+in+acute+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Activated Stat related transcription factors in acute leukemia</span></div><div class="casAuthors">Gouilleux-Gruart, Valerie; Debierre-Grockiego, Francoise; Gouilleux, Fabrice; Capiod, Jean-Claude; Claisse, Jean-Francois; Delobel, Jacques; Prin, Lionel</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">83-88</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">A review with 48 refs.  Cell proliferation and differentiation are under the control of cytokines and growth factors.  Different signaling pathways are involved in the transmission of a specific signal through successive phosphorylation and dephosphorylation of proteins leading to gene transcription necessary for growth and differentiation.  The cytokines and growth factors activate the Stat family of transcription factors.  The Jak-Stat pathway is essential for cytokine signal transduction.  Dysregulation of this cascade might lead to uncontrolled hematopoiesis.  Studies have been carried out to examine the functionality of this pathway in cells from patients with acute leukemia.  Members of the Stat protein family (Stat1, Stat3 and Stat5) are constitutively activated in cells collected from some acute leukemias suggesting dysregulation of the Jak-Stat pathway.  Evidence of the existence of constitutively activated spliced variants of Stat3 and Stat5 proteins are described.  The mechanisms of such activation remain to be clarified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTIAQtiJJmd7Vg90H21EOLACvtfcHk0lgzxz-LQ46KQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis1arsLw%253D&md5=fcc96d3e8c66aadaeffd6855dc14a3b4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3109%2F10428199709058334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428199709058334%26sid%3Dliteratum%253Aachs%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DDebierre-Grockiego%26aufirst%3DF.%26aulast%3DGouilleux%26aufirst%3DF.%26aulast%3DCapiod%26aufirst%3DJ.%2BC.%26aulast%3DClaisse%26aufirst%3DJ.%2BF.%26aulast%3DDelobel%26aufirst%3DJ.%26aulast%3DPrin%26aufirst%3DL.%26atitle%3DActivated%2520Stat%2520related%2520transcription%2520factors%2520in%2520acute%2520leukemia%26jtitle%3DLeuk.%2520Lymphoma%26date%3D1997%26volume%3D28%26spage%3D83%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desaint, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claisse, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capiod, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delobel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber-Nordt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusanter-Fourt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyfus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prin, L.</span><span> </span><span class="NLM_article-title">STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1692</span><span class="NLM_x">–</span> <span class="NLM_lpage">1697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=1692-1697&author=V.+Gouilleux-Gruartauthor=F.+Gouilleuxauthor=C.+Desaintauthor=J.+C.+Claisseauthor=J.+F.+Capiodauthor=J.+Delobelauthor=R.+Weber-Nordtauthor=I.+Dusanter-Fourtauthor=F.+Dreyfusauthor=B.+Gronerauthor=L.+Prin&title=STAT-related+transcription+factors+are+constitutively+activated+in+peripheral+blood+cells+from+acute+leukemia+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DGouilleux%26aufirst%3DF.%26aulast%3DDesaint%26aufirst%3DC.%26aulast%3DClaisse%26aufirst%3DJ.%2BC.%26aulast%3DCapiod%26aufirst%3DJ.%2BF.%26aulast%3DDelobel%26aufirst%3DJ.%26aulast%3DWeber-Nordt%26aufirst%3DR.%26aulast%3DDusanter-Fourt%26aufirst%3DI.%26aulast%3DDreyfus%26aufirst%3DF.%26aulast%3DGroner%26aufirst%3DB.%26aulast%3DPrin%26aufirst%3DL.%26atitle%3DSTAT-related%2520transcription%2520factors%2520are%2520constitutively%2520activated%2520in%2520peripheral%2520blood%2520cells%2520from%2520acute%2520leukemia%2520patients%26jtitle%3DBlood%26date%3D1996%26volume%3D87%26spage%3D1692%26epage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Weber-Nordt, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertelsmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, J.</span><span> </span><span class="NLM_article-title">Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1996&pages=809-816&author=R.+M.+Weber-Nordtauthor=C.+Egenauthor=J.+Wehingerauthor=W.+Ludwigauthor=V.+Gouilleux-Gruartauthor=R.+Mertelsmannauthor=J.+Finke&title=Constitutive+activation+of+STAT+proteins+in+primary+lymphoid+and+myeloid+leukemia+cells+and+in+Epstein-Barr+virus+%28EBV%29-related+lymphoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber-Nordt%26aufirst%3DR.%2BM.%26aulast%3DEgen%26aufirst%3DC.%26aulast%3DWehinger%26aufirst%3DJ.%26aulast%3DLudwig%26aufirst%3DW.%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DMertelsmann%26aufirst%3DR.%26aulast%3DFinke%26aufirst%3DJ.%26atitle%3DConstitutive%2520activation%2520of%2520STAT%2520proteins%2520in%2520primary%2520lymphoid%2520and%2520myeloid%2520leukemia%2520cells%2520and%2520in%2520Epstein-Barr%2520virus%2520%2528EBV%2529-related%2520lymphoma%2520cell%2520lines%26jtitle%3DBlood%26date%3D1996%26volume%3D88%26spage%3D809%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vannucchi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passamonti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervantes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">JAK inhibitor therapy for myelofibrosis: Critical assessment of value and limitations</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=218-225&author=A.+Pardananiauthor=A.+M.+Vannucchiauthor=F.+Passamontiauthor=F.+Cervantesauthor=T.+Barbuiauthor=A.+Tefferi&title=JAK+inhibitor+therapy+for+myelofibrosis%3A+Critical+assessment+of+value+and+limitations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DVannucchi%26aufirst%3DA.%2BM.%26aulast%3DPassamonti%26aufirst%3DF.%26aulast%3DCervantes%26aufirst%3DF.%26aulast%3DBarbui%26aufirst%3DT.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DJAK%2520inhibitor%2520therapy%2520for%2520myelofibrosis%253A%2520Critical%2520assessment%2520of%2520value%2520and%2520limitations%26jtitle%3DLeukemia%26date%3D2011%26volume%3D25%26spage%3D218%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Quintás-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=127-140&author=A.+Quint%C3%A1s-Cardamaauthor=H.+Kantarjianauthor=J.+Cortesauthor=S.+Verstovsek&title=Janus+kinase+inhibitors+for+the+treatment+of+myeloproliferative+neoplasias+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuint%25C3%25A1s-Cardama%26aufirst%3DA.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasias%2520and%2520beyond%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">A high-throughput assay for signal transducer and activator of transcription 5b based on fluorescence polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2008&pages=249-254&author=J.+Mullerauthor=J.+Schustauthor=T.+Berg&title=A+high-throughput+assay+for+signal+transducer+and+activator+of+transcription+5b+based+on+fluorescence+polarization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DSchust%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DA%2520high-throughput%2520assay%2520for%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25205b%2520based%2520on%2520fluorescence%2520polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D375%26spage%3D249%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Siddiquee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greedy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">7391</span><span class="NLM_x">–</span> <span class="NLM_lpage">7396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1073%2Fpnas.0609757104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=17463090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslWqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=7391-7396&author=K.+Siddiqueeauthor=S.+Zhangauthor=W.+C.+Guidaauthor=M.+A.+Blaskovichauthor=B.+Greedyauthor=H.+R.+Lawrenceauthor=M.+L.+R.+Yipauthor=R.+Joveauthor=M.+M.+McLaughlinauthor=N.+J.+Lawrenceauthor=S.+M.+Sebtiauthor=J.+Turkson&title=Selective+chemical+probe+inhibitor+of+Stat3%2C+identified+through+structure-based+virtual+screening%2C+induces+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Elective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity</span></div><div class="casAuthors">Siddiquee, Khandaker; Zhang, Shumin; Guida, Wayne C.; Blaskovich, Michelle A.; Greddy, Benjamin; Lawrence, Harshani R.; Yip, M. L. Richard; Jove, Richard; McLaughlin, Mark M.; Lawrence, Nicholas J.; Sebti, Said M.; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7391-7396</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">531-201 (NSC 74859) is a chem. probe inhibitor of Stat3 activity, which was identified from the National Cancer Institute chem. libraries by using structure-based virtual screening with a computer model of the Stat3 SH2 domain bound to its Stat3 phosphotyrosine peptide derived from the x-ray crystal structure of the Stat3β homodimer.  S3I-201 inhibits Stat3 · Stat3 complex formation and Stat3 DNA-binding and transcriptional activities.  Furthermore, S3I-201 inhibits growth and induces apoptosis preferentially in tumor cells that contain persistently activated Stat3.  Constitutively dimerized and active Stat3C and Stat3 SH2 domain rescue tumor cells from S3I-201-induced apoptosis.  Finally, S3I-201 inhibits the expression of the Stat3-regulated genes encoding cyclin D1, Bcl-xL, and surviving and inhibits the growth of human breast tumors in vivo.  These findings strongly suggest that the antitumor activity of S3I-201 is mediated in part through inhibition of aberrant Stat3 activation and provide the proof-of-concept for the potential clin. use of Stat3 inhibitors such as S3I-201 in tumors harboring aberrant Stat3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAfmqUniFENbVg90H21EOLACvtfcHk0lg3ygyGrslc0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslWqsbY%253D&md5=85decf56fc7852990f56c6f64165ad9d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0609757104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0609757104%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiquee%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DGreedy%26aufirst%3DB.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DSelective%2520chemical%2520probe%2520inhibitor%2520of%2520Stat3%252C%2520identified%2520through%2520structure-based%2520virtual%2520screening%252C%2520induces%2520antitumor%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D7391%26epage%3D7396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, B. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharmeen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahani, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Disruption of transcriptionally active stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: Potent in vitro and tumor cell activities</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1959</span><span class="NLM_x">–</span> <span class="NLM_lpage">1964</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1959-1964&author=S.+Fletcherauthor=J.+Singhauthor=X.+Zhangauthor=P.+Yueauthor=B.+D.+G.+Pageauthor=S.+Sharmeenauthor=V.+M.+Shahaniauthor=W.+Zhaoauthor=A.+D.+Schimmerauthor=J.+Turksonauthor=P.+T.+Gunning&title=Disruption+of+transcriptionally+active+stat3+dimers+with+non-phosphorylated%2C+salicylic+acid-based+small+molecules%3A+Potent+in+vitro+and+tumor+cell+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DPage%26aufirst%3DB.%2BD.%2BG.%26aulast%3DSharmeen%26aufirst%3DS.%26aulast%3DShahani%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26aulast%3DTurkson%26aufirst%3DJ.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DDisruption%2520of%2520transcriptionally%2520active%2520stat3%2520dimers%2520with%2520non-phosphorylated%252C%2520salicylic%2520acid-based%2520small%2520molecules%253A%2520Potent%2520in%2520vitro%2520and%2520tumor%2520cell%2520activities%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D1959%26epage%3D1964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1398-1409&author=X.+Zhangauthor=P.+Yueauthor=S.+Fletcherauthor=W.+Zhaoauthor=P.+T.+Gunningauthor=J.+Turkson&title=A+novel+small-molecule+disrupts+Stat3+SH2+domain-phosphotyrosine+interactions+and+Stat3-dependent+tumor+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small-molecule%2520disrupts%2520Stat3%2520SH2%2520domain-phosphotyrosine%2520interactions%2520and%2520Stat3-dependent%2520tumor%2520processes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1398%26epage%3D1409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasseur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, U.</span><span> </span><span class="NLM_article-title">A high-throughput STAT binding assay using fluorescence polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1997&pages=29-36&author=P.+Wuauthor=M.+Brasseurauthor=U.+Schindler&title=A+high-throughput+STAT+binding+assay+using+fluorescence+polarization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DBrasseur%26aufirst%3DM.%26aulast%3DSchindler%26aufirst%3DU.%26atitle%3DA%2520high-throughput%2520STAT%2520binding%2520assay%2520using%2520fluorescence%2520polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D249%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Schust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1016%2Fj.ab.2004.03.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=15183768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2004&pages=114-118&author=J.+Schustauthor=T.+Berg&title=A+high-throughput+fluorescence+polarization+assay+for+signal+transducer+and+activator+of+transcription+3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3</span></div><div class="casAuthors">Schust, Jochen; Berg, Thorsten</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-118</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Signal transducer and activator of transcription 3 (STAT3) is overactive in a wide variety of human tumors.  Activity of STAT3 requires its own SH2-domain-mediated binding to phosphotyrosine-contg. sequences.  We have developed a high-throughput binding assay, based on fluorescence polarization, which allows screening for small mols. that bind to the STAT3 SH2 domain and thereby inhibit its activity.  The basis for this assay is the binding of a fluorescein-labeled phosphotyrosine-peptide derived from the interleukin-6 receptor subunit gp130 to unphosphorylated STAT3 with a Kd of 150 nM.  The assay is stable with regard to salt concn., DMSO concn., and time.  It has been adapted to a 384-well format, with a Z' value of 0.87, and can be used to screen for small mols. that bind to the STAT3 SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVl15diFUVYrVg90H21EOLACvtfcHk0ljuE9DJrQg0Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslSjsLc%253D&md5=12e81ff2254c87f281669b719af08ad5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.03.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.03.024%26sid%3Dliteratum%253Aachs%26aulast%3DSchust%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DA%2520high-throughput%2520fluorescence%2520polarization%2520assay%2520for%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D330%26spage%3D114%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Bromberg, J.</span><span> </span><span class="NLM_article-title">Stat proteins and oncogenesis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=1139-1142&author=J.+Bromberg&title=Stat+proteins+and+oncogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromberg%26aufirst%3DJ.%26atitle%3DStat%2520proteins%2520and%2520oncogenesis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D1139%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0lgMttoU5NBdbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Quentmeier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaborski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, H. G.</span><span> </span><span class="NLM_article-title">FLT3 mutations in acute myeloid leukemia cell lines</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=120-124&author=H.+Quentmeierauthor=J.+Reinhardtauthor=M.+Zaborskiauthor=H.+G.+Drexler&title=FLT3+mutations+in+acute+myeloid+leukemia+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuentmeier%26aufirst%3DH.%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DZaborski%26aufirst%3DM.%26aulast%3DDrexler%26aufirst%3DH.%2BG.%26atitle%3DFLT3%2520mutations%2520in%2520acute%2520myeloid%2520leukemia%2520cell%2520lines%26jtitle%3DLeukemia%26date%3D2003%26volume%3D17%26spage%3D120%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">De Groot, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaijmakers, J. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, J. -. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenderman, L.</span><span> </span><span class="NLM_article-title">STAT5 activation by Bcr-Abl contributes to transformation of K562 leukemia cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1108</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1999&pages=1108-1112&author=R.+P.+De+Grootauthor=J.+A.+M.+Raaijmakersauthor=J.+-.+J.+Lammersauthor=R.+Joveauthor=L.+Koenderman&title=STAT5+activation+by+Bcr-Abl+contributes+to+transformation+of+K562+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGroot%26aufirst%3DR.%2BP.%26aulast%3DRaaijmakers%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DLammers%26aufirst%3DJ.%2B-.%2BJ.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DKoenderman%26aufirst%3DL.%26atitle%3DSTAT5%2520activation%2520by%2520Bcr-Abl%2520contributes%2520to%2520transformation%2520of%2520K562%2520leukemia%2520cells%26jtitle%3DBlood%26date%3D1999%26volume%3D94%26spage%3D1108%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Meinke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barahmand-Pour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohrl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoiber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, T.</span><span> </span><span class="NLM_article-title">Activation of different Stat5 isoforms contributes to cell-type- restricted signaling in response to interferons</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6937</span><span class="NLM_x">–</span> <span class="NLM_lpage">6944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1128%2FMCB.16.12.6937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=8943349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADyaK28XntVyksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=6937-6944&author=A.+Meinkeauthor=F.+Barahmand-Pourauthor=S.+Wohrlauthor=D.+Stoiberauthor=T.+Decker&title=Activation+of+different+Stat5+isoforms+contributes+to+cell-type-+restricted+signaling+in+response+to+interferons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons</span></div><div class="casAuthors">Meinke, Andreas; Barahmand-Pour, Fariba; Woehrl, Stefan; Stoiber, Dagmar</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6937-6944</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tyrosine phosphorylation and activation of the transcription factor Stat5 occur in response to stimuli like granulocyte-macrophage colony-stimulating factor, interleukin-3, or erythropoietin that stimulate both proliferation and differentiation of hematopoietic cells.  It is unclear whether Stat5 is part of a proliferative response or part of the events leading to cellular differentiation.  Here the authors report that agents promoting differentiation but not proliferation of hematopoietic cells, like phorbol ester or both types of interferons (IFNs), activate Stat5 in promonocytic U937 cells.  Both IFN types caused tyrosine phosphorylation and DNA binding of predominantly one Stat5 isoform (Stat5a) despite expression of both Stat5a and Stat5b proteins.  Monocytic differentiation of U937 cells led to a strong decrease in IFN-γ-mediated activation of Stat5 but not of Stat1.  Transactivation of Stat5-target genes occurred in response to IFN-γ, which activates both Stat5 and Stat1, but not in response to granulocyte-macrophage colony-stimulating factor, which activates only Stat5.  Tyrosine phosphorylation of Stat5 is not generally part of the IFN response.  IFN-γ did not cause Stat5 activation in HeLa cells, despite the expression of both Stat5 isoforms at similar levels.  By contrast, IFN-α caused tyrosine phosphorylation and DNA binding of exclusively the b isoform of Stat5, and activated Stat5b formed a DNA binding activity previously found in HeLa cells and designated IFN-α activation factor 2.  Taken together, the results demonstrate that ligand binding of IFN receptors leads to an isoform-specific activation of Stat5 in a restricted no. of cell lineages.  Moreover, they suggest that Stat5 might be part of the differentiation response of myeloid cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTnLtFVEeWD7Vg90H21EOLACvtfcHk0lgMttoU5NBdbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntVyksrY%253D&md5=9a6c436d8c8bd93fb2559974e80f8005</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.12.6937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.12.6937%26sid%3Dliteratum%253Aachs%26aulast%3DMeinke%26aufirst%3DA.%26aulast%3DBarahmand-Pour%26aufirst%3DF.%26aulast%3DWohrl%26aufirst%3DS.%26aulast%3DStoiber%26aufirst%3DD.%26aulast%3DDecker%26aufirst%3DT.%26atitle%3DActivation%2520of%2520different%2520Stat5%2520isoforms%2520contributes%2520to%2520cell-type-%2520restricted%2520signaling%2520in%2520response%2520to%2520interferons%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D6937%26epage%3D6944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Atsushi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, H.</span><span> </span><span class="NLM_article-title">Calpain is a signal transducer and activator of transcription (STAT)3 and Stat5 protease</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1850</span><span class="NLM_x">–</span> <span class="NLM_lpage">1852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=1850-1852&author=O.+Atsushiauthor=W.+Hiroshiauthor=H.+Fujita&title=Calpain+is+a+signal+transducer+and+activator+of+transcription+%28STAT%293+and+Stat5+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtsushi%26aufirst%3DO.%26aulast%3DHiroshi%26aufirst%3DW.%26aulast%3DFujita%26aufirst%3DH.%26atitle%3DCalpain%2520is%2520a%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%2520%2528STAT%25293%2520and%2520Stat5%2520protease%26jtitle%3DBlood%26date%3D2002%26volume%3D99%26spage%3D1850%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Yoshimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabbarzadeh-Tabrizi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocnik, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikushige, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagafuji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niiro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashi, K.</span><span> </span><span class="NLM_article-title">FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">5034</span><span class="NLM_x">–</span> <span class="NLM_lpage">5043</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=5034-5043&author=G.+Yoshimotoauthor=T.+Miyamotoauthor=S.+Jabbarzadeh-Tabriziauthor=T.+Iinoauthor=J.+L.+Rocnikauthor=Y.+Kikushigeauthor=Y.+Moriauthor=T.+Shimaauthor=H.+Iwasakiauthor=K.+Takenakaauthor=K.+Nagafujiauthor=S.+Mizunoauthor=H.+Niiroauthor=G.+D.+Gillilandauthor=K.+Akashi&title=FLT3-ITD+up-regulates+MCL-1+to+promote+survival+of+stem+cells+in+acute+myeloid+leukemia+via+FLT3-ITD-specific+STAT5+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimoto%26aufirst%3DG.%26aulast%3DMiyamoto%26aufirst%3DT.%26aulast%3DJabbarzadeh-Tabrizi%26aufirst%3DS.%26aulast%3DIino%26aufirst%3DT.%26aulast%3DRocnik%26aufirst%3DJ.%2BL.%26aulast%3DKikushige%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DY.%26aulast%3DShima%26aufirst%3DT.%26aulast%3DIwasaki%26aufirst%3DH.%26aulast%3DTakenaka%26aufirst%3DK.%26aulast%3DNagafuji%26aufirst%3DK.%26aulast%3DMizuno%26aufirst%3DS.%26aulast%3DNiiro%26aufirst%3DH.%26aulast%3DGilliland%26aufirst%3DG.%2BD.%26aulast%3DAkashi%26aufirst%3DK.%26atitle%3DFLT3-ITD%2520up-regulates%2520MCL-1%2520to%2520promote%2520survival%2520of%2520stem%2520cells%2520in%2520acute%2520myeloid%2520leukemia%2520via%2520FLT3-ITD-specific%2520STAT5%2520activation%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D5034%26epage%3D5043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 65 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jinyun Dong, Xiang-Dong Cheng, Wei-Dong Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Jiang-Jiang Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 8884-8915. <a href="https://doi.org/10.1021/acs.jmedchem.1c00629" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00629</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00629%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BUpdate%252Bon%252BDevelopment%252Bof%252BSmall-Molecule%252BSTAT3%252BInhibitors%252Bfor%252BCancer%252BTherapy%25253A%252BFrom%252BPhosphorylation%252BInhibition%252Bto%252BProtein%252BDegradation%26aulast%3DDong%26aufirst%3DJinyun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D06042021%26date%3D25062021%26volume%3D64%26issue%3D13%26spage%3D8884%26epage%3D8915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Julian Gräb, Angela Berg, Linda Blechschmidt, Barbara Klüver, Stefan Rubner, Darwin Y. Fu, Jens Meiler, Martin Gräber, <span class="NLM_string-name hlFld-ContribAuthor">Thorsten Berg</span>. </span><span class="cited-content_cbyCitation_article-title">The STAT5b Linker Domain Mediates the Selectivity of Catechol Bisphosphates for STAT5b over STAT5a. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (4)
                                     , 796-805. <a href="https://doi.org/10.1021/acschembio.9b00137" title="DOI URL">https://doi.org/10.1021/acschembio.9b00137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00137%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DThe%252BSTAT5b%252BLinker%252BDomain%252BMediates%252Bthe%252BSelectivity%252Bof%252BCatechol%252BBisphosphates%252Bfor%252BSTAT5b%252Bover%252BSTAT5a%26aulast%3DGr%25C3%25A4b%26aufirst%3DJulian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D20022019%26date%3D05032019%26date%3D18032019%26date%3D05032019%26volume%3D14%26issue%3D4%26spage%3D796%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abbarna A.  Cumaraswamy</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Lewis</span>, <span class="hlFld-ContribAuthor ">Mulu  Geletu</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Todic</span>, <span class="hlFld-ContribAuthor ">Diego B.  Diaz</span>, <span class="hlFld-ContribAuthor ">Xin Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">Carla E.  Brown</span>, <span class="hlFld-ContribAuthor ">Rob C.  Laister</span>, <span class="hlFld-ContribAuthor ">David  Muench</span>, <span class="hlFld-ContribAuthor ">Kagan  Kerman</span>, <span class="hlFld-ContribAuthor ">H. Leighton  Grimes</span>, <span class="hlFld-ContribAuthor ">Mark D.  Minden</span>, and <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>  . </span><span class="cited-content_cbyCitation_article-title">Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (11)
                                     , 1202-1206. <a href="https://doi.org/10.1021/ml500165r" title="DOI URL">https://doi.org/10.1021/ml500165r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500165r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500165r%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNanomolar-Potency%252BSmall%252BMolecule%252BInhibitor%252Bof%252BSTAT5%252BProtein%26aulast%3DCumaraswamy%26aufirst%3DAbbarna%2BA.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D27042014%26date%3D19092014%26date%3D03102014%26date%3D13112014%26date%3D19092014%26volume%3D5%26issue%3D11%26spage%3D1202%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alvina I.  Khamidullina</span>, <span class="hlFld-ContribAuthor ">Ekaterina A.  Varlamova</span>, <span class="hlFld-ContribAuthor ">Nour Alhuda  Hammoud</span>, <span class="hlFld-ContribAuthor ">Margarita A.  Yastrebova</span>, <span class="hlFld-ContribAuthor ">Alexandra V.  Bruter</span>. </span><span class="cited-content_cbyCitation_article-title">Gene Transcription as a Therapeutic Target in Leukemia. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (14)
                                     , 7340. <a href="https://doi.org/10.3390/ijms22147340" title="DOI URL">https://doi.org/10.3390/ijms22147340</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22147340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22147340%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DGene%252BTranscription%252Bas%252Ba%252BTherapeutic%252BTarget%252Bin%252BLeukemia%26aulast%3DKhamidullina%26aufirst%3DAlvina%2BI.%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D14%26spage%3D7340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miriam  Pons</span>, <span class="hlFld-ContribAuthor ">Yanira  Zeyn</span>, <span class="hlFld-ContribAuthor ">Stella  Zahn</span>, <span class="hlFld-ContribAuthor ">Nisintha  Mahendrarajah</span>, <span class="hlFld-ContribAuthor ">Brent D. G.  Page</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Walburgis  Brenner</span>, <span class="hlFld-ContribAuthor ">Falk  Butter</span>, <span class="hlFld-ContribAuthor ">Oliver H.  Krämer</span>. </span><span class="cited-content_cbyCitation_article-title">Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (14)
                                     , 3464. <a href="https://doi.org/10.3390/cancers13143464" title="DOI URL">https://doi.org/10.3390/cancers13143464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13143464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13143464%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DOncogenic%252BKinase%252BCascades%252BInduce%252BMolecular%252BMechanisms%252BThat%252BProtect%252BLeukemic%252BCell%252BModels%252Bfrom%252BLethal%252BEffects%252Bof%252BDe%252BNovo%252BdNTP%252BSynthesis%252BInhibition%26aulast%3DPons%26aufirst%3DMiriam%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D14%26spage%3D3464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Léopold  Thabault</span>, <span class="hlFld-ContribAuthor ">Maxime  Liberelle</span>, <span class="hlFld-ContribAuthor ">Raphaël  Frédérick</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting protein self-association in drug design. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>26 </em>
                                    (5)
                                     , 1148-1163. <a href="https://doi.org/10.1016/j.drudis.2021.01.028" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.01.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.01.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.01.028%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DTargeting%252Bprotein%252Bself-association%252Bin%252Bdrug%252Bdesign%26aulast%3DThabault%26aufirst%3DL%25C3%25A9opold%26date%3D2021%26volume%3D26%26issue%3D5%26spage%3D1148%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marion  Polomski</span>, <span class="hlFld-ContribAuthor ">Marie  Brachet‐Botineau</span>, <span class="hlFld-ContribAuthor ">Ludovic  Juen</span>, <span class="hlFld-ContribAuthor ">Marie‐Claude  Viaud‐Massuard</span>, <span class="hlFld-ContribAuthor ">Fabrice  Gouilleux</span>, <span class="hlFld-ContribAuthor ">Gildas  Prié</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors Targeting STAT5 Signaling in Myeloid Leukemias: New Tetrahydroquinoline Derivatives with Improved Antileukemic Potential. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (6)
                                     , 1034-1046. <a href="https://doi.org/10.1002/cmdc.202000841" title="DOI URL">https://doi.org/10.1002/cmdc.202000841</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000841&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000841%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DInhibitors%252BTargeting%252BSTAT5%252BSignaling%252Bin%252BMyeloid%252BLeukemias%25253A%252BNew%252BTetrahydroquinoline%252BDerivatives%252Bwith%252BImproved%252BAntileukemic%252BPotential%26aulast%3DPolomski%26aufirst%3DMarion%26date%3D2021%26date%3D2021%26volume%3D16%26issue%3D6%26spage%3D1034%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Maranto</span>, <span class="hlFld-ContribAuthor ">Vindhya  Udhane</span>, <span class="hlFld-ContribAuthor ">Jing  Jia</span>, <span class="hlFld-ContribAuthor ">Ranjit  Verma</span>, <span class="hlFld-ContribAuthor ">Gerhard  Müller-Newen</span>, <span class="hlFld-ContribAuthor ">Peter S.  LaViolette</span>, <span class="hlFld-ContribAuthor ">Michael  Pereckas</span>, <span class="hlFld-ContribAuthor ">Lavannya  Sabharwal</span>, <span class="hlFld-ContribAuthor ">Scott  Terhune</span>, <span class="hlFld-ContribAuthor ">Nagarajan  Pattabiraman</span>, <span class="hlFld-ContribAuthor ">Vincent C.O.  Njar</span>, <span class="hlFld-ContribAuthor ">John D.  Imig</span>, <span class="hlFld-ContribAuthor ">Liang  Wang</span>, <span class="hlFld-ContribAuthor ">Marja T.  Nevalainen</span>. </span><span class="cited-content_cbyCitation_article-title">Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (11)
                                     , 3412. <a href="https://doi.org/10.3390/cancers12113412" title="DOI URL">https://doi.org/10.3390/cancers12113412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12113412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12113412%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DProspects%252Bfor%252BClinical%252BDevelopment%252Bof%252BStat5%252BInhibitor%252BIST5-002%25253A%252BHigh%252BTranscriptomic%252BSpecificity%252Bin%252BProstate%252BCancer%252Band%252BLow%252BToxicity%252BIn%252BVivo%26aulast%3DMaranto%26aufirst%3DCristina%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D11%26spage%3D3412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clarissa Esmeralda  Halim</span>, <span class="hlFld-ContribAuthor ">Shuo  Deng</span>, <span class="hlFld-ContribAuthor ">Mei Shan  Ong</span>, <span class="hlFld-ContribAuthor ">Celestial T.  Yap</span>. </span><span class="cited-content_cbyCitation_article-title">Involvement of STAT5 in Oncogenesis. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2020,</strong> <em>8 </em>
                                    (9)
                                     , 316. <a href="https://doi.org/10.3390/biomedicines8090316" title="DOI URL">https://doi.org/10.3390/biomedicines8090316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines8090316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines8090316%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DInvolvement%252Bof%252BSTAT5%252Bin%252BOncogenesis%26aulast%3DHalim%26aufirst%3DClarissa%2BEsmeralda%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D9%26spage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julian  Gräb</span>, <span class="hlFld-ContribAuthor ">Thorsten  Berg</span>. </span><span class="cited-content_cbyCitation_article-title">The Selectivity of Fosfosal for STAT5b over STAT5a is Mediated by Arg566 in the Linker Domain. </span><span class="cited-content_cbyCitation_journal-name">ChemBioChem</span><span> <strong>2020,</strong> <em>21 </em>
                                    (16)
                                     , 2264-2267. <a href="https://doi.org/10.1002/cbic.202000111" title="DOI URL">https://doi.org/10.1002/cbic.202000111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbic.202000111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbic.202000111%26sid%3Dliteratum%253Aachs%26jtitle%3DChemBioChem%26atitle%3DThe%252BSelectivity%252Bof%252BFosfosal%252Bfor%252BSTAT5b%252Bover%252BSTAT5a%252Bis%252BMediated%252Bby%252BArg566%252Bin%252Bthe%252BLinker%252BDomain%26aulast%3DGr%25C3%25A4b%26aufirst%3DJulian%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D16%26spage%3D2264%26epage%3D2267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Chen</span>, <span class="hlFld-ContribAuthor ">Angela N.  Koehler</span>. </span><span class="cited-content_cbyCitation_article-title">Transcription Factor Inhibition: Lessons Learned and Emerging Targets. </span><span class="cited-content_cbyCitation_journal-name">Trends in Molecular Medicine</span><span> <strong>2020,</strong> <em>26 </em>
                                    (5)
                                     , 508-518. <a href="https://doi.org/10.1016/j.molmed.2020.01.004" title="DOI URL">https://doi.org/10.1016/j.molmed.2020.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molmed.2020.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molmed.2020.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Molecular%2520Medicine%26atitle%3DTranscription%252BFactor%252BInhibition%25253A%252BLessons%252BLearned%252Band%252BEmerging%252BTargets%26aulast%3DChen%26aufirst%3DAndrew%26date%3D2020%26volume%3D26%26issue%3D5%26spage%3D508%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuyao  Huang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhong</span>, <span class="hlFld-ContribAuthor ">Hui  Dong</span>, <span class="hlFld-ContribAuthor ">Qiyao  Zheng</span>, <span class="hlFld-ContribAuthor ">Shuo  Shi</span>, <span class="hlFld-ContribAuthor ">Kai  Zhu</span>, <span class="hlFld-ContribAuthor ">Xinming  Qu</span>, <span class="hlFld-ContribAuthor ">Wenhao  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaolei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanxiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>187 </em>, 111922. <a href="https://doi.org/10.1016/j.ejmech.2019.111922" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111922%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevisiting%252Bsignal%252Btransducer%252Band%252Bactivator%252Bof%252Btranscription%252B3%252B%252528STAT3%252529%252Bas%252Ban%252Banticancer%252Btarget%252Band%252Bits%252Binhibitor%252Bdiscovery%25253A%252BWhere%252Bare%252Bwe%252Band%252Bwhere%252Bshould%252Bwe%252Bgo%25253F%26aulast%3DHuang%26aufirst%3DQiuyao%26date%3D2020%26volume%3D187%26spage%3D111922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">O. A.  Lodochnikova</span>, <span class="hlFld-ContribAuthor ">E. A.  Akhmetshina</span>, <span class="hlFld-ContribAuthor ">E. R.  Mingaleva</span>, <span class="hlFld-ContribAuthor ">V. A.  Startseva</span>, <span class="hlFld-ContribAuthor ">I. A.  Litvinov</span>, <span class="hlFld-ContribAuthor ">V. V.  Plemenkov</span>, <span class="hlFld-ContribAuthor ">L. E.  Nikitina</span>. </span><span class="cited-content_cbyCitation_article-title">Stable and reproducible supramolecular motif in the crystal structure of sulfonamides of the benzothiazine series fused to an epoxybornane moiety. </span><span class="cited-content_cbyCitation_journal-name">Russian Chemical Bulletin</span><span> <strong>2020,</strong> <em>69 </em>
                                    (2)
                                     , 313-319. <a href="https://doi.org/10.1007/s11172-020-2762-2" title="DOI URL">https://doi.org/10.1007/s11172-020-2762-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11172-020-2762-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11172-020-2762-2%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Chemical%2520Bulletin%26atitle%3DStable%252Band%252Breproducible%252Bsupramolecular%252Bmotif%252Bin%252Bthe%252Bcrystal%252Bstructure%252Bof%252Bsulfonamides%252Bof%252Bthe%252Bbenzothiazine%252Bseries%252Bfused%252Bto%252Ban%252Bepoxybornane%252Bmoiety%26aulast%3DLodochnikova%26aufirst%3DO.%2BA.%26date%3D2020%26date%3D2020%26volume%3D69%26issue%3D2%26spage%3D313%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert A.  Cerulli</span>, <span class="hlFld-ContribAuthor ">Joshua A.  Kritzer</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphotyrosine isosteres: past, present and future. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (4)
                                     , 583-605. <a href="https://doi.org/10.1039/C9OB01998G" title="DOI URL">https://doi.org/10.1039/C9OB01998G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB01998G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB01998G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DPhosphotyrosine%252Bisosteres%25253A%252Bpast%25252C%252Bpresent%252Band%252Bfuture%26aulast%3DCerulli%26aufirst%3DRobert%2BA.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D4%26spage%3D583%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manlio  Tolomeo</span>, <span class="hlFld-ContribAuthor ">Maria  Meli</span>, <span class="hlFld-ContribAuthor ">Stefania  Grimaudo</span>. </span><span class="cited-content_cbyCitation_article-title">STAT5 and STAT5 Inhibitors in Hematological Malignancies. </span><span class="cited-content_cbyCitation_journal-name">Anti-Cancer Agents in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>19 </em>
                                    (17)
                                     , 2036-2046. <a href="https://doi.org/10.2174/1871520619666190906160848" title="DOI URL">https://doi.org/10.2174/1871520619666190906160848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1871520619666190906160848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1871520619666190906160848%26sid%3Dliteratum%253Aachs%26jtitle%3DAnti-Cancer%2520Agents%2520in%2520Medicinal%2520Chemistry%26atitle%3DSTAT5%252Band%252BSTAT5%252BInhibitors%252Bin%252BHematological%252BMalignancies%26aulast%3DTolomeo%26aufirst%3DManlio%26date%3D2020%26volume%3D19%26issue%3D17%26spage%3D2036%26epage%3D2046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Phoebe F.  Lamie</span>, <span class="hlFld-ContribAuthor ">John N.  Philoppes</span>. </span><span class="cited-content_cbyCitation_article-title">2-Thiopyrimidine/chalcone hybrids: design, synthesis, ADMET prediction, and anticancer evaluation as STAT3/STAT5a inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 864-879. <a href="https://doi.org/10.1080/14756366.2020.1740922" title="DOI URL">https://doi.org/10.1080/14756366.2020.1740922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1740922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1740922%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3D2-Thiopyrimidine%25252Fchalcone%252Bhybrids%25253A%252Bdesign%25252C%252Bsynthesis%25252C%252BADMET%252Bprediction%25252C%252Band%252Banticancer%252Bevaluation%252Bas%252BSTAT3%25252FSTAT5a%252Binhibitors%26aulast%3DLamie%26aufirst%3DPhoebe%2BF.%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D864%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Brachet-Botineau</span>, <span class="hlFld-ContribAuthor ">Marion  Polomski</span>, <span class="hlFld-ContribAuthor ">Heidi A.  Neubauer</span>, <span class="hlFld-ContribAuthor ">Ludovic  Juen</span>, <span class="hlFld-ContribAuthor ">Damien  Hédou</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Viaud-Massuard</span>, <span class="hlFld-ContribAuthor ">Gildas  Prié</span>, <span class="hlFld-ContribAuthor ">Fabrice  Gouilleux</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (1)
                                     , 240. <a href="https://doi.org/10.3390/cancers12010240" title="DOI URL">https://doi.org/10.3390/cancers12010240</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12010240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12010240%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DPharmacological%252BInhibition%252Bof%252BOncogenic%252BSTAT3%252Band%252BSTAT5%252BSignaling%252Bin%252BHematopoietic%252BCancers%26aulast%3DBrachet-Botineau%26aufirst%3DMarie%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D1%26spage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ee Lin  Wong</span>, <span class="hlFld-ContribAuthor ">Eric  Nawrotzky</span>, <span class="hlFld-ContribAuthor ">Christoph  Arkona</span>, <span class="hlFld-ContribAuthor ">Boo Geun  Kim</span>, <span class="hlFld-ContribAuthor ">Samuel  Beligny</span>, <span class="hlFld-ContribAuthor ">Xinning  Wang</span>, <span class="hlFld-ContribAuthor ">Stefan  Wagner</span>, <span class="hlFld-ContribAuthor ">Michael  Lisurek</span>, <span class="hlFld-ContribAuthor ">Dirk  Carstanjen</span>, <span class="hlFld-ContribAuthor ">Jörg  Rademann</span>. </span><span class="cited-content_cbyCitation_article-title">The transcription factor STAT5 catalyzes Mannich ligation reactions yielding inhibitors of leukemic cell proliferation. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-07923-2" title="DOI URL">https://doi.org/10.1038/s41467-018-07923-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-07923-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-07923-2%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DThe%252Btranscription%252Bfactor%252BSTAT5%252Bcatalyzes%252BMannich%252Bligation%252Breactions%252Byielding%252Binhibitors%252Bof%252Bleukemic%252Bcell%252Bproliferation%26aulast%3DWong%26aufirst%3DEe%2BLin%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Christina  Wagner</span>, <span class="hlFld-ContribAuthor ">Elvin D.  de Araujo</span>, <span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">Heidi A.  Neubauer</span>, <span class="hlFld-ContribAuthor ">Marco  Herling</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Targeting Options for STAT3 and STAT5 in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (12)
                                     , 1930. <a href="https://doi.org/10.3390/cancers11121930" title="DOI URL">https://doi.org/10.3390/cancers11121930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11121930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11121930%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DDirect%252BTargeting%252BOptions%252Bfor%252BSTAT3%252Band%252BSTAT5%252Bin%252BCancer%26aulast%3DOrlova%26aufirst%3DAnna%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D12%26spage%3D1930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Kieslinger</span>, <span class="hlFld-ContribAuthor ">Alexander  Swoboda</span>, <span class="hlFld-ContribAuthor ">Nina  Kramer</span>, <span class="hlFld-ContribAuthor ">Barbara  Pratscher</span>, <span class="hlFld-ContribAuthor ">Birgitt  Wolfesberger</span>, <span class="hlFld-ContribAuthor ">Iwan A.  Burgener</span>. </span><span class="cited-content_cbyCitation_article-title">Companion Animals as Models for Inhibition of STAT3 and STAT5. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (12)
                                     , 2035. <a href="https://doi.org/10.3390/cancers11122035" title="DOI URL">https://doi.org/10.3390/cancers11122035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11122035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11122035%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCompanion%252BAnimals%252Bas%252BModels%252Bfor%252BInhibition%252Bof%252BSTAT3%252Band%252BSTAT5%26aulast%3DKieslinger%26aufirst%3DMatthias%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D12%26spage%3D2035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie  Brachet-Botineau</span>, <span class="hlFld-ContribAuthor ">Margaux  Deynoux</span>, <span class="hlFld-ContribAuthor ">Nicolas  Vallet</span>, <span class="hlFld-ContribAuthor ">Marion  Polomski</span>, <span class="hlFld-ContribAuthor ">Ludovic  Juen</span>, <span class="hlFld-ContribAuthor ">Olivier  Hérault</span>, <span class="hlFld-ContribAuthor ">Frédéric  Mazurier</span>, <span class="hlFld-ContribAuthor ">Marie-Claude  Viaud-Massuard</span>, <span class="hlFld-ContribAuthor ">Gildas  Prié</span>, <span class="hlFld-ContribAuthor ">Fabrice  Gouilleux</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (12)
                                     , 2043. <a href="https://doi.org/10.3390/cancers11122043" title="DOI URL">https://doi.org/10.3390/cancers11122043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11122043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11122043%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DA%252BNovel%252BInhibitor%252Bof%252BSTAT5%252BSignaling%252BOvercomes%252BChemotherapy%252BResistance%252Bin%252BMyeloid%252BLeukemia%252BCells%26aulast%3DBrachet-Botineau%26aufirst%3DMarie%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D12%26spage%3D2043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Polak</span>, <span class="hlFld-ContribAuthor ">Chernosky</span>, <span class="hlFld-ContribAuthor ">Smigiel</span>, <span class="hlFld-ContribAuthor ">Tamagno</span>, <span class="hlFld-ContribAuthor ">Jackson</span>. </span><span class="cited-content_cbyCitation_article-title">Balancing STAT Activity as a Therapeutic Strategy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (11)
                                     , 1716. <a href="https://doi.org/10.3390/cancers11111716" title="DOI URL">https://doi.org/10.3390/cancers11111716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11111716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11111716%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DBalancing%252BSTAT%252BActivity%252Bas%252Ba%252BTherapeutic%252BStrategy%26aulast%3DPolak%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D11%26spage%3D1716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wishrawana  S. Ratnayake</span>, <span class="hlFld-ContribAuthor ">Christopher  A. Apostolatos</span>, <span class="hlFld-ContribAuthor ">Mildred  Acevedo-Duncan</span>. </span><span class="cited-content_cbyCitation_article-title">Atypical Protein Kinase Cs in Melanoma Progression. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.83410" title="DOI URL">https://doi.org/10.5772/intechopen.83410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.83410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.83410%26sid%3Dliteratum%253Aachs%26atitle%3DAtypical%252BProtein%252BKinase%252BCs%252Bin%252BMelanoma%252BProgression%26aulast%3DS.%2BRatnayake%26aufirst%3DWishrawana%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DCutaneous%252BMelanoma%252B%25255BWorking%252BTitle%25255D%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">WISHRAWANA  RATNAYAKE</span>, <span class="hlFld-ContribAuthor ">CHRISTOPHER  APOSTOLATOS</span>, <span class="hlFld-ContribAuthor ">SLOAN  BREEDY</span>, <span class="hlFld-ContribAuthor ">ANDRE  APOSTOLATOS</span>, <span class="hlFld-ContribAuthor ">MILDRED  ACEVEDO-DUNCAN</span>. </span><span class="cited-content_cbyCitation_article-title">FOXO1 regulates oncogenic PKC-ι expression in melanoma inversely to c-Jun in an autocrine manner via IL-17E and ICAM-1 activation. </span><span class="cited-content_cbyCitation_journal-name">World Academy of Sciences Journal</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.3892/wasj.2018.2" title="DOI URL">https://doi.org/10.3892/wasj.2018.2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/wasj.2018.2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fwasj.2018.2%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Academy%2520of%2520Sciences%2520Journal%26atitle%3DFOXO1%252Bregulates%252Boncogenic%252BPKC-%2525CE%2525B9%252Bexpression%252Bin%252Bmelanoma%252Binversely%252Bto%252Bc-Jun%252Bin%252Ban%252Bautocrine%252Bmanner%252Bvia%252BIL-17E%252Band%252BICAM-1%252Bactivation%26aulast%3DRATNAYAKE%26aufirst%3DWISHRAWANA%26date%3D2018%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bettina  Wingelhofer</span>, <span class="hlFld-ContribAuthor ">Barbara  Maurer</span>, <span class="hlFld-ContribAuthor ">Elizabeth C.  Heyes</span>, <span class="hlFld-ContribAuthor ">Abbarna A.  Cumaraswamy</span>, <span class="hlFld-ContribAuthor ">Angelika  Berger-Becvar</span>, <span class="hlFld-ContribAuthor ">Elvin D.  de Araujo</span>, <span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Patricia  Freund</span>, <span class="hlFld-ContribAuthor ">Frank  Ruge</span>, <span class="hlFld-ContribAuthor ">Jisung  Park</span>, <span class="hlFld-ContribAuthor ">Gary  Tin</span>, <span class="hlFld-ContribAuthor ">Siawash  Ahmar</span>, <span class="hlFld-ContribAuthor ">Charles-Hugues  Lardeau</span>, <span class="hlFld-ContribAuthor ">Irina  Sadovnik</span>, <span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">György Miklós  Keserű</span>, <span class="hlFld-ContribAuthor ">Florian  Grebien</span>, <span class="hlFld-ContribAuthor ">Stefan  Kubicek</span>, <span class="hlFld-ContribAuthor ">Peter  Valent</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacologic inhibition of STAT5 in acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2018,</strong> <em>32 </em>
                                    (5)
                                     , 1135-1146. <a href="https://doi.org/10.1038/s41375-017-0005-9" title="DOI URL">https://doi.org/10.1038/s41375-017-0005-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-017-0005-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-017-0005-9%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DPharmacologic%252Binhibition%252Bof%252BSTAT5%252Bin%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DWingelhofer%26aufirst%3DBettina%26date%3D2018%26date%3D2018%26volume%3D32%26issue%3D5%26spage%3D1135%26epage%3D1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Keller</span>, <span class="hlFld-ContribAuthor ">Bettina  Wingelhofer</span>, <span class="hlFld-ContribAuthor ">Barbara  Peter</span>, <span class="hlFld-ContribAuthor ">Karin  Bauer</span>, <span class="hlFld-ContribAuthor ">Daniela  Berger</span>, <span class="hlFld-ContribAuthor ">Susanne  Gamperl</span>, <span class="hlFld-ContribAuthor ">Martin  Reifinger</span>, <span class="hlFld-ContribAuthor ">Sabine  Cerny-Reiterer</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Michael  Willmann</span>, <span class="hlFld-ContribAuthor ">Peter  Valent</span>, <span class="hlFld-ContribAuthor ">Emir  Hadzijusufovic</span>. </span><span class="cited-content_cbyCitation_article-title">The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma. </span><span class="cited-content_cbyCitation_journal-name">Veterinary and Comparative Oncology</span><span> <strong>2018,</strong> <em>16 </em>
                                    (1)
                                     , 55-68. <a href="https://doi.org/10.1111/vco.12311" title="DOI URL">https://doi.org/10.1111/vco.12311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/vco.12311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fvco.12311%26sid%3Dliteratum%253Aachs%26jtitle%3DVeterinary%2520and%2520Comparative%2520Oncology%26atitle%3DThe%252BJAK2%25252FSTAT5%252Bsignaling%252Bpathway%252Bas%252Ba%252Bpotential%252Btherapeutic%252Btarget%252Bin%252Bcanine%252Bmastocytoma%26aulast%3DKeller%26aufirst%3DAlexandra%26date%3D2018%26date%3D2017%26volume%3D16%26issue%3D1%26spage%3D55%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Orlova</span>, <span class="hlFld-ContribAuthor ">Bettina  Wingelhofer</span>, <span class="hlFld-ContribAuthor ">Heidi A.  Neubauer</span>, <span class="hlFld-ContribAuthor ">Barbara  Maurer</span>, <span class="hlFld-ContribAuthor ">Angelika  Berger-Becvar</span>, <span class="hlFld-ContribAuthor ">György Miklós  Keserű</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>, <span class="hlFld-ContribAuthor ">Peter  Valent</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2018,</strong> <em>22 </em>
                                    (1)
                                     , 45-57. <a href="https://doi.org/10.1080/14728222.2018.1406924" title="DOI URL">https://doi.org/10.1080/14728222.2018.1406924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14728222.2018.1406924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14728222.2018.1406924%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DEmerging%252Btherapeutic%252Btargets%252Bin%252Bmyeloproliferative%252Bneoplasms%252Band%252Bperipheral%252BT-cell%252Bleukemia%252Band%252Blymphomas%26aulast%3DOrlova%26aufirst%3DAnna%26date%3D2018%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D45%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ha Thi Thanh  Pham</span>, <span class="hlFld-ContribAuthor ">Barbara  Maurer</span>, <span class="hlFld-ContribAuthor ">Michaela  Prchal-Murphy</span>, <span class="hlFld-ContribAuthor ">Reinhard  Grausenburger</span>, <span class="hlFld-ContribAuthor ">Eva  Grundschober</span>, <span class="hlFld-ContribAuthor ">Tahereh  Javaheri</span>, <span class="hlFld-ContribAuthor ">Harini  Nivarthi</span>, <span class="hlFld-ContribAuthor ">Auke  Boersma</span>, <span class="hlFld-ContribAuthor ">Thomas  Kolbe</span>, <span class="hlFld-ContribAuthor ">Mohamed  Elabd</span>, <span class="hlFld-ContribAuthor ">Florian  Halbritter</span>, <span class="hlFld-ContribAuthor ">Jan  Pencik</span>, <span class="hlFld-ContribAuthor ">Zahra  Kazemi</span>, <span class="hlFld-ContribAuthor ">Florian  Grebien</span>, <span class="hlFld-ContribAuthor ">Markus  Hengstschläger</span>, <span class="hlFld-ContribAuthor ">Lukas  Kenner</span>, <span class="hlFld-ContribAuthor ">Stefan  Kubicek</span>, <span class="hlFld-ContribAuthor ">Matthias  Farlik</span>, <span class="hlFld-ContribAuthor ">Christoph  Bock</span>, <span class="hlFld-ContribAuthor ">Peter  Valent</span>, <span class="hlFld-ContribAuthor ">Mathias  Müller</span>, <span class="hlFld-ContribAuthor ">Thomas  Rülicke</span>, <span class="hlFld-ContribAuthor ">Veronika  Sexl</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>. </span><span class="cited-content_cbyCitation_article-title">STAT5BN642H is a driver mutation for T cell neoplasia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Clinical Investigation</span><span> <strong>2017,</strong> <em>128 </em>
                                    (1)
                                     , 387-401. <a href="https://doi.org/10.1172/JCI94509" title="DOI URL">https://doi.org/10.1172/JCI94509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/JCI94509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2FJCI94509%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Clinical%2520Investigation%26atitle%3DSTAT5BN642H%252Bis%252Ba%252Bdriver%252Bmutation%252Bfor%252BT%252Bcell%252Bneoplasia%26aulast%3DPham%26aufirst%3DHa%2BThi%2BThanh%26date%3D2017%26volume%3D128%26issue%3D1%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagarajan  Elumalai</span>, <span class="hlFld-ContribAuthor ">Angela  Berg</span>, <span class="hlFld-ContribAuthor ">Stefan  Rubner</span>, <span class="hlFld-ContribAuthor ">Linda  Blechschmidt</span>, <span class="hlFld-ContribAuthor ">Chen  Song</span>, <span class="hlFld-ContribAuthor ">Kalaiselvi  Natarajan</span>, <span class="hlFld-ContribAuthor ">Jörg  Matysik</span>, <span class="hlFld-ContribAuthor ">Thorsten  Berg</span>. </span><span class="cited-content_cbyCitation_article-title">Rational development of Stafib-2: a selective, nanomolar inhibitor of the transcription factor STAT5b. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-00920-3" title="DOI URL">https://doi.org/10.1038/s41598-017-00920-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-00920-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-00920-3%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DRational%252Bdevelopment%252Bof%252BStafib-2%25253A%252Ba%252Bselective%25252C%252Bnanomolar%252Binhibitor%252Bof%252Bthe%252Btranscription%252Bfactor%252BSTAT5b%26aulast%3DElumalai%26aufirst%3DNagarajan%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan  Metts</span>, <span class="hlFld-ContribAuthor ">Heath L.  Bradley</span>, <span class="hlFld-ContribAuthor ">Zhengqi  Wang</span>, <span class="hlFld-ContribAuthor ">Neil P.  Shah</span>, <span class="hlFld-ContribAuthor ">Reuben  Kapur</span>, <span class="hlFld-ContribAuthor ">Jack L.  Arbiser</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Bunting</span>. </span><span class="cited-content_cbyCitation_article-title">Imipramine blue sensitively and selectively targets FLT3-ITD positive acute myeloid leukemia cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-04796-1" title="DOI URL">https://doi.org/10.1038/s41598-017-04796-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-04796-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-04796-1%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DImipramine%252Bblue%252Bsensitively%252Band%252Bselectively%252Btargets%252BFLT3-ITD%252Bpositive%252Bacute%252Bmyeloid%252Bleukemia%252Bcells%26aulast%3DMetts%26aufirst%3DJonathan%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Lis</span>, <span class="hlFld-ContribAuthor ">Stefan  Rubner</span>, <span class="hlFld-ContribAuthor ">Martin  Roatsch</span>, <span class="hlFld-ContribAuthor ">Angela  Berg</span>, <span class="hlFld-ContribAuthor ">Tyler  Gilcrest</span>, <span class="hlFld-ContribAuthor ">Darwin  Fu</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Nguyen</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Schmidt</span>, <span class="hlFld-ContribAuthor ">Harald  Krautscheid</span>, <span class="hlFld-ContribAuthor ">Jens  Meiler</span>, <span class="hlFld-ContribAuthor ">Thorsten  Berg</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-017-17600-x" title="DOI URL">https://doi.org/10.1038/s41598-017-17600-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-017-17600-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-017-17600-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDevelopment%252Bof%252BErasin%25253A%252Ba%252Bchromone-based%252BSTAT3%252Binhibitor%252Bwhich%252Binduces%252Bapoptosis%252Bin%252BErlotinib-resistant%252Blung%252Bcancer%252Bcells%26aulast%3DLis%26aufirst%3DChristian%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Berg</span>, <span class="hlFld-ContribAuthor ">Thorsten  Berg</span>. </span><span class="cited-content_cbyCitation_article-title">A small-molecule screen identifies the antitrypanosomal agent suramin and analogues NF023 and NF449 as inhibitors of STAT5a/b. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (15)
                                     , 3349-3352. <a href="https://doi.org/10.1016/j.bmcl.2017.06.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.06.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.06.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bsmall-molecule%252Bscreen%252Bidentifies%252Bthe%252Bantitrypanosomal%252Bagent%252Bsuramin%252Band%252Banalogues%252BNF023%252Band%252BNF449%252Bas%252Binhibitors%252Bof%252BSTAT5a%25252Fb%26aulast%3DBerg%26aufirst%3DAngela%26date%3D2017%26volume%3D27%26issue%3D15%26spage%3D3349%26epage%3D3352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagarajan  Elumalai</span>, <span class="hlFld-ContribAuthor ">Kalaiselvi  Natarajan</span>, <span class="hlFld-ContribAuthor ">Thorsten  Berg</span>. </span><span class="cited-content_cbyCitation_article-title">Halogen-substituted catechol bisphosphates are potent and selective inhibitors of the transcription factor STAT5b. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (14)
                                     , 3871-3882. <a href="https://doi.org/10.1016/j.bmc.2017.05.039" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.05.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.05.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.05.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DHalogen-substituted%252Bcatechol%252Bbisphosphates%252Bare%252Bpotent%252Band%252Bselective%252Binhibitors%252Bof%252Bthe%252Btranscription%252Bfactor%252BSTAT5b%26aulast%3DElumalai%26aufirst%3DNagarajan%26date%3D2017%26volume%3D25%26issue%3D14%26spage%3D3871%26epage%3D3882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Fragiadaki</span>, <span class="hlFld-ContribAuthor ">Morgane  Lannoy</span>, <span class="hlFld-ContribAuthor ">Madeleine  Themanns</span>, <span class="hlFld-ContribAuthor ">Barbara  Maurer</span>, <span class="hlFld-ContribAuthor ">Wouter N.  Leonhard</span>, <span class="hlFld-ContribAuthor ">Dorien J.M.  Peters</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Albert C.M.  Ong</span>. </span><span class="cited-content_cbyCitation_article-title">STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease. </span><span class="cited-content_cbyCitation_journal-name">Kidney International</span><span> <strong>2017,</strong> <em>91 </em>
                                    (3)
                                     , 575-586. <a href="https://doi.org/10.1016/j.kint.2016.10.039" title="DOI URL">https://doi.org/10.1016/j.kint.2016.10.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.kint.2016.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.kint.2016.10.039%26sid%3Dliteratum%253Aachs%26jtitle%3DKidney%2520International%26atitle%3DSTAT5%252Bdrives%252Babnormal%252Bproliferation%252Bin%252Bautosomal%252Bdominant%252Bpolycystic%252Bkidney%252Bdisease%26aulast%3DFragiadaki%26aufirst%3DMaria%26date%3D2017%26volume%3D91%26issue%3D3%26spage%3D575%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David T.  Hoang</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Iczkowski</span>, <span class="hlFld-ContribAuthor ">Deepak  Kilari</span>, <span class="hlFld-ContribAuthor ">William  See</span>, <span class="hlFld-ContribAuthor ">Marja T.  Nevalainen</span>. </span><span class="cited-content_cbyCitation_article-title">Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (2)
                                     , 3724-3745. <a href="https://doi.org/10.18632/oncotarget.12554" title="DOI URL">https://doi.org/10.18632/oncotarget.12554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12554%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DAndrogen%252Breceptor-dependent%252Band%252B-independent%252Bmechanisms%252Bdriving%252Bprostate%252Bcancer%252Bprogression%25253A%252BOpportunities%252Bfor%252Btherapeutic%252Btargeting%252Bfrom%252Bmultiple%252Bangles%26aulast%3DHoang%26aufirst%3DDavid%2BT.%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D2%26spage%3D3724%26epage%3D3745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jan  Pencik</span>, <span class="hlFld-ContribAuthor ">Ha Thi Thanh  Pham</span>, <span class="hlFld-ContribAuthor ">Johannes  Schmoellerl</span>, <span class="hlFld-ContribAuthor ">Tahereh  Javaheri</span>, <span class="hlFld-ContribAuthor ">Michaela  Schlederer</span>, <span class="hlFld-ContribAuthor ">Zoran  Culig</span>, <span class="hlFld-ContribAuthor ">Olaf  Merkel</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>, <span class="hlFld-ContribAuthor ">Florian  Grebien</span>, <span class="hlFld-ContribAuthor ">Lukas  Kenner</span>. </span><span class="cited-content_cbyCitation_article-title">JAK-STAT signaling in cancer: From cytokines to non-coding genome. </span><span class="cited-content_cbyCitation_journal-name">Cytokine</span><span> <strong>2016,</strong> <em>87 </em>, 26-36. <a href="https://doi.org/10.1016/j.cyto.2016.06.017" title="DOI URL">https://doi.org/10.1016/j.cyto.2016.06.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cyto.2016.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cyto.2016.06.017%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%26atitle%3DJAK-STAT%252Bsignaling%252Bin%252Bcancer%25253A%252BFrom%252Bcytokines%252Bto%252Bnon-coding%252Bgenome%26aulast%3DPencik%26aufirst%3DJan%26date%3D2016%26volume%3D87%26spage%3D26%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel E.  Spratt</span>, <span class="hlFld-ContribAuthor ">Zachary S.  Zumsteg</span>, <span class="hlFld-ContribAuthor ">Felix Y.  Feng</span>, <span class="hlFld-ContribAuthor ">Scott A.  Tomlins</span>. </span><span class="cited-content_cbyCitation_article-title">Translational and clinical implications of the genetic landscape of prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Clinical Oncology</span><span> <strong>2016,</strong> <em>13 </em>
                                    (10)
                                     , 597-610. <a href="https://doi.org/10.1038/nrclinonc.2016.76" title="DOI URL">https://doi.org/10.1038/nrclinonc.2016.76</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrclinonc.2016.76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrclinonc.2016.76%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Clinical%2520Oncology%26atitle%3DTranslational%252Band%252Bclinical%252Bimplications%252Bof%252Bthe%252Bgenetic%252Blandscape%252Bof%252Bprostate%252Bcancer%26aulast%3DSpratt%26aufirst%3DDaniel%2BE.%26date%3D2016%26date%3D2016%26volume%3D13%26issue%3D10%26spage%3D597%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peace C.  Ezeh</span>, <span class="hlFld-ContribAuthor ">Huan  Xu</span>, <span class="hlFld-ContribAuthor ">Fredine T.  Lauer</span>, <span class="hlFld-ContribAuthor ">Ke Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Laurie G.  Hudson</span>, <span class="hlFld-ContribAuthor ">Scott W.  Burchiel</span>. </span><span class="cited-content_cbyCitation_article-title">Monomethylarsonous acid (MMA
              +3
              ) Inhibits IL-7 Signaling in Mouse Pre-B Cells. </span><span class="cited-content_cbyCitation_journal-name">Toxicological Sciences</span><span> <strong>2016,</strong> <em>149 </em>
                                    (2)
                                     , 289-299. <a href="https://doi.org/10.1093/toxsci/kfv233" title="DOI URL">https://doi.org/10.1093/toxsci/kfv233</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/toxsci/kfv233&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Ftoxsci%2Fkfv233%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicological%2520Sciences%26atitle%3DMonomethylarsonous%252Bacid%252B%252528MMA%252B%25252B3%252B%252529%252BInhibits%252BIL-7%252BSignaling%252Bin%252BMouse%252BPre-B%252BCells%26aulast%3DEzeh%26aufirst%3DPeace%2BC.%26date%3D2016%26date%3D2015%26volume%3D149%26issue%3D2%26spage%3D289%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romeo  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Filippo  Prencipe</span>, <span class="hlFld-ContribAuthor ">Carlota  Lopez-Cara</span>, <span class="hlFld-ContribAuthor ">Riccardo  Rondanin</span>, <span class="hlFld-ContribAuthor ">Daniele  Simoni</span>, <span class="hlFld-ContribAuthor ">Ernest  Hamel</span>, <span class="hlFld-ContribAuthor ">Stefania  Grimaudo</span>, <span class="hlFld-ContribAuthor ">Rosaria Maria  Pipitone</span>, <span class="hlFld-ContribAuthor ">Maria  Meli</span>, <span class="hlFld-ContribAuthor ">Manlio  Tolomeo</span>. </span><span class="cited-content_cbyCitation_article-title">Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>108 </em>, 39-52. <a href="https://doi.org/10.1016/j.ejmech.2015.11.022" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.11.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.11.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.11.022%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Biodoacetamido%252Bbenzoheterocyclic%252Bderivatives%252Bwith%252Bpotent%252Bantileukemic%252Bactivity%252Bare%252Binhibitors%252Bof%252BSTAT5%252Bphosphorylation%26aulast%3DRomagnoli%26aufirst%3DRomeo%26date%3D2016%26volume%3D108%26spage%3D39%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Florent  Langenfeld</span>, <span class="hlFld-ContribAuthor ">Yann  Guarracino</span>, <span class="hlFld-ContribAuthor ">Michel  Arock</span>, <span class="hlFld-ContribAuthor ">Alain  Trouvé</span>, <span class="hlFld-ContribAuthor ">Luba  Tchertanov</span>, . </span><span class="cited-content_cbyCitation_article-title">How Intrinsic Molecular Dynamics Control Intramolecular Communication in Signal Transducers and Activators of Transcription Factor STAT5. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (12)
                                     , e0145142. <a href="https://doi.org/10.1371/journal.pone.0145142" title="DOI URL">https://doi.org/10.1371/journal.pone.0145142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0145142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0145142%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DHow%252BIntrinsic%252BMolecular%252BDynamics%252BControl%252BIntramolecular%252BCommunication%252Bin%252BSignal%252BTransducers%252Band%252BActivators%252Bof%252BTranscription%252BFactor%252BSTAT5%26aulast%3DLangenfeld%26aufirst%3DFlorent%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3De0145142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingqing  Cai</span>, <span class="hlFld-ContribAuthor ">L. Jeffrey  Medeiros</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Xu</span>, <span class="hlFld-ContribAuthor ">Ken H.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">MYC
              -driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (36)
                                     , 38591-38616. <a href="https://doi.org/10.18632/oncotarget.5774" title="DOI URL">https://doi.org/10.18632/oncotarget.5774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.5774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.5774%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DMYC%252B-driven%252Baggressive%252BB-cell%252Blymphomas%25253A%252Bbiology%25252C%252Bentity%25252C%252Bdifferential%252Bdiagnosis%252Band%252Bclinical%252Bmanagement%26aulast%3DCai%26aufirst%3DQingqing%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D36%26spage%3D38591%26epage%3D38616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyong  Liao</span>, <span class="hlFld-ContribAuthor ">Lei  Gu</span>, <span class="hlFld-ContribAuthor ">Jenny  Vergalli</span>, <span class="hlFld-ContribAuthor ">Samanta A.  Mariani</span>, <span class="hlFld-ContribAuthor ">Marco  De Dominici</span>, <span class="hlFld-ContribAuthor ">Ravi K.  Lokareddy</span>, <span class="hlFld-ContribAuthor ">Ayush  Dagvadorj</span>, <span class="hlFld-ContribAuthor ">Puranik  Purushottamachar</span>, <span class="hlFld-ContribAuthor ">Peter A.  McCue</span>, <span class="hlFld-ContribAuthor ">Edouard  Trabulsi</span>, <span class="hlFld-ContribAuthor ">Costas D.  Lallas</span>, <span class="hlFld-ContribAuthor ">Shilpa  Gupta</span>, <span class="hlFld-ContribAuthor ">Elyse  Ellsworth</span>, <span class="hlFld-ContribAuthor ">Shauna  Blackmon</span>, <span class="hlFld-ContribAuthor ">Adam  Ertel</span>, <span class="hlFld-ContribAuthor ">Paolo  Fortina</span>, <span class="hlFld-ContribAuthor ">Benjamin  Leiby</span>, <span class="hlFld-ContribAuthor ">Guanjun  Xia</span>, <span class="hlFld-ContribAuthor ">Hallgeir  Rui</span>, <span class="hlFld-ContribAuthor ">David T.  Hoang</span>, <span class="hlFld-ContribAuthor ">Leonard G.  Gomella</span>, <span class="hlFld-ContribAuthor ">Gino  Cingolani</span>, <span class="hlFld-ContribAuthor ">Vincent  Njar</span>, <span class="hlFld-ContribAuthor ">Nagarajan  Pattabiraman</span>, <span class="hlFld-ContribAuthor ">Bruno  Calabretta</span>, <span class="hlFld-ContribAuthor ">Marja T.  Nevalainen</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2015,</strong> <em>14 </em>
                                    (8)
                                     , 1777-1793. <a href="https://doi.org/10.1158/1535-7163.MCT-14-0883" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-14-0883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-14-0883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-14-0883%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DStructure-Based%252BScreen%252BIdentifies%252Ba%252BPotent%252BSmall%252BMolecule%252BInhibitor%252Bof%252BStat5a%25252Fb%252Bwith%252BTherapeutic%252BPotential%252Bfor%252BProstate%252BCancer%252Band%252BChronic%252BMyeloid%252BLeukemia%26aulast%3DLiao%26aufirst%3DZhiyong%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D8%26spage%3D1777%26epage%3D1793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yantao  He</span>, <span class="hlFld-ContribAuthor ">Xing  Guo</span>, <span class="hlFld-ContribAuthor ">Zhi-Hong  Yu</span>, <span class="hlFld-ContribAuthor ">Li  Wu</span>, <span class="hlFld-ContribAuthor ">Andrea M.  Gunawan</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jack E.  Dixon</span>, <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A potent and selective inhibitor for the UBLCP1 proteasome phosphatase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (12)
                                     , 2798-2809. <a href="https://doi.org/10.1016/j.bmc.2015.03.066" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.03.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.03.066%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Bpotent%252Band%252Bselective%252Binhibitor%252Bfor%252Bthe%252BUBLCP1%252Bproteasome%252Bphosphatase%26aulast%3DHe%26aufirst%3DYantao%26date%3D2015%26volume%3D23%26issue%3D12%26spage%3D2798%26epage%3D2809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleonora  Gianti</span>, <span class="hlFld-ContribAuthor ">Randy J.  Zauhar</span>. </span><span class="cited-content_cbyCitation_article-title">An SH2 domain model of STAT5 in complex with phospho-peptides define “STAT5 Binding Signatures”. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2015,</strong> <em>29 </em>
                                    (5)
                                     , 451-470. <a href="https://doi.org/10.1007/s10822-015-9835-6" title="DOI URL">https://doi.org/10.1007/s10822-015-9835-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-015-9835-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-015-9835-6%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DAn%252BSH2%252Bdomain%252Bmodel%252Bof%252BSTAT5%252Bin%252Bcomplex%252Bwith%252Bphospho-peptides%252Bdefine%252B%2525E2%252580%25259CSTAT5%252BBinding%252BSignatures%2525E2%252580%25259D%26aulast%3DGianti%26aufirst%3DEleonora%26date%3D2015%26date%3D2015%26volume%3D29%26issue%3D5%26spage%3D451%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagarajan  Elumalai</span>, <span class="hlFld-ContribAuthor ">Angela  Berg</span>, <span class="hlFld-ContribAuthor ">Kalaiselvi  Natarajan</span>, <span class="hlFld-ContribAuthor ">Andrej  Scharow</span>, <span class="hlFld-ContribAuthor ">Thorsten  Berg</span>. </span><span class="cited-content_cbyCitation_article-title">Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2015,</strong> <em>127 </em>
                                    (16)
                                     , 4840-4845. <a href="https://doi.org/10.1002/ange.201410672" title="DOI URL">https://doi.org/10.1002/ange.201410672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201410672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201410672%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DNanomolar%252BInhibitors%252Bof%252Bthe%252BTranscription%252BFactor%252BSTAT5b%252Bwith%252BHigh%252BSelectivity%252Bover%252BSTAT5a%26aulast%3DElumalai%26aufirst%3DNagarajan%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D16%26spage%3D4840%26epage%3D4845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagarajan  Elumalai</span>, <span class="hlFld-ContribAuthor ">Angela  Berg</span>, <span class="hlFld-ContribAuthor ">Kalaiselvi  Natarajan</span>, <span class="hlFld-ContribAuthor ">Andrej  Scharow</span>, <span class="hlFld-ContribAuthor ">Thorsten  Berg</span>. </span><span class="cited-content_cbyCitation_article-title">Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2015,</strong> <em>54 </em>
                                    (16)
                                     , 4758-4763. <a href="https://doi.org/10.1002/anie.201410672" title="DOI URL">https://doi.org/10.1002/anie.201410672</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201410672&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201410672%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DNanomolar%252BInhibitors%252Bof%252Bthe%252BTranscription%252BFactor%252BSTAT5b%252Bwith%252BHigh%252BSelectivity%252Bover%252BSTAT5a%26aulast%3DElumalai%26aufirst%3DNagarajan%26date%3D2015%26date%3D2015%26volume%3D54%26issue%3D16%26spage%3D4758%26epage%3D4763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serge  Haan</span>, <span class="hlFld-ContribAuthor ">Christelle  Bahlawane</span>, <span class="hlFld-ContribAuthor ">Jiali  Wang</span>, <span class="hlFld-ContribAuthor ">Petr V  Nazarov</span>, <span class="hlFld-ContribAuthor ">Arnaud  Muller</span>, <span class="hlFld-ContribAuthor ">René  Eulenfeld</span>, <span class="hlFld-ContribAuthor ">Claude  Haan</span>, <span class="hlFld-ContribAuthor ">Catherine  Rolvering</span>, <span class="hlFld-ContribAuthor ">Laurent  Vallar</span>, <span class="hlFld-ContribAuthor ">Venkata P  Satagopam</span>, <span class="hlFld-ContribAuthor ">Thomas  Sauter</span>, <span class="hlFld-ContribAuthor ">Monique Yvonne  Wiesinger</span>. </span><span class="cited-content_cbyCitation_article-title">The oncogenic FIP1L1-PDGFR
              α
              fusion protein displays skewed signaling properties compared to its wild-type PDGFR
              α
              counterpart. </span><span class="cited-content_cbyCitation_journal-name">JAK-STAT</span><span> <strong>2015,</strong> <em>4 </em>
                                    (1)
                                     , e1062596. <a href="https://doi.org/10.1080/21623996.2015.1062596" title="DOI URL">https://doi.org/10.1080/21623996.2015.1062596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/21623996.2015.1062596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F21623996.2015.1062596%26sid%3Dliteratum%253Aachs%26jtitle%3DJAK-STAT%26atitle%3DThe%252Boncogenic%252BFIP1L1-PDGFR%252B%2525CE%2525B1%252Bfusion%252Bprotein%252Bdisplays%252Bskewed%252Bsignaling%252Bproperties%252Bcompared%252Bto%252Bits%252Bwild-type%252BPDGFR%252B%2525CE%2525B1%252Bcounterpart%26aulast%3DHaan%26aufirst%3DSerge%26date%3D2015%26date%3D2015%26volume%3D4%26issue%3D1%26spage%3De1062596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicolas  Zeidan</span>, <span class="hlFld-ContribAuthor ">Han  Su</span>, <span class="hlFld-ContribAuthor ">Milèna  Aitken</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>, <span class="hlFld-ContribAuthor ">Kagan  Kerman</span>. </span><span class="cited-content_cbyCitation_article-title">Magnetic bead-based electrochemical detection of interaction between epigallocatechin-3-gallate and STAT proteins. </span><span class="cited-content_cbyCitation_journal-name">Analytical Methods</span><span> <strong>2015,</strong> <em>7 </em>
                                    (8)
                                     , 3566-3569. <a href="https://doi.org/10.1039/C5AY00169B" title="DOI URL">https://doi.org/10.1039/C5AY00169B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5AY00169B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5AY00169B%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Methods%26atitle%3DMagnetic%252Bbead-based%252Belectrochemical%252Bdetection%252Bof%252Binteraction%252Bbetween%252Bepigallocatechin-3-gallate%252Band%252BSTAT%252Bproteins%26aulast%3DZeidan%26aufirst%3DNicolas%26date%3D2015%26date%3D2015%26volume%3D7%26issue%3D8%26spage%3D3566%26epage%3D3569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angelika  Berger</span>, <span class="hlFld-ContribAuthor ">Veronika  Sexl</span>, <span class="hlFld-ContribAuthor ">Peter  Valent</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2014,</strong> <em>5 </em>
                                    (20)
                                     , 9564-9576. <a href="https://doi.org/10.18632/oncotarget.2465" title="DOI URL">https://doi.org/10.18632/oncotarget.2465</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.2465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.2465%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DInhibition%252Bof%252BSTAT5%25253A%252BA%252Btherapeutic%252Boption%252Bin%252BBCR-ABL1-driven%252Bleukemia%26aulast%3DBerger%26aufirst%3DAngelika%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D20%26spage%3D9564%26epage%3D9576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Małgorzata  Szeląg</span>, <span class="hlFld-ContribAuthor ">Anna  Czerwoniec</span>, <span class="hlFld-ContribAuthor ">Joanna  Wesoly</span>, <span class="hlFld-ContribAuthor ">Hans A.R.  Bluyssen</span>. </span><span class="cited-content_cbyCitation_article-title">Comparative screening and validation as a novel tool to identify STAT-specific inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2014,</strong> <em>740 </em>, 417-420. <a href="https://doi.org/10.1016/j.ejphar.2014.05.047" title="DOI URL">https://doi.org/10.1016/j.ejphar.2014.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2014.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2014.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DComparative%252Bscreening%252Band%252Bvalidation%252Bas%252Ba%252Bnovel%252Btool%252Bto%252Bidentify%252BSTAT-specific%252Binhibitors%26aulast%3DSzel%25C4%2585g%26aufirst%3DMa%25C5%2582gorzata%26date%3D2014%26volume%3D740%26spage%3D417%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riccardo  Rondanin</span>, <span class="hlFld-ContribAuthor ">Daniele  Simoni</span>, <span class="hlFld-ContribAuthor ">Romeo  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Riccardo  Baruchello</span>, <span class="hlFld-ContribAuthor ">Paolo  Marchetti</span>, <span class="hlFld-ContribAuthor ">Cristiana  Costantini</span>, <span class="hlFld-ContribAuthor ">Sara  Fochi</span>, <span class="hlFld-ContribAuthor ">Giacomo  Padroni</span>, <span class="hlFld-ContribAuthor ">Stefania  Grimaudo</span>, <span class="hlFld-ContribAuthor ">Rosaria Maria  Pipitone</span>, <span class="hlFld-ContribAuthor ">Maria  Meli</span>, <span class="hlFld-ContribAuthor ">Manlio  Tolomeo</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of activated STAT5 in Bcr/Abl expressing leukemia cells with new pimozide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (18)
                                     , 4568-4574. <a href="https://doi.org/10.1016/j.bmcl.2014.07.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DInhibition%252Bof%252Bactivated%252BSTAT5%252Bin%252BBcr%25252FAbl%252Bexpressing%252Bleukemia%252Bcells%252Bwith%252Bnew%252Bpimozide%252Bderivatives%26aulast%3DRondanin%26aufirst%3DRiccardo%26date%3D2014%26volume%3D24%26issue%3D18%26spage%3D4568%26epage%3D4574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shengjuan  Shao</span>, <span class="hlFld-ContribAuthor ">Rilei  Yu</span>, <span class="hlFld-ContribAuthor ">Yanqing  Yu</span>, <span class="hlFld-ContribAuthor ">Yanni  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Dual-inhibitors of STAT5 and STAT3: studies from molecular docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2014,</strong> <em>20 </em>
                                    (8)
                                     <a href="https://doi.org/10.1007/s00894-014-2399-x" title="DOI URL">https://doi.org/10.1007/s00894-014-2399-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-014-2399-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-014-2399-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DDual-inhibitors%252Bof%252BSTAT5%252Band%252BSTAT3%25253A%252Bstudies%252Bfrom%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DShao%26aufirst%3DShengjuan%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">X  Zhang</span>, <span class="hlFld-ContribAuthor ">M A  Blaskovich</span>, <span class="hlFld-ContribAuthor ">K D  Forinash</span>, <span class="hlFld-ContribAuthor ">S M  Sebti</span>. </span><span class="cited-content_cbyCitation_article-title">Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2014,</strong> <em>111 </em>
                                    (5)
                                     , 894-902. <a href="https://doi.org/10.1038/bjc.2014.349" title="DOI URL">https://doi.org/10.1038/bjc.2014.349</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/bjc.2014.349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fbjc.2014.349%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DWithacnistin%252Binhibits%252Brecruitment%252Bof%252BSTAT3%252Band%252BSTAT5%252Bto%252Bgrowth%252Bfactor%252Band%252Bcytokine%252Breceptors%252Band%252Binduces%252Bregression%252Bof%252Bbreast%252Btumours%26aulast%3DZhang%26aufirst%3DX%26date%3D2014%26date%3D2014%26volume%3D111%26issue%3D5%26spage%3D894%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. V.  Mironova</span>, <span class="hlFld-ContribAuthor ">O. A.  Lodochnikova</span>, <span class="hlFld-ContribAuthor ">D. B.  Krivolapov</span>, <span class="hlFld-ContribAuthor ">Ya. V.  Veremeichik</span>, <span class="hlFld-ContribAuthor ">V. V.  Plemenkov</span>, <span class="hlFld-ContribAuthor ">I. A.  Litvinov</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structure of cyclic sulfin- and sulfonamides of the thiazine series: Conformation, intra- and intermolecular interactions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Structural Chemistry</span><span> <strong>2014,</strong> <em>55 </em>
                                    (3)
                                     , 539-547. <a href="https://doi.org/10.1134/S0022476614030238" title="DOI URL">https://doi.org/10.1134/S0022476614030238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S0022476614030238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS0022476614030238%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Structural%2520Chemistry%26atitle%3DCrystal%252Bstructure%252Bof%252Bcyclic%252Bsulfin-%252Band%252Bsulfonamides%252Bof%252Bthe%252Bthiazine%252Bseries%25253A%252BConformation%25252C%252Bintra-%252Band%252Bintermolecular%252Binteractions%26aulast%3DMironova%26aufirst%3DE.%2BV.%26date%3D2014%26date%3D2014%26volume%3D55%26issue%3D3%26spage%3D539%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanna L. M.  Rajala</span>, <span class="hlFld-ContribAuthor ">Kimmo  Porkka</span>, <span class="hlFld-ContribAuthor ">Jaroslaw P.  Maciejewski</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Loughran</span>, <span class="hlFld-ContribAuthor ">Satu  Mustjoki</span>. </span><span class="cited-content_cbyCitation_article-title">Uncovering the pathogenesis of large granular lymphocytic leukemia—novel
              STAT3
              and
              STAT5b
              mutations. </span><span class="cited-content_cbyCitation_journal-name">Annals of Medicine</span><span> <strong>2014,</strong> <em>46 </em>
                                    (3)
                                     , 114-122. <a href="https://doi.org/10.3109/07853890.2014.882105" title="DOI URL">https://doi.org/10.3109/07853890.2014.882105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/07853890.2014.882105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F07853890.2014.882105%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Medicine%26atitle%3DUncovering%252Bthe%252Bpathogenesis%252Bof%252Blarge%252Bgranular%252Blymphocytic%252Bleukemia%2525E2%252580%252594novel%252BSTAT3%252Band%252BSTAT5b%252Bmutations%26aulast%3DRajala%26aufirst%3DHanna%2BL.%2BM.%26date%3D2014%26date%3D2014%26volume%3D46%26issue%3D3%26spage%3D114%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernd  Groner</span>, <span class="hlFld-ContribAuthor ">Vida  Vafaizadeh</span>. </span><span class="cited-content_cbyCitation_article-title">Cytokine regulation of mammary gland development and epithelial cell functions through discrete activities of Stat proteins. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2014,</strong> <em>382 </em>
                                    (1)
                                     , 552-559. <a href="https://doi.org/10.1016/j.mce.2013.08.019" title="DOI URL">https://doi.org/10.1016/j.mce.2013.08.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2013.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2013.08.019%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3DCytokine%252Bregulation%252Bof%252Bmammary%252Bgland%252Bdevelopment%252Band%252Bepithelial%252Bcell%252Bfunctions%252Bthrough%252Bdiscrete%252Bactivities%252Bof%252BStat%252Bproteins%26aulast%3DGroner%26aufirst%3DBernd%26date%3D2014%26volume%3D382%26issue%3D1%26spage%3D552%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Kosan</span>, <span class="hlFld-ContribAuthor ">Torsten  Ginter</span>, <span class="hlFld-ContribAuthor ">Thorsten  Heinzel</span>, <span class="hlFld-ContribAuthor ">Oliver H  Krämer</span>. </span><span class="cited-content_cbyCitation_article-title">STAT5 acetylation. </span><span class="cited-content_cbyCitation_journal-name">JAK-STAT</span><span> <strong>2013,</strong> <em>2 </em>
                                    (4)
                                     , e26102. <a href="https://doi.org/10.4161/jkst.26102" title="DOI URL">https://doi.org/10.4161/jkst.26102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/jkst.26102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fjkst.26102%26sid%3Dliteratum%253Aachs%26jtitle%3DJAK-STAT%26atitle%3DSTAT5%252Bacetylation%26aulast%3DKosan%26aufirst%3DChristian%26date%3D2013%26date%3D2014%26volume%3D2%26issue%3D4%26spage%3De26102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dziyana  Kraskouskaya</span>, <span class="hlFld-ContribAuthor ">Eugenia  Duodu</span>, <span class="hlFld-ContribAuthor ">Carolynn C.  Arpin</span>, <span class="hlFld-ContribAuthor ">Patrick T.  Gunning</span>. </span><span class="cited-content_cbyCitation_article-title">Progress towards the development of SH2 domain inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2013,</strong> <em>42 </em>
                                    (8)
                                     , 3337. <a href="https://doi.org/10.1039/c3cs35449k" title="DOI URL">https://doi.org/10.1039/c3cs35449k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3cs35449k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3cs35449k%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DProgress%252Btowards%252Bthe%252Bdevelopment%252Bof%252BSH2%252Bdomain%252Binhibitors%26aulast%3DKraskouskaya%26aufirst%3DDziyana%26date%3D2013%26volume%3D42%26issue%3D8%26spage%3D3337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Furqan</span>, <span class="hlFld-ContribAuthor ">Akintunde  Akinleye</span>, <span class="hlFld-ContribAuthor ">Nikhil  Mukhi</span>, <span class="hlFld-ContribAuthor ">Varun  Mittal</span>, <span class="hlFld-ContribAuthor ">Yamei  Chen</span>, <span class="hlFld-ContribAuthor ">Delong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">STAT inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2013,</strong> <em>6 </em>
                                    (1)
                                     , 90. <a href="https://doi.org/10.1186/1756-8722-6-90" title="DOI URL">https://doi.org/10.1186/1756-8722-6-90</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/1756-8722-6-90&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2F1756-8722-6-90%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DSTAT%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DFurqan%26aufirst%3DMuhammad%26date%3D2013%26volume%3D6%26issue%3D1%26spage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Wieczorek</span>, <span class="hlFld-ContribAuthor ">Torsten  Ginter</span>, <span class="hlFld-ContribAuthor ">Peter  Brand</span>, <span class="hlFld-ContribAuthor ">Thorsten  Heinzel</span>, <span class="hlFld-ContribAuthor ">Oliver H.  Krämer</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylation modulates the STAT signaling code. </span><span class="cited-content_cbyCitation_journal-name">Cytokine & Growth Factor Reviews</span><span> <strong>2012,</strong> <em>23 </em>
                                    (6)
                                     , 293-305. <a href="https://doi.org/10.1016/j.cytogfr.2012.06.005" title="DOI URL">https://doi.org/10.1016/j.cytogfr.2012.06.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cytogfr.2012.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cytogfr.2012.06.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCytokine%2520%2526%2520Growth%2520Factor%2520Reviews%26atitle%3DAcetylation%252Bmodulates%252Bthe%252BSTAT%252Bsignaling%252Bcode%26aulast%3DWieczorek%26aufirst%3DMartin%26date%3D2012%26volume%3D23%26issue%3D6%26spage%3D293%26epage%3D305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga A.  Timofeeva</span>, <span class="hlFld-ContribAuthor ">Nadya I.  Tarasova</span>. </span><span class="cited-content_cbyCitation_article-title">Alternative ways of modulating JAK-STAT pathway. </span><span class="cited-content_cbyCitation_journal-name">JAK-STAT</span><span> <strong>2012,</strong> <em>1 </em>
                                    (4)
                                     , 274-284. <a href="https://doi.org/10.4161/jkst.22313" title="DOI URL">https://doi.org/10.4161/jkst.22313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/jkst.22313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fjkst.22313%26sid%3Dliteratum%253Aachs%26jtitle%3DJAK-STAT%26atitle%3DAlternative%252Bways%252Bof%252Bmodulating%252BJAK-STAT%252Bpathway%26aulast%3DTimofeeva%26aufirst%3DOlga%2BA.%26date%3D2012%26date%3D2014%26volume%3D1%26issue%3D4%26spage%3D274%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter A.  Cohen</span>, <span class="hlFld-ContribAuthor ">Jennifer S.  Ko</span>, <span class="hlFld-ContribAuthor ">Walter J.  Storkus</span>, <span class="hlFld-ContribAuthor ">Christopher D.  Spencer</span>, <span class="hlFld-ContribAuthor ">Judy M.  Bradley</span>, <span class="hlFld-ContribAuthor ">Jessica E.  Gorman</span>, <span class="hlFld-ContribAuthor ">Dustin B.  McCurry</span>, <span class="hlFld-ContribAuthor ">Soroya  Zorro-Manrique</span>, <span class="hlFld-ContribAuthor ">Anna Lucia  Dominguez</span>, <span class="hlFld-ContribAuthor ">Latha B.  Pathangey</span>, <span class="hlFld-ContribAuthor ">Patricia A.  Rayman</span>, <span class="hlFld-ContribAuthor ">Brian I.  Rini</span>, <span class="hlFld-ContribAuthor ">Sandra J.  Gendler</span>, <span class="hlFld-ContribAuthor ">James H.  Finke</span>. </span><span class="cited-content_cbyCitation_article-title">Myeloid-derived Suppressor Cells Adhere to Physiologic STAT3- vs STAT5-dependent Hematopoietic Programming, Establishing Diverse Tumor-Mediated Mechanisms of Immunologic Escape. </span><span class="cited-content_cbyCitation_journal-name">Immunological Investigations</span><span> <strong>2012,</strong> <em>41 </em>
                                    (6-7)
                                     , 680-710. <a href="https://doi.org/10.3109/08820139.2012.703745" title="DOI URL">https://doi.org/10.3109/08820139.2012.703745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/08820139.2012.703745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F08820139.2012.703745%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunological%2520Investigations%26atitle%3DMyeloid-derived%252BSuppressor%252BCells%252BAdhere%252Bto%252BPhysiologic%252BSTAT3-%252Bvs%252BSTAT5-dependent%252BHematopoietic%252BProgramming%25252C%252BEstablishing%252BDiverse%252BTumor-Mediated%252BMechanisms%252Bof%252BImmunologic%252BEscape%26aulast%3DCohen%26aufirst%3DPeter%2BA.%26date%3D2012%26date%3D2012%26volume%3D41%26issue%3D6-7%26spage%3D680%26epage%3D710" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliver H.  Krämer</span>, <span class="hlFld-ContribAuthor ">Richard  Moriggl</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylation and sumoylation control STAT5 activation antagonistically. </span><span class="cited-content_cbyCitation_journal-name">JAK-STAT</span><span> <strong>2012,</strong> <em>1 </em>
                                    (3)
                                     , 203-207. <a href="https://doi.org/10.4161/jkst.21232" title="DOI URL">https://doi.org/10.4161/jkst.21232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/jkst.21232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fjkst.21232%26sid%3Dliteratum%253Aachs%26jtitle%3DJAK-STAT%26atitle%3DAcetylation%252Band%252Bsumoylation%252Bcontrol%252BSTAT5%252Bactivation%252Bantagonistically%26aulast%3DKr%25C3%25A4mer%26aufirst%3DOliver%2BH.%26date%3D2012%26date%3D2014%26volume%3D1%26issue%3D3%26spage%3D203%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michal  Bar-Natan</span>, <span class="hlFld-ContribAuthor ">Erik A.  Nelson</span>, <span class="hlFld-ContribAuthor ">Michael  Xiang</span>, <span class="hlFld-ContribAuthor ">David A.  Frank</span>. </span><span class="cited-content_cbyCitation_article-title">STAT signaling in the pathogenesis and treatment of myeloid malignancies. </span><span class="cited-content_cbyCitation_journal-name">JAK-STAT</span><span> <strong>2012,</strong> <em>1 </em>
                                    (2)
                                     , 55-64. <a href="https://doi.org/10.4161/jkst.20006" title="DOI URL">https://doi.org/10.4161/jkst.20006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4161/jkst.20006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4161%2Fjkst.20006%26sid%3Dliteratum%253Aachs%26jtitle%3DJAK-STAT%26atitle%3DSTAT%252Bsignaling%252Bin%252Bthe%252Bpathogenesis%252Band%252Btreatment%252Bof%252Bmyeloid%252Bmalignancies%26aulast%3DBar-Natan%26aufirst%3DMichal%26date%3D2012%26date%3D2014%26volume%3D1%26issue%3D2%26spage%3D55%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">. </span><span class="cited-content_cbyCitation_journal-name">World Academy of Sciences Journal</span><span> <strong>,</strong>,<a href="https://doi.org/10.3892/wasj" title="DOI URL">https://doi.org/10.3892/wasj</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3892/wasj&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3892%2Fwasj%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Academy%2520of%2520Sciences%2520Journal" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Low energy GOLD<sup>45</sup>-docked <b>SF-1-088</b> (yellow) in the STAT5a SH2 domain (pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U">1Y1U</a>): pink = hydrophobic residues; blue = hydrophilic residues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Western blot analysis of STAT5 inhibition in K562 cells treated with <b>BP-1-107</b>, <b>BP-1-108</b>, <b>SF-1-087</b>, and <b>SF-1-088</b> STAT5 inhibitors. The different sized bands in the pSTAT5 and STAT5 panels arise due to alternate forms (STAT5a and STAT5b) and post-translational modifications of the proteins.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24, 25)</a> (B) Dose-dependent inhibition of pSTAT5 by <b>BP-1-108</b> as measured by phospho-flow cytometry. (C) Minimal inhibition of pSTAT3. (D) pAkt by <b>BP-1-108</b> as measured by phospho-flow cytometry.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. K562 cells nontreated or treated with imatinib or <b>BP-1-108</b> were fixed and stained for the levels of pSTAT5 and pERK1,2. The <i>Y</i> axis is pSTAT5, and the <i>X</i> axis is pERK1,2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of <b>BP-1-108</b> on IL-3 mediated phosphorylation of STAT5. IL-3 dependent 32D cells were assessed for the level of pSTAT5 by flow cytometry under different growth conditions; with IL-3 (green line), IL-3 and <b>BP-1-108</b> (blue line); or no IL-3 (orange line).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. RT-PCR analysis of K562 whole cell lysates treated with <b>BP-1-108</b>, <b>BP-1–75</b><b>, BP-1–111</b>, and <b>SF-1-087</b> to evaluate the levels of cMYC, Cyclin D1, Cyclin D2, and MCL-1 transcripts.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/medium/jm-2011-00720n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chromatin immunoprecipitation of <i>C-MYC</i> and <i>cyclin D1</i> promoters using STAT5 antibody in K562 cells treated with 40 μM <b>BP-1-108</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-3/jm200720n/production/images/large/jm-2011-00720n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm200720n&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i29">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lai, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, F. M.</span><span> </span><span class="NLM_article-title">Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches</span> <span class="citation_source-journal">Drug Resist. Updates</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">78</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1016%2Fj.drup.2010.04.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=20471303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVSmur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=67-78&author=S.+Y.+Laiauthor=F.+M.+Johnson&title=Defining+the+role+of+the+JAK-STAT+pathway+in+head+and+neck+and+thoracic+malignancies%3A+Implications+for+future+therapeutic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: Implications for future therapeutic approaches</span></div><div class="casAuthors">Lai, Stephen Y.; Johnson, Faye M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Resistance Updates</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">67-78</span>CODEN:
                <span class="NLM_cas:coden">DRUPFW</span>;
        ISSN:<span class="NLM_cas:issn">1368-7646</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the role of the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway has been most extensively studied in hematopoietic cells and hematol. malignancies, it is also activated in epithelial tumors, including those originating in the lungs and head and neck.  The canonical pathway involves the activation of JAK following ligand binding to cytokine receptors.  The activated JAKs then phosphorylate STAT proteins, leading to their dimerization and translocation into the nucleus.  In the nucleus, STATs act as transcription factors with pleiotropic downstream effects.  STATs can be activated independently of JAKs, most notably by c-Src kinases.  In cancer cells, STAT3 and STAT5 activation leads to the increased expression of downstream target genes, leading to increased cell proliferation, cell survival, angiogenesis, and immune system evasion.  STAT3 and STAT5 are expressed and activated in head and neck squamous cell carcinoma (HNSCC) where they contribute to cell survival and proliferation.  In HNSCC, STATs can be activated by a no. of signal transduction pathways, including the epidermal growth factor receptor (EGFR), α7 nicotinic receptor, interleukin (IL) receptor, and erythropoietin receptor pathways.  Activated STATs are also expressed in lung cancer, but the biol. effects of JAK/STAT inhibition in this cancer are variable.  In lung cancer, STAT3 can be activated by multiple pathways, including EGFR.  Several approaches have been used to inhibit STAT3 in the hopes of developing an antitumor agent.  Although several STAT3-specific agents are promising, none are in clin. development, mostly because of drug delivery and stability issues.  In contrast, several JAK inhibitors are in clin. development.  These orally available, ATP-competitive, small-mol. kinase inhibitors are being tested in myeloproliferative disorders.  Future studies will det. whether JAK inhibitors are useful in the treatment of HNSCC or lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZgZHT6MxwX7Vg90H21EOLACvtfcHk0lgbAS8OllcSwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVSmur8%253D&md5=76183fde53da20b0a15bb4f000feb8f5</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.drup.2010.04.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drup.2010.04.001%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DS.%2BY.%26aulast%3DJohnson%26aufirst%3DF.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520the%2520JAK-STAT%2520pathway%2520in%2520head%2520and%2520neck%2520and%2520thoracic%2520malignancies%253A%2520Implications%2520for%2520future%2520therapeutic%2520approaches%26jtitle%3DDrug%2520Resist.%2520Updates%26date%3D2010%26volume%3D13%26spage%3D67%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Müller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperl, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">Discovery of chromone-based inhibitors of the transcription factor STAT5</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=723-727&author=J.+M%C3%BCllerauthor=B.+Sperlauthor=W.+Reindlauthor=A.+Kiesslingauthor=T.+Berg&title=Discovery+of+chromone-based+inhibitors+of+the+transcription+factor+STAT5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DJ.%26aulast%3DSperl%26aufirst%3DB.%26aulast%3DReindl%26aufirst%3DW.%26aulast%3DKiessling%26aufirst%3DA.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520chromone-based%2520inhibitors%2520of%2520the%2520transcription%2520factor%2520STAT5%26jtitle%3DChemBioChem%26date%3D2008%26volume%3D9%26spage%3D723%26epage%3D727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Page, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ball, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Signal transducer and activator of transcription 3 inhibitors: A patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1517%2F13543776.2011.539205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=21114420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFyktrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=65-83&author=B.+D.+Pageauthor=D.+P.+Ballauthor=P.+T.+Gunning&title=Signal+transducer+and+activator+of+transcription+3+inhibitors%3A+A+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transducer and activator of transcription 3 inhibitors: a patent review</span></div><div class="casAuthors">Page, Brent D. G.; Ball, Daniel P.; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-83</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Aberrant activation of signal transducer and activator of transcription (Stat) 3, a member of the STAT family of proteins, is prevalent in numerous human cancers and is now widely recognized as a crit. mol. abnormality and a master regulator of tumor processes.  Thus, the identification of potent and selective Stat3 inhibitors will have a high com. potential as anticancer drugs, given the many tumors in which Stat3 is implicated.  Areas covered in this review: This review covers the structures and activities of direct inhibitors of Stat3 protein activity described in the patent literature since the research field's inception in 2001.  The patents reviewed include peptide and peptidomimetic compds., small mols., oligonucleotides and platinum-based Stat3 inhibitors.  What the reader will gain: Readers will gain an understanding of how Stat3 protein function has been inhibited by a wide variety of structurally diverse therapeutic compds.  Readers will learn about which classes of patented Stat3 inhibitors are most advanced toward clin. trials, and will be exposed to the proposed mechanisms of inhibition and scope of their application in treating human cancers.  Take home message: Numerous groups have shown that in vivo administration of inhibitors of activated Stat3 induce human tumor regression in xenograft models.  Indeed, the growing no. of preclin. studies in numerous cancer types, as well as the first Phase 0 clin. trial of a Stat3 inhibitor, suggest that Stat3 is a valid and exciting therapeutic target for mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogO9J3Yw_G5bVg90H21EOLACvtfcHk0ljy5-Iyrs1MdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFyktrvJ&md5=338065a442a0de9993a90b1c25a5e084</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F13543776.2011.539205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2011.539205%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DB.%2BD.%26aulast%3DBall%26aufirst%3DD.%2BP.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DSignal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520inhibitors%253A%2520A%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2011%26volume%3D21%26spage%3D65%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewry, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahani, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, B. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein</span> <span class="citation_source-journal">Biochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">833</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1139%2FO09-044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=19935868" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVGjsrzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2009&pages=825-833&author=S.+Fletcherauthor=J.+A.+Drewryauthor=V.+M.+Shahaniauthor=B.+D.+G.+Pageauthor=P.+T.+Gunning&title=Molecular+disruption+of+oncogenic+signal+transducer+and+activator+of+transcription+3+%28STAT3%29+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein</span></div><div class="casAuthors">Fletcher, Steven; Drewry, Joel A.; Shahani, Vijay M.; Page, Brent D. G.; Gunning, Patrick T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">825-833</span>CODEN:
                <span class="NLM_cas:coden">BCBIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0829-8211</span>.
    
            (<span class="NLM_cas:orgname">National Research Council of Canada</span>)
        </div><div class="casAbstract">A review.  Signal transducer and activator of transcription protein 3 (STAT3) is a latent cytosolic transcription factor that is widely recognized as being a master regulator of the cellular functions that lead to the cancer phenotype.  Constitutively activated STAT3 protein activity is routinely obsd. in human cancers, promoting uncontrolled cell proliferation and suppressing apoptosis.  Until relatively recently, inhibition of STAT3 transcriptional activity was achieved indirectly via suppression of upstream kinase activators and extracellular cytokine and (or) growth factor stimuli.  However, activated STAT3 forms transcriptionally functional STAT3-STAT3 dimers, providing a valid juncture for targeted downstream mol. inhibition.  STAT3's prominent role in cancer has seen a decade of innovative and novel approaches to targeting constitutively active STAT3 protein-protein complexes.  This mini-review outlines the progress made towards identifying mol. agents capable of silencing aberrant STAT3 signaling through the disruption of STAT3 complexation events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu6ixTckciHLVg90H21EOLACvtfcHk0ljy5-Iyrs1MdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVGjsrzL&md5=fd14e8ec8d52605bfaac7e83dca75d21</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1139%2FO09-044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252FO09-044%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DDrewry%26aufirst%3DJ.%2BA.%26aulast%3DShahani%26aufirst%3DV.%2BM.%26aulast%3DPage%26aufirst%3DB.%2BD.%2BG.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DMolecular%2520disruption%2520of%2520oncogenic%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%2520%2528STAT3%2529%2520protein%26jtitle%3DBiochem.%2520Cell%2520Biol.%26date%3D2009%26volume%3D87%26spage%3D825%26epage%3D833" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Haftchenary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avadisian, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Inhibiting aberrant Stat3 function with molecular therapeutics: A progress report</span> <span class="citation_source-journal">Anticancer Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=115-127&author=S.+Haftchenaryauthor=M.+Avadisianauthor=P.+T.+Gunning&title=Inhibiting+aberrant+Stat3+function+with+molecular+therapeutics%3A+A+progress+report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHaftchenary%26aufirst%3DS.%26aulast%3DAvadisian%26aufirst%3DM.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DInhibiting%2520aberrant%2520Stat3%2520function%2520with%2520molecular%2520therapeutics%253A%2520A%2520progress%2520report%26jtitle%3DAnticancer%2520Drugs%26date%3D2011%26volume%3D22%26spage%3D115%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Neculai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neculai, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verrier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klumpp, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pfitzner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span> </span><span class="NLM_article-title">Structure of the unphosphorylated STAT5a dimer</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">40782</span><span class="NLM_x">–</span> <span class="NLM_lpage">40787</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=40782-40787&author=D.+Neculaiauthor=A.+M.+Neculaiauthor=S.+Verrierauthor=K.+Straubauthor=K.+Klumppauthor=E.+Pfitznerauthor=S.+Becker&title=Structure+of+the+unphosphorylated+STAT5a+dimer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeculai%26aufirst%3DD.%26aulast%3DNeculai%26aufirst%3DA.%2BM.%26aulast%3DVerrier%26aufirst%3DS.%26aulast%3DStraub%26aufirst%3DK.%26aulast%3DKlumpp%26aufirst%3DK.%26aulast%3DPfitzner%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%26atitle%3DStructure%2520of%2520the%2520unphosphorylated%2520STAT5a%2520dimer%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D40782%26epage%3D40787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Tan, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevalainen, M. T.</span><span> </span><span class="NLM_article-title">Signal transducer and activator of transcription 5A/B in prostate and breast cancers</span> <span class="citation_source-journal">Endocr. Relat. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">367</span><span class="NLM_x">–</span> <span class="NLM_lpage">390</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1677%2FERC-08-0013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=18508994" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXosVGjsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=367-390&author=S.+H.+Tanauthor=M.+T.+Nevalainen&title=Signal+transducer+and+activator+of+transcription+5A%2FB+in+prostate+and+breast+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Signal transducer and activator of transcription 5A/B in prostate and breast cancers</span></div><div class="casAuthors">Tan, Shyh-Han; Nevalainen, Marja T.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine-Related Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">367-390</span>CODEN:
                <span class="NLM_cas:coden">ERCAE9</span>;
        ISSN:<span class="NLM_cas:issn">1351-0088</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">A review.  Protein kinase signaling pathways, such as Janus kinase 2-Signal transducer and activator of transcription 5A/B (JAK2-STAT5A/B), are of significant interest in the search for new therapeutic strategies in both breast and prostate cancers.  In prostate cancer, the components of the JAK2-STAT5A/B signaling pathway provide mol. targets for small-mol. inhibition of survival and growth signals of the cells.  At the same time, new evidence suggests that the STAT5A/B signaling pathway is involved in the transition of organ-confined prostate cancer to hormone-refractory disease.  This implies that the active JAK2-STAT5A/B signaling pathway potentially provides the means for pharmacol. intervention of clin. prostate cancer progression.  In addn., active STAT5A/B may serve as a prognostic marker for identification of those primary prostate cancers that are likely to progress to aggressive disease.  In breast cancer, the role of STAT5A/B is more complex.  STAT5A/B may have a dual role in the regulation of malignant mammary epithelium.  Data accumulated from mouse models of breast cancer suggest that in early stages of breast cancer STAT5A/B may promote malignant transformation and enhance growth of the tumor.  This is in contrast to established breast cancer, where STAT5A/B may mediate the crit. cues for maintaining the differentiation of mammary epithelium.  In addn., present data suggest that activation of STAT5A/B in breast cancer predicts favorable clin. outcome.  The dual nature of STAT5A/B action in breast cancer makes the therapeutic use of STAT5 A/B more complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0kOyp-BAmKrVg90H21EOLACvtfcHk0lgldEhgXXc_gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXosVGjsrw%253D&md5=eff440bb054c1e33352e71a8b26b72e3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1677%2FERC-08-0013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252FERC-08-0013%26sid%3Dliteratum%253Aachs%26aulast%3DTan%26aufirst%3DS.%2BH.%26aulast%3DNevalainen%26aufirst%3DM.%2BT.%26atitle%3DSignal%2520transducer%2520and%2520activator%2520of%2520transcription%25205A%252FB%2520in%2520prostate%2520and%2520breast%2520cancers%26jtitle%3DEndocr.%2520Relat.%2520Cancer%26date%3D2008%26volume%3D15%26spage%3D367%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ferbeyre, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriggl, R.</span><span> </span><span class="NLM_article-title">The role of Stat5 transcription factors as tumor suppressors or oncogenes</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1815</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1815&publication_year=2011&pages=104-114&author=G.+Ferbeyreauthor=R.+Moriggl&title=The+role+of+Stat5+transcription+factors+as+tumor+suppressors+or+oncogenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerbeyre%26aufirst%3DG.%26aulast%3DMoriggl%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520Stat5%2520transcription%2520factors%2520as%2520tumor%2520suppressors%2520or%2520oncogenes%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2011%26volume%3D1815%26spage%3D104%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debierre-Grockiego, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capiod, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claisse, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delobel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prin, L.</span><span> </span><span class="NLM_article-title">Activated Stat related transcription factors in acute leukemia</span> <span class="citation_source-journal">Leuk. Lymphoma</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.3109%2F10428199709058334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=9498707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXis1arsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1997&pages=83-88&author=V.+Gouilleux-Gruartauthor=F.+Debierre-Grockiegoauthor=F.+Gouilleuxauthor=J.+C.+Capiodauthor=J.+F.+Claisseauthor=J.+Delobelauthor=L.+Prin&title=Activated+Stat+related+transcription+factors+in+acute+leukemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Activated Stat related transcription factors in acute leukemia</span></div><div class="casAuthors">Gouilleux-Gruart, Valerie; Debierre-Grockiego, Francoise; Gouilleux, Fabrice; Capiod, Jean-Claude; Claisse, Jean-Francois; Delobel, Jacques; Prin, Lionel</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia & Lymphoma</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1/2</span>),
    <span class="NLM_cas:pages">83-88</span>CODEN:
                <span class="NLM_cas:coden">LELYEA</span>;
        ISSN:<span class="NLM_cas:issn">1042-8194</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">A review with 48 refs.  Cell proliferation and differentiation are under the control of cytokines and growth factors.  Different signaling pathways are involved in the transmission of a specific signal through successive phosphorylation and dephosphorylation of proteins leading to gene transcription necessary for growth and differentiation.  The cytokines and growth factors activate the Stat family of transcription factors.  The Jak-Stat pathway is essential for cytokine signal transduction.  Dysregulation of this cascade might lead to uncontrolled hematopoiesis.  Studies have been carried out to examine the functionality of this pathway in cells from patients with acute leukemia.  Members of the Stat protein family (Stat1, Stat3 and Stat5) are constitutively activated in cells collected from some acute leukemias suggesting dysregulation of the Jak-Stat pathway.  Evidence of the existence of constitutively activated spliced variants of Stat3 and Stat5 proteins are described.  The mechanisms of such activation remain to be clarified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTIAQtiJJmd7Vg90H21EOLACvtfcHk0lgldEhgXXc_gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXis1arsLw%253D&md5=fcc96d3e8c66aadaeffd6855dc14a3b4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3109%2F10428199709058334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F10428199709058334%26sid%3Dliteratum%253Aachs%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DDebierre-Grockiego%26aufirst%3DF.%26aulast%3DGouilleux%26aufirst%3DF.%26aulast%3DCapiod%26aufirst%3DJ.%2BC.%26aulast%3DClaisse%26aufirst%3DJ.%2BF.%26aulast%3DDelobel%26aufirst%3DJ.%26aulast%3DPrin%26aufirst%3DL.%26atitle%3DActivated%2520Stat%2520related%2520transcription%2520factors%2520in%2520acute%2520leukemia%26jtitle%3DLeuk.%2520Lymphoma%26date%3D1997%26volume%3D28%26spage%3D83%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desaint, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claisse, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capiod, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delobel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber-Nordt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusanter-Fourt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dreyfus, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prin, L.</span><span> </span><span class="NLM_article-title">STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">1692</span><span class="NLM_x">–</span> <span class="NLM_lpage">1697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1996&pages=1692-1697&author=V.+Gouilleux-Gruartauthor=F.+Gouilleuxauthor=C.+Desaintauthor=J.+C.+Claisseauthor=J.+F.+Capiodauthor=J.+Delobelauthor=R.+Weber-Nordtauthor=I.+Dusanter-Fourtauthor=F.+Dreyfusauthor=B.+Gronerauthor=L.+Prin&title=STAT-related+transcription+factors+are+constitutively+activated+in+peripheral+blood+cells+from+acute+leukemia+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DGouilleux%26aufirst%3DF.%26aulast%3DDesaint%26aufirst%3DC.%26aulast%3DClaisse%26aufirst%3DJ.%2BC.%26aulast%3DCapiod%26aufirst%3DJ.%2BF.%26aulast%3DDelobel%26aufirst%3DJ.%26aulast%3DWeber-Nordt%26aufirst%3DR.%26aulast%3DDusanter-Fourt%26aufirst%3DI.%26aulast%3DDreyfus%26aufirst%3DF.%26aulast%3DGroner%26aufirst%3DB.%26aulast%3DPrin%26aufirst%3DL.%26atitle%3DSTAT-related%2520transcription%2520factors%2520are%2520constitutively%2520activated%2520in%2520peripheral%2520blood%2520cells%2520from%2520acute%2520leukemia%2520patients%26jtitle%3DBlood%26date%3D1996%26volume%3D87%26spage%3D1692%26epage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Weber-Nordt, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehinger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludwig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouilleux-Gruart, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mertelsmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finke, J.</span><span> </span><span class="NLM_article-title">Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">809</span><span class="NLM_x">–</span> <span class="NLM_lpage">816</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1996&pages=809-816&author=R.+M.+Weber-Nordtauthor=C.+Egenauthor=J.+Wehingerauthor=W.+Ludwigauthor=V.+Gouilleux-Gruartauthor=R.+Mertelsmannauthor=J.+Finke&title=Constitutive+activation+of+STAT+proteins+in+primary+lymphoid+and+myeloid+leukemia+cells+and+in+Epstein-Barr+virus+%28EBV%29-related+lymphoma+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeber-Nordt%26aufirst%3DR.%2BM.%26aulast%3DEgen%26aufirst%3DC.%26aulast%3DWehinger%26aufirst%3DJ.%26aulast%3DLudwig%26aufirst%3DW.%26aulast%3DGouilleux-Gruart%26aufirst%3DV.%26aulast%3DMertelsmann%26aufirst%3DR.%26aulast%3DFinke%26aufirst%3DJ.%26atitle%3DConstitutive%2520activation%2520of%2520STAT%2520proteins%2520in%2520primary%2520lymphoid%2520and%2520myeloid%2520leukemia%2520cells%2520and%2520in%2520Epstein-Barr%2520virus%2520%2528EBV%2529-related%2520lymphoma%2520cell%2520lines%26jtitle%3DBlood%26date%3D1996%26volume%3D88%26spage%3D809%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Pardanani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vannucchi, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passamonti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervantes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span> </span><span class="NLM_article-title">JAK inhibitor therapy for myelofibrosis: Critical assessment of value and limitations</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">225</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=218-225&author=A.+Pardananiauthor=A.+M.+Vannucchiauthor=F.+Passamontiauthor=F.+Cervantesauthor=T.+Barbuiauthor=A.+Tefferi&title=JAK+inhibitor+therapy+for+myelofibrosis%3A+Critical+assessment+of+value+and+limitations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPardanani%26aufirst%3DA.%26aulast%3DVannucchi%26aufirst%3DA.%2BM.%26aulast%3DPassamonti%26aufirst%3DF.%26aulast%3DCervantes%26aufirst%3DF.%26aulast%3DBarbui%26aufirst%3DT.%26aulast%3DTefferi%26aufirst%3DA.%26atitle%3DJAK%2520inhibitor%2520therapy%2520for%2520myelofibrosis%253A%2520Critical%2520assessment%2520of%2520value%2520and%2520limitations%26jtitle%3DLeukemia%26date%3D2011%26volume%3D25%26spage%3D218%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Quintás-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=127-140&author=A.+Quint%C3%A1s-Cardamaauthor=H.+Kantarjianauthor=J.+Cortesauthor=S.+Verstovsek&title=Janus+kinase+inhibitors+for+the+treatment+of+myeloproliferative+neoplasias+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuint%25C3%25A1s-Cardama%26aufirst%3DA.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasias%2520and%2520beyond%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Muller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">A high-throughput assay for signal transducer and activator of transcription 5b based on fluorescence polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2008&pages=249-254&author=J.+Mullerauthor=J.+Schustauthor=T.+Berg&title=A+high-throughput+assay+for+signal+transducer+and+activator+of+transcription+5b+based+on+fluorescence+polarization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DSchust%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DA%2520high-throughput%2520assay%2520for%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25205b%2520based%2520on%2520fluorescence%2520polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D375%26spage%3D249%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Siddiquee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaskovich, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greedy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">7391</span><span class="NLM_x">–</span> <span class="NLM_lpage">7396</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1073%2Fpnas.0609757104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=17463090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlslWqsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=7391-7396&author=K.+Siddiqueeauthor=S.+Zhangauthor=W.+C.+Guidaauthor=M.+A.+Blaskovichauthor=B.+Greedyauthor=H.+R.+Lawrenceauthor=M.+L.+R.+Yipauthor=R.+Joveauthor=M.+M.+McLaughlinauthor=N.+J.+Lawrenceauthor=S.+M.+Sebtiauthor=J.+Turkson&title=Selective+chemical+probe+inhibitor+of+Stat3%2C+identified+through+structure-based+virtual+screening%2C+induces+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Elective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity</span></div><div class="casAuthors">Siddiquee, Khandaker; Zhang, Shumin; Guida, Wayne C.; Blaskovich, Michelle A.; Greddy, Benjamin; Lawrence, Harshani R.; Yip, M. L. Richard; Jove, Richard; McLaughlin, Mark M.; Lawrence, Nicholas J.; Sebti, Said M.; Turkson, James</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7391-7396</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">531-201 (NSC 74859) is a chem. probe inhibitor of Stat3 activity, which was identified from the National Cancer Institute chem. libraries by using structure-based virtual screening with a computer model of the Stat3 SH2 domain bound to its Stat3 phosphotyrosine peptide derived from the x-ray crystal structure of the Stat3β homodimer.  S3I-201 inhibits Stat3 · Stat3 complex formation and Stat3 DNA-binding and transcriptional activities.  Furthermore, S3I-201 inhibits growth and induces apoptosis preferentially in tumor cells that contain persistently activated Stat3.  Constitutively dimerized and active Stat3C and Stat3 SH2 domain rescue tumor cells from S3I-201-induced apoptosis.  Finally, S3I-201 inhibits the expression of the Stat3-regulated genes encoding cyclin D1, Bcl-xL, and surviving and inhibits the growth of human breast tumors in vivo.  These findings strongly suggest that the antitumor activity of S3I-201 is mediated in part through inhibition of aberrant Stat3 activation and provide the proof-of-concept for the potential clin. use of Stat3 inhibitors such as S3I-201 in tumors harboring aberrant Stat3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAfmqUniFENbVg90H21EOLACvtfcHk0liGpqWjxv20pA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlslWqsbY%253D&md5=85decf56fc7852990f56c6f64165ad9d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0609757104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0609757104%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiquee%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DBlaskovich%26aufirst%3DM.%2BA.%26aulast%3DGreedy%26aufirst%3DB.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DYip%26aufirst%3DM.%2BL.%2BR.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DMcLaughlin%26aufirst%3DM.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DSelective%2520chemical%2520probe%2520inhibitor%2520of%2520Stat3%252C%2520identified%2520through%2520structure-based%2520virtual%2520screening%252C%2520induces%2520antitumor%2520activity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D7391%26epage%3D7396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, B. D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharmeen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shahani, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schimmer, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span> </span><span class="NLM_article-title">Disruption of transcriptionally active stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: Potent in vitro and tumor cell activities</span> <span class="citation_source-journal">ChemBioChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1959</span><span class="NLM_x">–</span> <span class="NLM_lpage">1964</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1959-1964&author=S.+Fletcherauthor=J.+Singhauthor=X.+Zhangauthor=P.+Yueauthor=B.+D.+G.+Pageauthor=S.+Sharmeenauthor=V.+M.+Shahaniauthor=W.+Zhaoauthor=A.+D.+Schimmerauthor=J.+Turksonauthor=P.+T.+Gunning&title=Disruption+of+transcriptionally+active+stat3+dimers+with+non-phosphorylated%2C+salicylic+acid-based+small+molecules%3A+Potent+in+vitro+and+tumor+cell+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DPage%26aufirst%3DB.%2BD.%2BG.%26aulast%3DSharmeen%26aufirst%3DS.%26aulast%3DShahani%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DSchimmer%26aufirst%3DA.%2BD.%26aulast%3DTurkson%26aufirst%3DJ.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26atitle%3DDisruption%2520of%2520transcriptionally%2520active%2520stat3%2520dimers%2520with%2520non-phosphorylated%252C%2520salicylic%2520acid-based%2520small%2520molecules%253A%2520Potent%2520in%2520vitro%2520and%2520tumor%2520cell%2520activities%26jtitle%3DChemBioChem%26date%3D2009%26volume%3D10%26spage%3D1959%26epage%3D1964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunning, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkson, J.</span><span> </span><span class="NLM_article-title">A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processes</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1409</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=1398-1409&author=X.+Zhangauthor=P.+Yueauthor=S.+Fletcherauthor=W.+Zhaoauthor=P.+T.+Gunningauthor=J.+Turkson&title=A+novel+small-molecule+disrupts+Stat3+SH2+domain-phosphotyrosine+interactions+and+Stat3-dependent+tumor+processes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYue%26aufirst%3DP.%26aulast%3DFletcher%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DGunning%26aufirst%3DP.%2BT.%26aulast%3DTurkson%26aufirst%3DJ.%26atitle%3DA%2520novel%2520small-molecule%2520disrupts%2520Stat3%2520SH2%2520domain-phosphotyrosine%2520interactions%2520and%2520Stat3-dependent%2520tumor%2520processes%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D1398%26epage%3D1409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasseur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, U.</span><span> </span><span class="NLM_article-title">A high-throughput STAT binding assay using fluorescence polarization</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">249</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=249&publication_year=1997&pages=29-36&author=P.+Wuauthor=M.+Brasseurauthor=U.+Schindler&title=A+high-throughput+STAT+binding+assay+using+fluorescence+polarization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DP.%26aulast%3DBrasseur%26aufirst%3DM.%26aulast%3DSchindler%26aufirst%3DU.%26atitle%3DA%2520high-throughput%2520STAT%2520binding%2520assay%2520using%2520fluorescence%2520polarization%26jtitle%3DAnal.%2520Biochem.%26date%3D1997%26volume%3D249%26spage%3D29%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Schust, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1016%2Fj.ab.2004.03.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=15183768" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslSjsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2004&pages=114-118&author=J.+Schustauthor=T.+Berg&title=A+high-throughput+fluorescence+polarization+assay+for+signal+transducer+and+activator+of+transcription+3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput fluorescence polarization assay for signal transducer and activator of transcription 3</span></div><div class="casAuthors">Schust, Jochen; Berg, Thorsten</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-118</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Signal transducer and activator of transcription 3 (STAT3) is overactive in a wide variety of human tumors.  Activity of STAT3 requires its own SH2-domain-mediated binding to phosphotyrosine-contg. sequences.  We have developed a high-throughput binding assay, based on fluorescence polarization, which allows screening for small mols. that bind to the STAT3 SH2 domain and thereby inhibit its activity.  The basis for this assay is the binding of a fluorescein-labeled phosphotyrosine-peptide derived from the interleukin-6 receptor subunit gp130 to unphosphorylated STAT3 with a Kd of 150 nM.  The assay is stable with regard to salt concn., DMSO concn., and time.  It has been adapted to a 384-well format, with a Z' value of 0.87, and can be used to screen for small mols. that bind to the STAT3 SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVl15diFUVYrVg90H21EOLACvtfcHk0ljEpq5AL2AHVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslSjsLc%253D&md5=12e81ff2254c87f281669b719af08ad5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.03.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.03.024%26sid%3Dliteratum%253Aachs%26aulast%3DSchust%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DA%2520high-throughput%2520fluorescence%2520polarization%2520assay%2520for%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%25203%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D330%26spage%3D114%26epage%3D118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Bromberg, J.</span><span> </span><span class="NLM_article-title">Stat proteins and oncogenesis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">1139</span><span class="NLM_x">–</span> <span class="NLM_lpage">1142</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=1139-1142&author=J.+Bromberg&title=Stat+proteins+and+oncogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromberg%26aufirst%3DJ.%26atitle%3DStat%2520proteins%2520and%2520oncogenesis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2002%26volume%3D109%26spage%3D1139%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willett, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R.</span><span> </span><span class="NLM_article-title">Development and validation of a genetic algorithm for flexible docking</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">748</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1006%2Fjmbi.1996.0897" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=9126849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1997&pages=727-748&author=G.+Jonesauthor=P.+Willettauthor=R.+C.+Glenauthor=A.+R.+Leachauthor=R.+Taylor&title=Development+and+validation+of+a+genetic+algorithm+for+flexible+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a genetic algorithm for flexible docking</span></div><div class="casAuthors">Jones, Gareth; Willett, Peter; Glen, Robert C.; Leach, Andrew R.; Taylor, Robin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">727-748</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">Prediction of small mol. binding modes to macromols. of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem).  We report the development and validation of the program GOLD (Genetic Optimization for Ligand Docking).  GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding.  Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm.  The advanced algorithm has been tested on a dataset of 100 complexes extd. from the Brookhaven Protein Data Bank.  When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the exptl. binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP3I60Rl2uorVg90H21EOLACvtfcHk0ljEpq5AL2AHVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXis1KntLo%253D&md5=476a2b1d8f80f3ba418052fe29d735ca</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1006%2Fjmbi.1996.0897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fjmbi.1996.0897%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DG.%26aulast%3DWillett%26aufirst%3DP.%26aulast%3DGlen%26aufirst%3DR.%2BC.%26aulast%3DLeach%26aufirst%3DA.%2BR.%26aulast%3DTaylor%26aufirst%3DR.%26atitle%3DDevelopment%2520and%2520validation%2520of%2520a%2520genetic%2520algorithm%2520for%2520flexible%2520docking%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1997%26volume%3D267%26spage%3D727%26epage%3D748" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Quentmeier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaborski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, H. G.</span><span> </span><span class="NLM_article-title">FLT3 mutations in acute myeloid leukemia cell lines</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=120-124&author=H.+Quentmeierauthor=J.+Reinhardtauthor=M.+Zaborskiauthor=H.+G.+Drexler&title=FLT3+mutations+in+acute+myeloid+leukemia+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuentmeier%26aufirst%3DH.%26aulast%3DReinhardt%26aufirst%3DJ.%26aulast%3DZaborski%26aufirst%3DM.%26aulast%3DDrexler%26aufirst%3DH.%2BG.%26atitle%3DFLT3%2520mutations%2520in%2520acute%2520myeloid%2520leukemia%2520cell%2520lines%26jtitle%3DLeukemia%26date%3D2003%26volume%3D17%26spage%3D120%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">De Groot, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raaijmakers, J. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammers, J. -. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koenderman, L.</span><span> </span><span class="NLM_article-title">STAT5 activation by Bcr-Abl contributes to transformation of K562 leukemia cells</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1108</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1999&pages=1108-1112&author=R.+P.+De+Grootauthor=J.+A.+M.+Raaijmakersauthor=J.+-.+J.+Lammersauthor=R.+Joveauthor=L.+Koenderman&title=STAT5+activation+by+Bcr-Abl+contributes+to+transformation+of+K562+leukemia+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGroot%26aufirst%3DR.%2BP.%26aulast%3DRaaijmakers%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DLammers%26aufirst%3DJ.%2B-.%2BJ.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DKoenderman%26aufirst%3DL.%26atitle%3DSTAT5%2520activation%2520by%2520Bcr-Abl%2520contributes%2520to%2520transformation%2520of%2520K562%2520leukemia%2520cells%26jtitle%3DBlood%26date%3D1999%26volume%3D94%26spage%3D1108%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Meinke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barahmand-Pour, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohrl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoiber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, T.</span><span> </span><span class="NLM_article-title">Activation of different Stat5 isoforms contributes to cell-type- restricted signaling in response to interferons</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">6937</span><span class="NLM_x">–</span> <span class="NLM_lpage">6944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm200720n&amp;key=10.1128%2FMCB.16.12.6937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm200720n&amp;key=8943349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm200720n&amp;key=1%3ACAS%3A528%3ADyaK28XntVyksrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=6937-6944&author=A.+Meinkeauthor=F.+Barahmand-Pourauthor=S.+Wohrlauthor=D.+Stoiberauthor=T.+Decker&title=Activation+of+different+Stat5+isoforms+contributes+to+cell-type-+restricted+signaling+in+response+to+interferons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons</span></div><div class="casAuthors">Meinke, Andreas; Barahmand-Pour, Fariba; Woehrl, Stefan; Stoiber, Dagmar</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6937-6944</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Tyrosine phosphorylation and activation of the transcription factor Stat5 occur in response to stimuli like granulocyte-macrophage colony-stimulating factor, interleukin-3, or erythropoietin that stimulate both proliferation and differentiation of hematopoietic cells.  It is unclear whether Stat5 is part of a proliferative response or part of the events leading to cellular differentiation.  Here the authors report that agents promoting differentiation but not proliferation of hematopoietic cells, like phorbol ester or both types of interferons (IFNs), activate Stat5 in promonocytic U937 cells.  Both IFN types caused tyrosine phosphorylation and DNA binding of predominantly one Stat5 isoform (Stat5a) despite expression of both Stat5a and Stat5b proteins.  Monocytic differentiation of U937 cells led to a strong decrease in IFN-γ-mediated activation of Stat5 but not of Stat1.  Transactivation of Stat5-target genes occurred in response to IFN-γ, which activates both Stat5 and Stat1, but not in response to granulocyte-macrophage colony-stimulating factor, which activates only Stat5.  Tyrosine phosphorylation of Stat5 is not generally part of the IFN response.  IFN-γ did not cause Stat5 activation in HeLa cells, despite the expression of both Stat5 isoforms at similar levels.  By contrast, IFN-α caused tyrosine phosphorylation and DNA binding of exclusively the b isoform of Stat5, and activated Stat5b formed a DNA binding activity previously found in HeLa cells and designated IFN-α activation factor 2.  Taken together, the results demonstrate that ligand binding of IFN receptors leads to an isoform-specific activation of Stat5 in a restricted no. of cell lineages.  Moreover, they suggest that Stat5 might be part of the differentiation response of myeloid cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTnLtFVEeWD7Vg90H21EOLACvtfcHk0lgLzu1Bpy3vTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XntVyksrY%253D&md5=9a6c436d8c8bd93fb2559974e80f8005</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.12.6937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.12.6937%26sid%3Dliteratum%253Aachs%26aulast%3DMeinke%26aufirst%3DA.%26aulast%3DBarahmand-Pour%26aufirst%3DF.%26aulast%3DWohrl%26aufirst%3DS.%26aulast%3DStoiber%26aufirst%3DD.%26aulast%3DDecker%26aufirst%3DT.%26atitle%3DActivation%2520of%2520different%2520Stat5%2520isoforms%2520contributes%2520to%2520cell-type-%2520restricted%2520signaling%2520in%2520response%2520to%2520interferons%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D6937%26epage%3D6944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Atsushi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroshi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, H.</span><span> </span><span class="NLM_article-title">Calpain is a signal transducer and activator of transcription (STAT)3 and Stat5 protease</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">1850</span><span class="NLM_x">–</span> <span class="NLM_lpage">1852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=1850-1852&author=O.+Atsushiauthor=W.+Hiroshiauthor=H.+Fujita&title=Calpain+is+a+signal+transducer+and+activator+of+transcription+%28STAT%293+and+Stat5+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtsushi%26aufirst%3DO.%26aulast%3DHiroshi%26aufirst%3DW.%26aulast%3DFujita%26aufirst%3DH.%26atitle%3DCalpain%2520is%2520a%2520signal%2520transducer%2520and%2520activator%2520of%2520transcription%2520%2528STAT%25293%2520and%2520Stat5%2520protease%26jtitle%3DBlood%26date%3D2002%26volume%3D99%26spage%3D1850%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Yoshimoto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jabbarzadeh-Tabrizi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rocnik, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikushige, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takenaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagafuji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niiro, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akashi, K.</span><span> </span><span class="NLM_article-title">FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">5034</span><span class="NLM_x">–</span> <span class="NLM_lpage">5043</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=5034-5043&author=G.+Yoshimotoauthor=T.+Miyamotoauthor=S.+Jabbarzadeh-Tabriziauthor=T.+Iinoauthor=J.+L.+Rocnikauthor=Y.+Kikushigeauthor=Y.+Moriauthor=T.+Shimaauthor=H.+Iwasakiauthor=K.+Takenakaauthor=K.+Nagafujiauthor=S.+Mizunoauthor=H.+Niiroauthor=G.+D.+Gillilandauthor=K.+Akashi&title=FLT3-ITD+up-regulates+MCL-1+to+promote+survival+of+stem+cells+in+acute+myeloid+leukemia+via+FLT3-ITD-specific+STAT5+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshimoto%26aufirst%3DG.%26aulast%3DMiyamoto%26aufirst%3DT.%26aulast%3DJabbarzadeh-Tabrizi%26aufirst%3DS.%26aulast%3DIino%26aufirst%3DT.%26aulast%3DRocnik%26aufirst%3DJ.%2BL.%26aulast%3DKikushige%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DY.%26aulast%3DShima%26aufirst%3DT.%26aulast%3DIwasaki%26aufirst%3DH.%26aulast%3DTakenaka%26aufirst%3DK.%26aulast%3DNagafuji%26aufirst%3DK.%26aulast%3DMizuno%26aufirst%3DS.%26aulast%3DNiiro%26aufirst%3DH.%26aulast%3DGilliland%26aufirst%3DG.%2BD.%26aulast%3DAkashi%26aufirst%3DK.%26atitle%3DFLT3-ITD%2520up-regulates%2520MCL-1%2520to%2520promote%2520survival%2520of%2520stem%2520cells%2520in%2520acute%2520myeloid%2520leukemia%2520via%2520FLT3-ITD-specific%2520STAT5%2520activation%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D5034%26epage%3D5043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1Y1U','PDB','1Y1U'); return false;">PDB: 1Y1U</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i27"><a href="/doi/suppl/10.1021/jm200720n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23167"></div></div></div></div></div><hr /></hr><p class="last">Chemical methods; selected FP binding data; cell culture, treatment and viability testing; annexin V/PI assay; determining the inhibition of intracellular Stat5, Stat3, and Stat1 phosphorylation; real-time RT-CR; chromatin immunoprecipitation (ChIP); effect of BP-1-108 on Stat5 by electrophoretic mobility shift assay (EMSA); sequences of primers used in quantitative real-time RT-PCR; and sequences of primers used in promoter regions amplification post ChIP. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm200720n/suppl_file/jm200720n_si_001.pdf">jm200720n_si_001.pdf (532.98 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm200720n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-3%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm200720n" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm200720n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e0af27fbc2d956","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
